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List of abbreviations 
 
A7R5 rat aortic smooth muscle cell line 
ACTC1 cardiac alpha actin 
ANF atrial natriuretic factor 
ATP2A2 ATPase, Ca2+ transporting 2 (cardiac form) 
bHLH basic helix-loop-helix 
BNP brain type natriuretic peptide  
C2C12 mouse skeletal myoblast cell line 
CHCHD10 coiled-coil-helix-coiled-coil-helix domain containing 10 
CNS conserved non-coding sequence  
COX cytochrome-c-oxidase 
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DBTSS Database of transcription start sites 
DNA deoxyribonucleic acid 
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FZD frizzled homolog (Drosophila) 
GATA4 GATA binding protein 4 
GATA6 GATA binding protein 6 
GBAS glioblastoma amplified sequence 
HDAC histone deacetylase 
HOX homeodomain / homeobox 
HSPB7 heat shock 27 kDa protein family member 7 
kb kilo bases 
LOXL1 lysyl oxidase-like 1  
MEF2 myocyte enhancing factor 2 
MYBPC1 myosin binding protein C, slow type 
MYH6 myosin heavy chain 6 / alpha myosin heavy chain 
MYL2 myosin light chain 2  
MYL3 myosin light chain 3 
MYL7 myosin light chain 7 
MYOCD myocardin 
MyoD myogenic differentiation factor 
MYOG myogenin 
NKE NKX2-5 response elements 
NKX2-5 NK2 transcription factor related, locus 5 (Drosophila) 
NPPA natriuretic peptide precursor, atria type 
NPPB natriuretic peptide precursor, brain type  
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NRVCM neonatal rat ventricular cardiomyocyte 
PWM positional weight matrix 
RNApolII RNA polymerase II 
RT-QPCR reverse transcription-quantitive polymerase chain reaction 
SP1 SP1 transcription factor / specificity protein 1 
SRE serum response element  
SRF serum Response Factor 
SURF1 surfeit 1 
TBX5 T-box 5 
TCAP telethonin/ titin capping protein 
TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box) 
TF transcription factor 
TFBS transcription factor binding site 
TIC transcription initiation complex 
TSS transcription start site 
WNT wingless-type MMTV integration site family 
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Introduction 
The human body requires a continuous flow of blood for it to 
function. Blood supplies the tissues with nutrients and oxygen and 
carries of waste products for disposal. The force required for 
transporting blood throughout the body is provided by the continuous 
contractions of the heart. It is overt that disturbances in the function of 
this vital organ can be disastrous. Decreased heart function can lead to 
impairments in the function of other organ systems and can eventually 
become life threatening. 
 
 
 
 
Figure 1. Transcription.  
In the nucleus, an mRNA sequence is synthesized based on the genetic code on 
one of the DNA strands. After transcription, the mRNA is transported to the 
cytoplasm where the mRNA-sequence is translated into a peptide. This peptide 
will undergo further processing into its final protein form. 
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Like any other organ, a healthy functioning heart relies on a tight 
regulation of the proteome; the integral set of proteins present at any 
given time and place. The spatial and temporal composition of the 
proteome is greatly dependent on the composition of the transcriptome, 
the set of messenger RNA (mRNA) molecules that serve as the template 
for the synthesis of proteins (translation) (figure 1). A key mechanism in 
governing the transcriptome is controlling the activation of 
transcription, the process in which the enzyme RNA-polymerase 
synthesizes the mRNA intermediate based on its DNA template. 
Transcription, interplay between DNA and proteins 
Initiation of transcription is the result of a highly complex and tightly 
regulated interplay between specific sequences located within the DNA 
and regulatory proteins called transcription factors (TFs). TFs can act 
via direct binding to the DNA and/or as co-factor by interacting with 
other TFs. The DNA-binding factors bind to specific regulatory 
sequences in the DNA, the transcription factor binding sites (TFBs). 
Most of the regulatory sequences are believed to be located within 
regions 5’ of the genes’ coding sequences. For a TF to exert its activity, it 
usually has to act in concert with others. As a result, co-operating TFBs 
typically occur together in modules. The DNA-region containing the 
sequences involved in the transcriptional regulation of a gene is called 
the promoter (figure 2A). By varying the modular arrangements of 
TFBs, promoters are formed which are unique for each gene. 
Protein-protein and DNA-protein interactions act together in 
eventually assembling transcription initiating complexes at the specific 
transcription start sites of genes. To enable the formation of these 
complexes, some proteins may contribute by opening up the chromatin 
structures and/or assist in bending the DNA so that co-operating 
regulatory sequences are brought into close proximity of one another 
(see figure 2B).[1, 2] In cell-free systems, RNA-polymerase only requires 
a small set of often ubiquitously expressed transcription factors, such as 
the TATA-box binding protein, to initiate transcription at basal levels.[3] 
The promoter region targeted by this set of factors is the core promoter. 
However, for higher levels of transcription and a spatial and temporal 
specific transcription, additional factors are required.[4] Which TFs 
interact with the DNA depends on the availability of TFs within the 
nucleus of a given cell at a given time and on which TFBs are available 
on the DNA.  
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The composition of the complete set of factors involved is highly 
dynamic. In response to any kind of signal, proteins with a TF-function 
can become differentially regulated and transmit the signal to the 
nucleus, resulting in alterations in the transcriptome. 
 
 
 
Figure 2. Promoter structure. 
Top panel (A) shows a gene (transcription unit) with its 5’ proximal promoter. 
Binding sites in the DNA for transcription factors are indicated as vertical bars. 
The transcription start site is indicated with the bend arrow. In the bottom 
panel (B) is depicted how transcription factors bind to the DNA and interact. 
DNA is made accessible through the actions of chromatin remodeling proteins, 
other transcription activating factors (TAFs) form complexes that lead to the 
activation of the RNA-polymerase II.  
Figure adapted from: Wray et al.[5] © 2003 by the Society for Molecular 
Biology and Evolution. MBE Online: http://www.mbe.oxfordjournals.org/  
Identifying regulatory elements 
At the onset of our studies, no prior studies had been undertaken to 
investigate the transcriptional regulation of cardiac-specific genes as a 
group. Only for a few it was known which elements within their 
promoter brought about their individual tissue-specific expression 
profile.[6-10] Instead of focusing on only a single gene, we set out to 
investigate whether the cardiac-specific genes as a group shared a 
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common set of cis-regulatory elements, that eventually led to restricting 
transcription (and thus the final expression) of genes to the heart. 
The identification of individual functionally relevant regulatory 
elements within a single promoter can be a daunting task. A separate 
laboratory experiment would be required to determine the role of each 
and every regulatory element. Since such individualistic screening is not 
feasible for large scale studies, other approaches are required. Genes 
expressed at the same time and place are prone to recruit a shared set of 
TFs. Their co-expression is thus also likely to result from the presence of 
similar regulatory elements within their promoters. In addition, it has 
also been found that the regulatory mechanisms of transcription of 
many genes, including cardiac genes, are often conserved for the 
orthologues genes across species.[8, 10, 11] Based on this principle, 
numerous bioinformatics programs have been developed to identify 
which regulatory elements are enriched within the promoters of a set of 
co-expressed genes when compared to a background set.[12] In this 
way lists can be generated of motifs and or modules most likely to be 
involved in the transcriptional response of interest. The labor-intensive 
and more costly laboratory studies can then be specifically targeted to 
the validation of the computer derived (in sillico) results (see figure 3). 
Models for research of cardiac transcription 
Cardiac research benefits from the fact that the heart or a similar 
organ is present in all higher organisms. From Drosophila to vertebrates 
there is a strong conservation in the mechanisms driving 
cardiogenesis.[13, 14] Since there is no ‘simple’ human model system to 
study transcription regulation in ventricular cardiomyocytes, studies in 
this field are typically performed using primary cell cultures of rat or 
mice cardiomyocytes. Like humans, also muridae have hearts consisting 
of separate atria and ventricles. As with the use of any model there are 
some restraints in the translation of the results from the model to for 
example the human situation. Despite the many similarities also some 
key differences exist. One of the most striking ones besides size is 
probably the rate of contraction. Where the number of beats per minute 
for the human heart is around 70, the heart rate of rat or mice can reach 
over 500.  
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Figure 3. Flow diagram for the identification and validation of regulatory 
promoter motifs. 
Genes expressed at the same time and place are prone to recruit a shared set of 
TFs. Their co-expression is thus also likely to result from the presence of 
similar regulatory elements within their promoters. Identifying such shared 
promoter elements can assist in identifying which regulatory mechanisms are 
involved in establishing a specific gene expression-profile under a given set of 
conditions.  
 
 
In the absence of electrical pulsing, the functionality of 
cardiomyocytes in culture rapidly diminishes.[15] Applying electrical 
pulsing has been found to conserve the contractile activity by triggering 
calcium sparks.[16, 17] Additional studies showed that by applying 
electrical stimulation, the expression of several cardiac-specific genes is 
increased and the ultra-structures of the cardiomyocytes are maintained 
while these would be lost otherwise.[18, 19] Despite the apparent 
relevance of electric signals for cardiomyocytes, no study has been 
published that describes the effects of electric pulsing on the whole 
cardiomyocyte transcriptome. Furthermore, there also remains the 
question of to what extent the changes in transcription observed for the 
individual genes were the result of the electric stimuli or their 
consequential contractions. To fully understand the role of electrical 
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signaling it is therefore important to establish whether genes respond 
differently to electrical stimuli and contractions. 
 
Predicting gene function using transcriptomics data 
Alongside gene expression data on targets of interest, experiments 
with expression micro-arrays also produce data on the thousands of 
other genes, including some that have remained poorly annotated. 
These transcriptomics data can also be used to predict the functional 
role of genes lacking functional annotation. This is done based on the 
hypothesis that genes which are functionally related are subject to 
shared transcriptional regulatory mechanisms. For example, Walker and 
colleagues identified eight ‘new’ genes involved in prostate cancer based 
on their profiles of co-expression with known ‘prostate cancer related 
genes.[20] Expression profile analyses can thus provide valuable new 
insights in the possible functional role of genes. 
Aims of the study 
Many questions still remained on various aspects of the cardiac 
transcriptome. In our studies we addressed the following. First, to what 
level does the cardiac muscle-specific gene expression program overlap 
with the programs of the other muscle tissues, and to what extent is it 
unique to the heart? Is there a common transcription regulatory 
program that lays at the basis of restricting the expression of genes to 
the cardiac muscle? Second, what is the effect of electrical stimuli at the 
level of the transcriptome? Which genes and associated processes are 
hereby affected? Third, is there, analogous to the stretch specific 
program, also an electrical-pulsing specific response and if so, which 
factors are involved?[21] 
Transcriptomics data can also be used to predict gene functions. 
Several genes with a heart-enriched expression profile are still awaiting 
their functional annotation. This brings about the fourth question; can 
we utilize the often ample available expression data to identify the 
functional roles of these genes?  
Besides investigating these questions we also aimed at the 
identification of promoters of genes for which these had not been 
identified yet. By determining the promoters of individual genes active 
in one or more of the various types of muscle, we generate the tools that 
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can be used in experiments to validate the findings from the genome-
wide studies.  
 
Outline of the dissertation 
In chapter 2 an overview is presented of the transcription factors 
involved in the activation of cardiac-specific genes and of the regulatory 
networks in which they exert their function. 
In our studies we made extensive use of bioinformatics, however, 
some sort of experimental validation is eventually required to validate 
the results obtained. Furthermore, the set of cardiac genes for which the 
promoters had been described was fairly limited. Therefore we created 
a number of luciferase-reporter constructs based on human promoter 
sequences (chapter 3). These constructs enabled us to test tissue 
specificity of promoter constructs and the relevance of motifs identified 
in the bioinformatics analyses. Where other studies often only reported 
which promoter fragments of cardiac genes were sufficient for driving 
expression in cardiomyocytes, we investigated in addition also the 
degree of tissue specificity. 
To investigate the effects of electrical pulsing on cardiomyocyte 
transcription we developed a system in which we were able to culture 
cardiomyocytes for longer periods while continuously subjecting them 
to electrical stimulation. This system and the associating culture 
protocol were described in chapter 4. 
In order to identify the effects of electrical pulsing on the 
cardiomyocyte transcriptome on a genome-wide scale, we performed a 
comprehensive microarray study, presented in chapter 5. Besides 
identifying which genes are differentially expressed as a result of 
electric pulsing, we also distinguished in our study whether differential 
expression was resulting from the electrical pulsing on itself apart from 
the evoked contractions. 
In chapter 6 we described how bioinformatics analyses were 
employed to identify which regulatory elements are responsible for 
restricting the expression of genes to the heart. In addition, it presents 
potential candidate motifs responsible for the eventually link up of the 
electrical signals with the transcription machinery. 
TCF7L2 which was identified in chapter 6 as a modulator of the 
transcriptional response to electrical pulsing, is a well known target of 
β-catenin signaling.[22] In chapter 7, we reported on how we further 
investigated the relation of this signaling pathway with that activated by 
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electrical pulsing, and also on the possibility to manipulate these 
mechanisms by using pharmacological compounds. 
As an example of how gene-expression data can be employed to 
identify the functional role of a gene, we used the approach of guilt by 
association to elucidate the function of a mitochondrial gene with a 
heart-enriched expression profile (chapter 8).  
Finally, Chapter 9 provides an overall discussion of the research 
presented in this dissertation. 
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Abstract 
Constituting one of the three muscle types in the human body, 
cardiomyocytes share many similarities with the other muscles but at 
the same time display several unique features. The unique properties 
are obtained through the activity of several genes of which the 
expression is highly enriched in or even completely limited to only the 
cardiomyocytes. At the basis of the tissue-specific expression of these 
genes lays an intricate network of transcription factors which in part is 
shared with the skeletal and smooth muscle cells and in addition 
involves several key factors that to a large extend are restricted to 
cardiomyocytes. While most overviews are primarily focused on the 
actions of individual transcription factors here, we deliberate on 
interactions amongst the collective of transcriptional initiators, inducers 
and inhibitors involved in regulating the cardiac expression at the 
transcription level, taking into account the different levels of tissue 
specificity and the possible modes of action of the factors involved. The 
picture that emerges is that of a core network with MEF2 at its center. 
Together with key cardiac-enriched players like GATA4/6, NKX2-5, 
HAND2 and more ubiquitous factors like SRF and additional factors it 
controls the regulation of many of the heart-specific genes. Additional 
activators and a variety of inhibitors provide further fine tuning of 
transcription and together form the eventual regulatory machinery that 
gives rise to the formation of the complex organ that is the heart. 
Introduction 
The human body contains three different highly specialized types of 
muscle: cardiac, skeletal and smooth muscle performing their function 
at different locations, controlled by distinctive mechanisms. Smooth 
muscle enables the contraction of blood vessels, the gastro-intestinal 
tract and organs like the bladder and uterus. Its relatively slow 
contractions are controlled by the autonomous nervous system in 
contrast to the fast contractions of skeletal muscles that are controlled 
by the somatic nervous system and the continuous rhythmic 
contractions of the heart muscle initiated upon signals originating in the 
sinus node. The differences in contractile characteristics require 
adaptations in the architecture of the contractile apparatus, metabolism 
and other elements involved such as ion channels within and in between 
the cells. Thus apart from all being types of muscle and consequentially 
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sharing many similarities, the gene expression programs of the muscles 
also have very distinctive features. 
In this review we explore the regulatory mechanisms at the 
transcription level that lead to the restriction of gene expression within 
cardiomyocytes, the heart’s unique muscle cells. Only for a small 
number of genes expressed in cardiomyocytes is known which 
regulatory sequences confer the restriction of their expression to this 
specific cell type. Numerous articles elaborate on specific transcription 
factors (TFs) and their role in a particular promoter of a cardiac gene. 
Concise overviews, however, of the bigger regulatory networks in which 
these factors are involved are very limited, especially the mechanisms of 
how these networks of interacting proteins lead to the tissue-specific 
transcription activation. Here we provide an integral overview of the 
transcription regulatory networks leading to cardiomyocyte specific 
expression of various genes. 
From general to cardiac-specific transcription 
Regulating transcription is one of the key control mechanisms in the 
process of gene expression. Most protein encoding genes depend for 
their transcription on the activation of RNA polymerase II 
(RNApolII).[1] In association with several fairly ubiquitous expressed 
factors, RNApolII is capable of driving transcription at low (basal) levels 
in cell-free systems.[2] Because of some functional redundancy there 
exist quite some variation amongst promoters in which of these core-
factors are employed.[3] Some of these factors are required to bind to 
specific DNA sequences within the DNA, the so-called core-promoter 
elements such as: TATA-box, Initiator (Inr) and downstream promoter 
element (DPE).[4, 5] To obtain expression levels above that of the basal 
expression additional, often more gene-specific TFs, are required.[6] 
These gene-specific TFs are shared by multiple genes with a similar 
promoter structure. As a result the DNA of the activated genes is 
relocated to specific sites within the nucleus where they become 
transcribed within close proximity of one another: the transcription 
factories.[7] Also active RNApolII readily resides at high concentrations 
in a hyper-phosphorylated form at transcription factories and the 
factories are maintained even in absence of transcription.[8, 9]  
Just like many other proteins also the expression of TF-encoding 
genes, especially the gene-specific, occurs in a spatial and temporal 
specific manner. Enrichment of gene expression in a tissue can be 
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scored through calculating entropy whereby the expression in one 
tissue is compared to that in a set of other tissues. To determine the 
enrichment of all transcription factors within the heart we determined 
their Shanon entropy values as described by Schug et al..[10] For the 
calculations we made use of an extensive publicly accessible dataset 
from the Neurocrine corporation that contains expression data over 65 
different human tissues.[11] All TFs were selected based on being 
annotated with the gene ontology (GO) term of ‘transcription factor 
activity’. The entropy for genes in heart ventricle and atria were 
determined separately since although both being an primary component 
of the heart, the structures are very different from one another and 
some transcription factors display a strong specificity for one of the two.  
In table 1 we present the twenty most ventricle-specific transcription 
factors and in addition indicated their ranking in atria. It can be seen 
clearly that several factors such as GATA4 and GATA6 exhibit somewhat 
similar tissue specificity for ventricle and atria while others, HEY2 
(hairy/enhancer-of-split-related with YRPW motif 2) in particular, seem 
to be highly specific for ventricle. Furthermore it becomes apparent that 
some isoforms encoded by the same gene, e.g. TBX5 (T-box 5), display 
different degrees of tissue specificity for ventricle and atria. In figure 1 
we present a graphical display of a selection of TFs present within 1 kb 
of the proximal promoter of cardiac and non-cardiac genes. In addition, 
we calculated for each gene the Shanon entropy values for cardiac 
ventricle, skeletal muscle and the cerebellum. Indeed the proximal 
promoters of the cardiac genes are enriched with binding sites for TFs 
like NKX2-5 and GATA. However, more noticeable is the abundance of 
SP1, SRF and MEF2. Although none of them ranks amongst the top 
cardiac-specific TFs, they do play a pivotal role in determining cardiac 
specificity by recruiting more cardiac-specific (co-) factors. Studies on 
the mechanisms of regulating cardiac genes were often focused on 
either NPPA, encoding the precursor peptide of atrial natriuretic factor 
(ANF) or cardiac alpha actin (ACTC1).[12, 13] In the following sections 
we elucidate on their regulation and the interactions of the TFs 
involved. A graphical representation of all mentioned interactions 
between TFs is given in figure 2. 
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Table 1. Ranking of transcription factors according to tissue specificity in 
adult heart ventricle and atrium 
 
Rank 
ventricle  
Rank 
atrium 
HGNC
ID Gene Title 
1 1 Gata6 GATA binding protein 6
2 4 Gata4 GATA binding protein 4
3 7 Nkx2-5 NK2 transcription factor related, locus 5 
(Drosophila) 
4 6 MYOCD myocardin
5 1071 Hey2 hairy/enhancer-of-split-related with YRPW motif 2 
6 38 Sox7 SRY (sex determining region Y)-box 7
7 2 TBX5 T-box 5
8 51 UHRF1 ubiquitin-like with PHD and ring finger domains 1 
9 26 CSDA cold shock domain protein A
10 22 Mitf microphthalmia-associated transcription factor 
11 78 Sox7 SRY (sex determining region Y)-box 7
12 63 Mitf microphthalmia-associated transcription factor 
13 113 Hand1 heart and neural crest derivatives expressed 1 
14 30 Heyl hairy/enhancer-of-split related with YRPW motif-1 
15 73 ace2 angiotensin I converting enzyme 
16 36 Epas1 endothelial PAS domain protein 1
17 53 Nr4a2 nuclear receptor subfamily 4, group A, member 2 
18 5 TBX5 T-box 5
19 18 MSRB2 methionine sulfoxide reductase B2
20 27 Mef2a Myocyte enhancer factor 2a
Genes are ranked by increasing Shanon entropy values calculated from average 
gene-expression in the dataset of Roth et al.(2006) encompassing 353 samples 
from 65 tissues. 
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Figure 2. Overview of regulatory networks between transcription factors. 
Each line represents direct interaction between two transcription factors, 
additional factors that may be required for the interactions are not indicated. 
Associations given as continuous lines lead to activation of target genes, dotted 
lines indicate repressor activity by factor with inhibitory function (black 
boxes). Nkx2-5 can replace YY1 at target sequences, thereby removing YY1’s 
inhibitory activity (dashed line). Names of factors highly enriched in 
cardiomyocytes are underlined. 
 
Regulation of the NPPA promoter 
Although the name might suggest otherwise, NPPA expression is not 
restricted to the atria, but also occurs in the heart ventricles, lungs, liver 
and pituitary gland.[14] The proximal promoter fragment of 700 bp 
appears to be sufficient for driving cardiac expression of NPPA (see 
figure 3).[15]  
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NKX2-5 
In the NPPA promoter a key role is played by the cardiac-enriched 
transcription factor NKX2-5 the vertebrate homologue of the Drosophila 
Tinman (Tin) which is crucial for cardiogenesis.[16] Its expression 
precedes that of the cardiac-specific genes alpha myosin heavy chain 
(MYH6), NPPA and ACTC1.[16-18] In vertebrates NKX2-5 is expressed 
during all the stages of life, initially throughout different tissues but in 
later stages of life it becomes more restricted to the heart.[17, 19] NKX2-
5 is a member of the NK2 class of homeodomain/ homeobox (Hox)-
containing transcription factors. Hox-proteins on themselves often do 
not have high binding affinity but when bound by co-factors binding 
specificity and affinity are increased.[20] NKX2-5 can transactivate the 
mouse Nppa promoter through binding to two separate binding sites on 
the DNA, named NKX2-5 response elements (NKEs) with sequences 
CCAAGTG and TCAAGTG located at -91/ -78 and in tandem at -243/-221 
bp from the TSS.[20, 21] NKX2-5 binds to different sites on the DNA 
with varying affinity, binding is strong to TNNAGTG and weaker to 
CWTTAATTN.[22] Together with the zinc-finger protein GATA4, NKX2-5 
is capable of activating the NPPA promoter in non-cardiac  cells.[23] 
This and the ability of NKX2-5 to transactivate the Nppa promoter in 
fibroblasts demonstrate a crucial role of NKX2-5 in the activation of the 
cardiac  gene expression program. Higher affinity binding of NKX2-5 to 
the DNA can be obtained via interaction with GATA4: this protein 
induces a conformational change in that protein that takes away the 
inhibitory effect of the NKX2-5 C-terminal domain so that p300 can 
interact with the NKX2-5 N-terminal domain thereby contributing to 
DNA binding affinity.[24] 
GATA4 and p300 
Like NKX2-5, GATA4 is expressed in only a few tissues. In adults, 
expression is only found in the heart, liver, small intestine, ovary and 
testes.[15, 20, 25] GATA factors contain one or two zinc-finger domains 
that together with an adjacent conserved highly basic region form a 
domain that binds DNA to sequences containing the GATA motif with 
the consensus sequence WGATAR. The importance of GATA4 for NPPA 
transcription becomes apparent from the fact that Nppa promoter 
activity in mesodermal 10T1/2 cells requires direct binding of GATA4 to 
the DNA. Out of the two binding sites that are present: at -138 and -295 
bp, the proximal one is the most essential.[20, 26] GATA4 can 
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functionally be replaced to some extent by GATA6.[27] The two proteins 
also directly interact with each other thereby enhancing NPPA 
transcription, requiring only one of the factors to bind their shared 
consensus motif on the DNA.[28] Besides collaborating with other GATA 
factors, the GATA proteins act in synergy with a wide variety of other 
proteins besides NKX2-5. DNA bound GATA4 can recruit MEF2 to target 
promoters without requiring MEF2 itself to bind to DNA.[29] Together 
with the serum response factor (SRF) GATA4 can activate various SRE 
(serum response element, binding site for SRF) dependent 
promoters.[30]  
It has been shown that this GATA dependent activation of 
transcription involves recruitment of the general TF p300 that has 
histone acetyltransferase (HAT) activity and interacts with the basal 
transcription initiation complex (TIC) of RNA-polymerase II through 
binding to TBP.[31, 32] GATA4 is also likely to be involved in enabling 
binding of p300 to NKX2-5. By removing the impeding effect of NKX2-
5’s C-terminal domain GATA4 might enable direct interaction between 
NKX2-5 and p300.[24, 33] Other regulators of GATA factor activity are 
the serum response factor (SRF), NFAT and Friend of GATA (FOG) 
proteins.[31, 34, 35] The long isoform of the FOG-2 directly inhibits 
NPPA promoter activation by GATA4.[36] While this inhibitory long 
isoform occurs in many types of tissues the shorter more heart 
restricted isoform has no inhibitory effect on NPPA transcription. 
Besides NPPA, FOG-2 also influences transcription of brain type 
natriuretic peptide (BNP) and the heart specific SERCA-channel 
encoding gene ATP2A2.[36, 37] 
SP1 
In a rat hypertrophy model, it was found that activation of the Nppa 
promoter by GATA4 could be further increased through synergetic 
action with Sp1, a ubiquitous expressed zinc-finger protein.[38] For this 
activation SP1 must bind directly to SP1 binding sites within the 
proximal promoter. SP1 was shown to interact with GATA4 through 
direct protein-protein binding. Furthermore it was shown that 
recruitment of SP1 to its binding sites was increased at higher levels of 
GATA4.[38] 
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MEF2 
The expression of several cardiac  proteins in mice, including NPPA, 
requires the MADS-box protein myocytes enhancer factor 2C 
(MEF2C).[39] The MADS box domain facilitates binding to DNA and 
interaction with other TFs including dimerization with other MADS-box 
proteins. The distinguishing feature of the MEF2 proteins is the MEF2 
domain, a 29-amino acids domain that enables MEF2 interaction with 
other accessory factors and binding to its own specific DNA binding 
site.[40-43] MEF2 does not dimerize with other MADS-box factors such 
as SRF, but only forms homo and heterodimers with MEF2 proteins.[44] 
Similar to other MADS-box factors, MEF2 DNA-binding and activity is 
greatly influenced by sequences adjacent to the TFBS, in muscle-specific 
enhancers the overall MEF2 consensus sequence YTTA(W)4TAR has 
been found to be regularly flanked by a G/C rich motif termed the 
CCAAC-box.[45] The DNA binding specificity of the factors themselves is 
determined by the first amino acid of their MADS-box domain.[44, 46, 
47] However, there is some competition for the MEF2 site between 
MEF2 and ubiquitous nuclear factors.[48]  
There is a big variety of possible combinations of MEF2 proteins due 
to fact that many MEF2 isoforms are generated by alternative splicing in 
the transcription mediating C-terminal domain.[44] In vertebrates four 
MEF2 genes have been found: MEF2A, -B, -C and –D. MEF2A, -C and -D 
have the same binding specificity although MEF2B binds the same 
sequence with a lower affinity compared to the others. These isoforms 
are to some degree  tissue-specific, but all four MEF2 proteins are 
mainly expressed in myogenic cells and further muscle restricted 
transcriptional activity of MEF2 is obtained through post-translational 
regulation of MEF2.[49] MEF2 factors are found to be essential co-
regulators of myogenic basic helix-loop-helix (bHLH) proteins.[50] In 
conjunction they can initiate myogenesis. In mice MEF2C was shown to 
be required for the expression of a number of cardiac specific genes 
Nppa, Actc1, Myh6 and Hand2.[39, 51] MEF2 proteins can synergistically 
activate transcription by direct DNA binding or as co-factors.  
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For full activity MEF2C requires p300, the exact way of how this 
activation is obtained remains to be elucidated.[52, 53] In addition to 
bHLH proteins, it has also been observed that Sp1 and the HAND factors 
bind to MEF2. A combination of MEF2C and HAND2 is able to drive 
expression of NPPA in HELA cells, demonstrating the central role of 
MEF2 in NPPA expression.[42, 54] Another TF of the basal machinery 
targeted by MEF2 is the transcription elongation factor p-ETFb, which 
suggests that MEF2 can also affect the transcription after the initial 
initiation phase.[55]  
HAND 
HAND1 (Thing1, eHAND, HXT) and HAND2 (dHAND, HED, Thing2) 
are bHLH factors involved in determining the right and left ventricle 
formation.[56] The name HAND is derived from the tissues where the 
protein is expressed in embryonic stage: heart, autonomic nervous 
system and neural crest derivatives.[57] HAND1 is ventricle specific 
while HAND2 is expressed in both ventricles and atria of the human 
heart.[57-60] HAND1 and HAND2 can form homo- and hetero-dimers 
with themselves and other class B bHLH factors. Thattaliyath et al. found 
that HAND2 transcriptional activity can be independent of DNA-binding 
or presence of an E-box, but likely occurs in a hetero-dimer with an E-
protein.[61] E-boxes are frequently occurring motifs with the consensus 
sequence CANNTG targeted by a wide variety of transcription 
factors.[62] In addition to this they showed that HAND2 synergistically 
activates NPPA transcription together with NKX2-5 but not with GATA4. 
The experiments however, were performed with a -258 fragment of the 
NPPA promoter and by using HEK 293 cells. In similar experiments, in 
neonatal rat cardiomyocytes and with the use of a -623 promoter 
fragment Dai et al. determined that in the presence of p300, HAND2 and 
GATA4 do interact synergistically. Just as for the interaction of HAND2 
with NKX2-5 the synergistic activity was independent of an E-box but 
depended on the GATA-site.[63] Just like GATA4 also HAND2 binds 
directly to p300.[34] Both HAND1 and HAND2 can activate the NPPA 
promoter in conjunction with MEF2.[54, 64] For transactivation by 
HAND1, only MEF2 binding sites in the DNA are required. Binding of 
HAND1 did not increase DNA binding of MEF2, therefore it is believed 
that the increase in promoter activity is obtained through additional 
factors that are being attracted to the promoter by HAND1.[64]  
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TBX5 
Another highly cardiac-specific factor activating the NPPA promoter 
is TBX-5, a member of the Brachyury/T-box family of transcription 
factors. The T in the name was derived from the short tail phenotype of 
mice that were heterozygous for one of the T-box family members and 
the T-box itself is a sequence specific DNA-binding domain.[65] In 
mammals 18 T-box factor genes have been identified, six of them 
(Tbx1/2/3/5/19/20) are active in the developing heart.[66] TBX 
proteins are essential in establishing the cardiac architecture by 
contributing to the formation of the separate ventricles.[67] While 
TBX20 is expressed in the right ventricle, Tbx5 is expressed in the 
developing left ventricle and was shown to be involved in the formation 
of the septum between the two ventricles.[67] Knockdown experiments 
in zebrafish suggest that direct binding of TBX5 with MEF2C is required 
for TBX5 to carry out its’ function in cardiogenesis. In this interaction, 
MEF2C binds directly to the DNA-binding domain of TBX5 without the 
need of an MEF2-binding site.[68] 
As a result of alternative splicing two different forms of TBX5 exist 
with apparently different roles.[69] While the shorter TBX5a is more 
active in proliferating cells, the longer TBX5b form is higher expressed 
in differentiating cells. With progression into the adult stage the ratio 
TBX5b/TBX5a in the heart increases, on average the TBX5-b isoform 
ranks higher when scoring for cardiac specificity (see table 1).[69] 
Transactivation of the NPPA promoter is only obtained through the 
shorter TBX5a form and not through the longer TBX5b. Tbx5 directly 
binds the NPPA promoter via T-box binding elements (TBEs) of which 
there are three present in the NPPA promoter between positions -487 
and -80 bp, with the respective binding site sequences GGTGTGA, 
TCACACC and GTGACA.[70] These three sites enable, at least in vitro, a 
dose/effect response whereby NPPA expression increases with 
increasing levels of TBX5. Two highly similar TBEs that were identified 
in the connexin-40 promoter have the sequences GTGGGA and 
GTGACA.[70] TBX5 acts co-operatively with the GATA4 and NKX2-5 
transcription factors, both discussed earlier in this review. NKX2-5 has 
been shown to directly bind to TBX5 and synergistic activity of TBX5 
and GATA4 is known to increase NPPA-promoter activity in chicken.[67, 
70, 71]  
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Activation of the cardiac actin promoter 
Another well documented cardiac-specific promoter is that of the 
ACTC1 gene encoding cardiac actin, a major structural protein of the 
sarcomeres. While in humans the gene is only active in the heart, mice 
and rat also display expression of this gene in the skeletal muscle. This 
illustrates the overlap in some of the transcription regulatory 
mechanisms of heart and other muscles. For ACTC1 the immediate 
proximal promoter is sufficient for directing striated muscle-specific 
transcription activation.[72] Within the region –110 to +68, three 
essential transcription factor binding sites (TFBS) were identified: the 
Serum Response Element (SRE), a GC-rich box and an enhancer-box (E-
box). The respective binding factors for these sites are SRF, SP1 and the 
class B myogenic bHLH proteins MyoD and myogenin (see figure 4).[73] 
Without any of these three TFBS and their associated factors promoter 
activity is completely abolished due to a failure in the formation of the 
transcription initiation complex (TIC).[74] 
Myogenic factors 
The class B basic helix loop helix-proteins MyoD and the related 
myogenin (MYOG, myogenic factor 4), Myf5 and MRF4 have been found 
to be the main regulators for differentiation of skeletal muscle cells in 
both developing and adult organisms.[75, 76] These factors are also 
capable of converting various non-muscle cells into muscle and are 
therefore referred to as myogenic proteins.[77] Muscle differentiation is 
initiated upon arresting the cell division cycle in the G0 phase by 
MyoD.[76] For this arrest, and subsequent muscle differentiation, MyoD 
is required to form a multiyear complex with two histone 
acetyltransferase (HAT) factors: the ubiquitously expressed p300 and 
the more muscle restricted PCAF. Interestingly, only the histone acetyl 
transferase (HAT) activity of PCAF and not of p300 is required in the 
process.[78, 79] It was proposed by Berkes and co-workers that Pbx, 
which is bound constitutively to inactive chromatin, marks genes for 
activation by MyoD. MyoD activates the myogenin promoter through 
interacting with Pbx/Meis1 when in a heterodimer with E12.[80] 
Cardiac gene expression regulation appears only to employ 
myogenin and not MyoD. Early murine cardiac muscle completely lacks 
expression of both myogenic proteins MyoD and myogenin.[81] 
Myogenin however, was found to be expressed in the heart of adult 
Muridae and also as to be a component of the complex of transcription 
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factors that regulate ACTC1 transcription in humans.[74, 81, 82]Most 
class B myogenic factors cannot form homo-dimers efficiently and 
require the more ubiquitously expressed class A bHLH E-proteins to 
form hetero-dimers and thus become active.[61, 83, 84] In order to be 
able to function in the TIC of the ACTC1 promoter, myogenin has to form 
a hetero-dimer with E-12 so it can bind to SRF, another essential factor 
for ACTC1 transcription.[85, 86] 
Besides bases making up the E-box itself, also the two flanking bases 
are essential determinants for susceptibility to the myogenic factors and 
determine whether they act as activators or inhibitors. The two flanking 
bases in cis-orientation of the E-boxes are essential for this activity: 
while the sequence 5’- AGG CAGGTGGC - 3’ can function as a MyoD 
dependent enhancer, the sequence 5’ - CTGCAGGTGTT – 3’ cannot be 
activated by MyoD.[87] 
Sp1 
Although Sp1 plays a central role in ACTC1 regulation, it has little 
effect on ACTC1 expression when over-expressed in fibroblasts.[23] Sp1 
has been reported to interact functionally with several of the factors 
known to be essential for transcription in cardiac muscle: myogenin, 
SRF and MEF2. Both MEF2C and MEF2D can be directly bound by Sp1, 
leading to a synergistic activation of transcription. Sp1, SRF and 
myogenic bHLH together form a complex.[86, 87] Sp1 can bind the CCAC 
boxes which flank MEF2 sites with a muscle-specific enhancer 
function.[42] As with many other TFs, also the synergistic effect of Sp1 
combined with a MEF2 factor can occur without direct DNA binding of 
MEF2. Binding of Sp1 to a Sp1-specific site is sufficient to enable MEF2 
recruitment.[88]  
36 
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SRF 
SRF is a crucial factor in the transcription regulation in all muscle 
types. The protein often plays a key role, but does not determine tissue 
specificity.[89] Like the MEF2 factors it belongs to the MADS-box 
proteins family and binds to the common MADS-box binding sites with 
consensus sequence CCW6GG.[47] For the activation of promoters SRF 
often requires the recruitment of (co)factors for full activity, even when 
binding to SRE sites.[90] In skeletal muscle SRF is required for the 
activation of genes by the two myogenic factors MyoD and myogenin 
thereby depending on SRE sites and E-boxes.[77] MyoD and myogenin 
bind SRF as hetero-dimers with E12.[86] For the activation of the ACTC1 
promoter, binding of SRF to the most proximal SRE appeared to be 
essential.[85] These SREs can be bound by a complex consisting of SRF 
and NKX2-5 as well as the two proteins independent from each 
other.[82, 91] However, in order to activate the promoter, SRF needs to 
recruit NKX2-5 without the need for NKX2-5 itself to bind to the 
DNA.[23, 82] The requirement for SRF to interact with other TFS 
suggest that a wider context of positional spacing of CArG boxes within 
the promoter might be essential for the formation of a multi-protein 
complex eventually inducing RNApolII activity.[92] 
Fine tuning ACTC1 cardiac specificity 
Although SRE sites can recruit the cardiac-restricted NKX2-5, 
independent from- and in combination with SRF, the cardiac-specific 
transcription regulation of ACTC1 requires additional regulatory 
elements. None of the two putative GATA binding sites have been shown 
to bind GATA4 and deletion of them did not result in loss of activation 
by GATA4.[33] For the induction of the ACTC1 promoter, GATA4 can 
function as a cofactor while NKX2-5 is bound to the SREs.[20, 33] 
Two DNase I hypersensitive regions upstream of the TSS of ACTC1 
function as enhancers. At about -7 kbp, a site is present for the 
ubiquitous factor Embigin (Emb), that is capable of recruiting MEF2 in 
conjunction with p300 and Oct1 which binds to an adjacent site.[93] The 
second enhancer, located at –2.353 to -1.36 kbp, is only active in 
cultured cardiomyocytes and not in differentiated skeletal muscle or 
non muscle cells. Within this region resides a binding site for MEF2 
factors, at least MEF2A and MEF2D were shown to bind to this site.[94]  
38 
Transcription inducing co-factors  
Myocardin 
Amongst the more cardiac-specific genes depicted in figure 1 there is 
enrichment in the binding sites for SP1, SRF and MEF2. Although they 
themselves are not cardiac-specific factors they all enable potential 
recruitment of myocardin, the fourth most cardiac-specific TF (see table 
1) to the promoter. Myocardin occurs in two transcript forms arising 
from alternative splicing. The longer, strongly heart enriched transcript 
(see also table 1), contains an extra miniature exon that adds a 
premature stop-codon, leading to a shortened form of the protein.[95] 
The shorter transcript encoding the larger protein is enriched in smooth 
muscle. Neither form of myocardin is found in skeletal muscle.[95-98] In 
smooth muscle myocardin in conjunction with the class II histone 
deacetylase (HDAC) HDAC5, was shown to assist in differentiation by 
blocking the skeletal muscle program through inhibition of DNA-binding 
by the key myogenic factor MyoD.[99] In cardiac cells myocardin plays 
an important role in the early stages of differentiation after its 
transcription is activated by Nkx2-5.[100] Myocardin also has a 
transcription activating function, many genes in both cardiac and 
smooth muscle only become activated after the expression of 
myocardin.[95,101-103] Myocardin binds SRF via the SRF MADS-box 
when it is bound to CArG boxes and this binding is not influenced by the 
CArG box flanking sequences.  
Thyroid hormone receptor 
Several genes require the thyroid hormone receptor (TR) for their 
full activation. Two such genes, MYH6 and ATP2A2, are depicted in 
figure 1.[104, 105] For its transcriptional activation, TR requires the 
direct binding of MEF2 as cofactor.[106] 
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Repressors contribute to tissue specificity of 
transcription 
So far we primarily focused on the transcriptional activators of NPPA 
and ACTC. However, genes attain their tissue-specific transcriptional 
profile through a combination of activating and repressive mechanisms. 
A factor with a dual role of both inducer and repressor is the 
ubiquitously expressed TF Yin and Yang 1 (YY1). In muscle cells it 
primarily has been described as an inhibitor of transcription through 
binding to specific YY1 sites or SREs, making them inaccessible for 
SRF.[107] With increased differentiation YY1 activity diminishes and the 
SRE becomes accessible again for SRF.[107] For full repressor activity 
YY1 requires acetylation by p300 and PCAF so it can bind more strongly 
to HDACS.[108] However, HDACs can deacetylate YY1 again, thus 
forming a negative feedback loop.[108] In the heart repressive activity 
of YY1 can be lifted through the actions of the cardiac-enriched TF Nkx2-
5.[109] It has been shown that YY1 can be displaced from the ACTC1 
promoter by NKX2-5 together with SRF. This mechanism of 
counteracting YY1 thus only occurs in those few cell-types where YY1 
expression is low and/or NKX2-5 is expressed in sufficient amounts 
thus contributing to the tissue specificity of ACTC1 and other promoters 
such as MYH6 which like ACTC1 are also under control of YY1.[109, 110] 
Where YY1 blocks transcription through rendering the promoters 
inaccessible, the bHLH TF TWIST represses transcription via 
inactivation of key TFs by directly binding to them. Mouse TWIST can 
bind directly to the different bHLH myogenic factors.[111] In this way 
TWIST inhibits differentiation of cells into muscle lineages. Other factors 
of which the activity is repressed through direct binding of TWIST are 
MEF2 and the HATs p300 and PCAF.[112] 
Also in the formation of the separate compartments of the heart, the 
atria and ventricles, transcriptional repressors play a key role. For 
example the HEY TFs that are expressed primarily in the cardiovascular 
system and target GATA4 and GATA6 expression and influence their 
actions through direct binding without interfering with p300 binding by 
GATA4.[113, 114] The two HEY factors are distinctively active in one of 
the two: Hey1 is expressed in the atria and Hey2 in the ventricles (see 
also table 1).[115, 116] HEY2 expression assists in the differentiation of 
the ventricular cardiomyocytes by repressing the atrial gene 
expression.[117]  
A TF with a similar role to that of HEY2 is Irx4. This homologue to the 
Drosophila Iroquois homeobox factors is also expressed solely in the 
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ventricles and stimulates there the ventricle specific expression under 
control of NKX2-5 and HAND2 while at the same time inhibiting atrial-
specific gene expression.[118, 119] 
Maintaining the status quo 
Transcriptional inhibitors are not only important for 
compartmentalization but also for and maintaining a healthy status quo 
the cardiac tissue. Without inhibitors transcription would go on 
uncontrolled since, as mentioned earlier, the transcription factories with 
active RNApolII maintain present. Over-activation of MEF2 could for 
example lead to cardiomyopathy.[120] Class II histone deacetylases 
(HDACs) prevent over-activation of MEF2 through direct binding to a 
domain on MEF2 that is also targeted by HATs.[121, 122] Another clear 
example is the ventricle enriched homeodomain protein HOP, required 
to establish an appropriate number of cardiomyocytes by balancing 
proliferation and differentiation. Mutations in the gene in mice lead to 
ruptures in the ventricular walls of mice embryos.[123] The protein was 
first identified as an NKX2-5 dependent homeodomain protein 
antagonizing DNA binding by SRF and indeed the mice with mutated 
HOP had altered expression levels for many SRF target genes.[18, 123, 
124] Separately, HOP does not affect expression of NPPA, ACTC, but with 
addition of SRF the genes are down regulated in a dose dependent way, 
via inhibition of SRF binding to DNA. Furthermore HOP diminishes the 
responsiveness of NPPA and the smooth muscle gene SM22 to 
myocardin.[123] 
The transcriptional repressor JARID2 (jumonji/JMJ) has both 
repressive and activating properties. JARID2 represses NPPA 
transcription through direct binding to the key TFs Nkx2-5 and 
GATA4.[125] A stimulatory effect of JARID2 has been observed for 
MYH6, however in another study where a much smaller promoter 
fragment was used (368 bp instead of 5.6 kb), JARID2 was shown to 
repress the activity of MYH6 transcription.[126, 127] In the latter study 
JARID2 was shown to bind directly to MEF2 thereby inhibiting its 
binding to the thyroid receptor (TR) required for the synergistic 
activation of the MYH6 promoter.[106]  
Another repressor acting through inhibition of TR is the heart and 
brain enriched ‘friend of GATA’(FOG)-2.[128] FOG-2 inhibits the 
stimulating effect of THR-alpha on ATP2A2 expression by direct binding 
to THR-alpha.[37] FOG-2 is probably better known for its repressive 
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effect on the transcription of cardiac-specific genes via the inhibition of 
GATA4, whereby a possible mechanism is that of FOG-2 competing with 
GATA4 for binding of p300.[129, 130] 
Direct activation amidst key cardiac transcription 
factors 
The cardiac-specific transcription program starts with the synthesis 
of the transcription factors involved. The early expression in the heart of 
NKX2-5 depends on a GATA4 binding site at about 9.3 kb upstream in 
the promoter.[131] GATA-4 on itself is only capable of weak activation 
of the promoter; higher levels of NKX2-5 expression are obtained 
through recruiting GATA-4 to Smad sites by Smad1 and Smad4. A 
similar activity was also observed for GATA6.[132] 
In mouse embryonic development, Mef2C is a direct transcriptional 
target of GATA4.[133] In Drosophila a cardiac-specific enhancer is found 
6 kb upstream of the Mef2d gene. This enhancer contains two binding 
sites for the cardiac homeodomain protein Tinman NKX2-5 homologue, 
pointing to a role of Tinman in the regulation of MEF2 expression. On its 
turn MEF2 turns on the transcription of myogenic factors. Myogenin 
expression which is only initiated after the start of muscle 
differentiation is dependent on binding of the MADS-box protein MEF2 
to a MEF2 site in its promoter. Of the myogenin promoter 184 bp 
upstream of the TSS confers muscle specificity and auto regulation via 
an E-box.[87, 134] The expressed myogenin can contribute to inducing 
MEF2 transcription in non-myogenic cells in absence of mitogenic 
factors and other myogenic proteins such as MyoD.[48] Muscle 
differentiation proceeds further as a result from the regulatory loops 
existing between the myogenic factors themselves.[80] DNA binding 
activity of the MEF2A isoform is increased in presence of MyoD in non 
muscle cells. And on its turn MEF2A also induces the expression of 
MyoD.[135] 
Transcription of SRF in developing cardiac tissue of embryonic mice 
depends on binding of TBX2 and TBX5 to T-box binding sites in the 
3’UTR in synergy with the HAT protein HIV-1 Tat interacting protein 
(HTATIP). The 3’UTR in combination with a 0.5 kb 5’ flanking promoter 
sequence was sufficient for cardiac expression.[136] 
42 
Synopsis of the regulatory network of cardiac-
specific transcription 
The cardiac-specific genes depend for their transcription initiation 
on the activation of the same sub-processes as all other genes: 
chromatin remodeling, formation of the RNA polymerase holo-enzyme 
complex and its activation at the TSS. The limitation of cardiac 
specificity already starts at the level of chromatin remodeling. The 
recent finding of the interaction between the cardiac-enriched HAND2 
and Pbx suggest that cardiac genes could be marked for transcription in 
a way similar to that in skeletal muscle.[137] HAND2 on its turn can 
recruit key factors of the cardiac transcription program like MEF2, 
GATA4 and NKX2-5 and also additional ubiquitously expressed co-
factors such as p300 which are required for the transcription activation 
of genes by for example GATA4. GATA4 also functions in another 
chromatin remodeling mechanism active in cardiomyocytes, together 
with TBX5 and a cardiac-specific subunit of a chromatin remodeling 
complex: Baf60c.[138] Ones chromatin has become de-condensed 
various TFs can readily enhance further stabilization of the open 
structure through their histone acetylase function.  
MEF2 appears to be at the basis of the gene expression program in 
striated muscles and it does so in close co-operation with the powerful 
myogenic transcription factors. As if being a specialized form of skeletal 
muscle, the cardiomyocytes only employ a subset of these factors. While 
in skeletal muscle MyoD has been described as the dominating TF, in the 
heart only myogenin is active. In a similar fashion there is some 
variation in which isoforms of MEF2 are active. Although the combined 
action some factors can result in the expression of cardiac-specific genes 
even in non-muscle cells in vitro, the endogenous promoter of all the 
genes described here contain functional transcription factor binding 
sites that are targeted by MEF2 or contain binding sites for one or more 
TFs that can directly recruit MEF2. MEF2’s central role also becomes 
apparent from figure 2: at least four factors were shown to exert a direct 
inhibitory effect on MEF2 activity and no less than nine TFs work in 
synergy with MEF2. Taking into account the fact that MEF2 was shown 
to be required for transcriptional activity of many cardiac-specific genes 
and the fact that MEF2 is a direct downstream target of NKX2-5 it seems 
likely that also MEF2 is involved in the observed activation of cardiac-
specific genes upon expression of GATA4 and NKX2-5 in non-muscle 
cells. 
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Both GATA4 and NKX2-5 emerged from studies on cardiac gene 
regulation as key players. Both can act in different ways: through direct 
binding and as cofactors and furthermore they also function upstream of 
many factors. Figure 5 shows the direct activation of transcription of 
other essential cardiac transcription factors, especially by NKX2-5. The 
high degree of cardiac specificity of NKX2-5 (see table 1) combined with 
its functions as direct DNA binding factor, widely interacting co-factor 
and its activity in lifting the repressor activity of YY1 make this TF a 
crucial player in obtaining cardiac specificity of transcription initiation. 
A study performed by Ieda et al., showed that the combined activity of 
MEF2C, GATA4 and TBX5 was sufficient for the reprogramming of 
fibroblasts into cardiomyocytes.[139] Although NKX2-5 was thus not 
amongst these, the direct trans-activation of the latter by GATA4 would 
still enable it to play a role in this reprogramming. A study describing 
the translocation of NKX2-5 to the nucleus of stem cells in the earliest 
stages of differentiation confirms once more the crucial role of NKX2-5 
in steering the cardiomyocyte transcriptome.[140] 
 
 
  
 
Figure 5. Regulatory roles amongst cardiac  transcription factors. 
Arrows indicate direct activating role on transcription through binding to the 
target gene promoter. The circulatory loops of myogenin and TBX5 reflect the 
self induction of these factors. 
 
 
The more general SRF links together many elements of the cardiac 
transcriptional network and functions as the only known target for 
control of expression levels by the cardiac-enriched repressor HOP. Like 
MEF2, SRF connects the elements shared by the various muscle types 
with more cardiac-specific controllers and elements involved in 
controlling the core transcription machinery. Especially the ubiquitous 
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expressed p300 seems to be the principal factor for interacting with the 
core machinery.  
There seems to be not a single general mechanism leading to cardiac-
specific expression. The considerable variation in promoter structures 
of genes with a cardiac expression profile also becomes apparent from 
figure 1. Although it provides only visual information on possible 
binding sites for direct DNA binding proteins the figure clearly shows 
that the TFBS selected are highly enriched in the regulatory regions of 
cardiac genes compared to genes from other tissues, even including 
some of the closely related skeletal and smooth muscle. We described 
how many of the TFs involved in regulating cardiac-specific-
transcription can act both through direct DNA binding and also as non-
DNA binding co-factor, a relatively simple recording of the TFBs present 
within a promoter sequence thus only gives limited information on 
which TFs could possibly be involved in their regulation. The latter 
complicates an easy straightforward identification of all involved TFs 
through bioinformatics approaches demonstrating the need for 
experimental studies.  
While the core machinery for the transcription activation of cardiac-
specific expressed genes seems to be largely elucidated, knowledge of 
the promoters of many cardiac-specific genes is often non-existing or 
very limited at best. It is to be expected that further research in the 
regulation of these genes will result in the identification of 
transcriptional regulatory elements and factors that are yet unknown, 
and in functionally linking already known TFs to the cardiac-specific 
transcription machinery. 
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Abstract 
With the human genome decoded, one of the major tasks remaining 
is that of identifying the role of the non-coding elements. A considerable 
part of these non-coding elements are promoter sequences, involved in 
regulating transcription, the process in which the DNA is transcribed to 
the intermediate mRNA. For many genes little to nothing is known about 
their promoter sequences. Knowledge of their promoter architecture 
would however be desirable in order to understand the genes’ 
regulation in both health and disease. In this study we investigated the 
human promoters of a number of genes with a more cardiac-enriched 
expression profile, cysteine and glycine rich protein 3 (CSRP3), 
telethonin/ titin capping protein (TCAP), myosin light chain 3 (MYL3) 
and myosin light chain 7 (MYL7). Based on cross-species conservation 
and the occurrence of elements with known (heart-) muscle regulatory 
properties we selected and cloned their immediate 5’-flanking 
sequences of the genes. Experimental validation using luciferase 
reporter assays show that the tissue specificity of the selected fragments 
correlates with that of the expression profile from the endogenous 
genes. 
Introduction 
While for many genes the DNA sequences encoding the eventual 
proteins are known and often even functionally described into great 
detail, the characterization of the promoters is often lagging behind. 
Since transcription of a gene is the prelude to the eventual formation of 
a functional protein, research into the orchestration of a gene’s 
transcription can greatly assist in understanding how a gene functions. 
All this also holds true for many genes with a cardiac-enriched 
expression profile. The protein encoding sequences of many cardiac-
specific genes have been studied in detail, often in relation to mutations 
leading to hereditary heart-diseases.[1, 2] Meanwhile, somewhat 
surprisingly, the promoters of many of these genes have not been 
investigated at all. More knowledge on the role of regulatory elements 
within the promoter sequences and the transcription factors (TFs) 
associating with them could provide a better understanding of the 
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regulation of gene activity in the heart in both health and disease. 
Knowing which genes are targeted by a specific TF can for example aid 
in understanding cardiac disorders such as the Holt-Oram syndrome, 
which pathogenesis originates from mutations in the key cardiac 
transcription factor TBX5.[2] 
Identification of relevant promoter elements will eventually require 
some form of experimental validation. Luciferase reporter vectors have 
become one of the major tools for experimental studies on promoters. In 
the study presented here we described the partial identification of the 
promoter sequences of a number of genes involved in cardiomyocytes 
and their validation using transient transfection of luciferase reporter 
constructs in various types of muscle cells. Determining the tissue 
specificity of promoter fragments is important. Closely related types of 
tissues such as cardiac, skeletal and smooth muscle share many 
similarities, including some of the mechanisms involved in transcription. 
A good example is cardiac α-actin (ACTC1). For this gene, the proximal 
promoter region –110 to +68 is sufficient for restricting transcription to 
the striated muscles.[3] For the eventual cardiac-specific transcription 
of ACTC1, additional promoter-sequences are required, including an 
enhancer located within –2.353 to -1.36 kbp relative to the TSS.[4] For 
many genes with a cardiomyocyte specific expression profile it seems 
that a reasonably short stretch of the proximal promoter is often 
sufficient for driving their cardiomyocyte-specific transcription. For 
natriuretic peptide precursor type A (NPPA/ANF) and muscle α-myosin 
heavy chain (MYH6) respectively 700 bp and 344 bp of the 5’proximal 
sequences are sufficient for cardiac-specific expression.[5, 6] We 
therefore limited our search to the immediate 5’ flanking sequences. 
We present here the partial elucidation of promoter regions for the 
genes: cysteine and glycine-rich protein 3 (CSRP3), lysyl oxidase-like 1 
(LOXL1), myosin light chain 3 (MYL3), myosin light chain 7 (MYL7), heat 
shock 27 kDa protein family member-7 (HSPB7) and titin-capping 
protein / telethonin (TCAP). For some of the genes included in this 
study, little to none information had been available on their promoter so 
far, of others; previously published data was only available for the 
mouse promoters. In the study we present here we provide data on the 
transcriptional activity of the human promoters and demonstrated the 
tissue specificity of selected promoter fragments in various muscle 
tissues including cardiomyocytes. 
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Materials and methods 
Creation of promoter constructs 
Promoter sequences of interest were cloned into pGL4.10 (Promega, 
Madison, WI USA) using standard molecular biology techniques. The 
promoter regions were obtained via PCR on human DNA. Clones were 
verified through DNA sequencing using the BigDye cycle sequencing 
system (Applied Biosystems, Carlsbad CA USA). 
Cell culture and transfection 
Primary culture of neonatal rat ventricular myocytes: Primary 
cultures of neonatal rat ventricular cardiomyocytes were generated and 
prepared as described earlier.[7] C2C12 (mouse skeletal myoblasts) and 
A7R5 (rat aortic smooth muscle cells) cultures were obtained from 
ATCC (Manassas, VA USA). C2C12 cells were maintained in Dulbecco’s 
modified Eagle Medium, DMEM, 10% fetal bovine serum (FBS) and 
transferred to DMEM supplemented with 2% horse serum to induce and 
maintain differentiation. A7R5 cells were maintained in DMEM 
supplemented with 15% FBS, and for differentiation cells were grown in 
DMEM supplemented with 2% horse serum. 
Transfections 
Cells were transfected with plasmid using FugeneHD (Roche) 
according to manufacturer’s instructions. Transfection mixtures were 
composed to equal molar amounts of all promoter constructs. To adjust 
total DNA per transfection without introducing additional luciferase 
encoding DNA, ‘empty’ pGEM-Teasy (Promega, Madison, WI USA) was 
used. Transfection experiments were performed in 48 well plates, using 
1 µl Fugene HD and 0.33 µg total DNA per well. To enable correction for 
transfection efficiency, cells were co-transfected with 10 ng of pGL4.75, 
Renilla Luciferase under control of the CMV promoter (Promega, 
Madison, WI USA), per well. 
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Results 
Selection of promoter fragments 
Based on the public available databases of Symatlas (later replaced 
by BioGPS), the Reference database for gene expression analysis, RefExA 
(http://157.82.78.238/refexa/main_search.jsp), NCBI Gene Expression 
Omnibus (GEO) and the Database of Transcription start sites (DBTSS) 
we identified the relevant transcripts.[8-10] Genomic DNA sequences 
were retrieved via the Biomart website. Information deposited in the 
DBTSS combined with data from the NCBI Refseq database was used to 
determine the transcription start site of the chosen transcripts.[8, 9] 
This precise annotation of the transcription start site (TSS) is of great 
importance since genes can encode for different transcripts via the use 
of alternative promoters, which can be located at great distances from 
one another.[11] In relation to this DBTSS was very useful since it 
provides information on the TSS of full length cDNA clones obtained 
from samples from different tissues, including some representing the 
transcripts in various types of muscle. Also, attention was given to the 
presence of core transcription regulating elements such as TATA-boxes 
and INR-elements.  
Because of technical limitations such as transfection efficiency we 
limited the regions to be cloned to about 5 kb. Therefore, when 
screening for CNSs we focused on the region up to 5kb from the 
transcription start site. The screening for CNSs was done by comparing 
the human sequences with those of mice, rat, dog and cow in the 
genome-VISTA program.[12] The results of these alignments are 
provided as on-line available supplementary data. 
For the in vitro studies we focused on the strongly conserved regions 
(>70% homology with mouse, rat, dog or cow) directly upstream of the 
TSS. However in the case of MYL7 we observed also a very strong 
conservation in the first intron. To investigate the occurrence of crucial 
regulatory elements within this region we generated two clones, one 
including the transcribed region up to and including the second exon. 
Notion was also given to any non-conserved clusters of TFBs with a 
known involvement in regulating transcription in muscle.[13] For this 
we screened for matches to consensus binding site sequences as 
described by Xie et al.[14] and sequences available in the TRANSFAC 
database.[15] In the case of HSPB7, various candidate TSS were found, 
to include them all, we selected our cut off for this promoter fragment 
further downstream of the TSS presented by the Refseq NM_014424 
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mRNA. The selected promoter regions of the genes investigated are 
given in table 1. 
Validation of reporter constructs 
Of all the genes investigated, we cloned the human DNA-derived 
promoter regions in the pGL4.10 luciferase reporter vector. Of the genes 
CSRP3 and MYL7 two regions of varying length were selected. The 
proposed CSRP3 promoter region contains a short CNSs stretching to -
780 bp. However, several additional potentially crucial binding sites 
were identified further upstream, but still within such proximity that 
the combined region could still be cloned as one contiguous fragment. 
The first intron of MYL7 was found to contain a considerable amount of 
CNSs. To investigate their potential activity, an additional MYL7 
construct was generated containing the genomic region up to and 
including the second exon. Care was given to keep coding regions in 
frame of the ATG start codon located in the first exon of MYL7. 
The transcriptional activity and tissue specificity of the generated 
constructs were analyzed through transfections into cardiomyocytes, 
cell lines representative for skeletal muscle, smooth muscle and HELA 
cells (figure 1). For comparison of the tissue specificity of the genes we 
also performed transfections with a construct containing the smooth 
muscle-specific lysyl oxidase (LOXL1) promoter and with one baring the 
promoter of alpha myosin heavy chain (MYH6).[16, 17] 
The promoter fragments of MYL3 and MYL7 display a high degree of 
tissue specificity for cardiomyocytes. While the shorter CSRP3 promoter 
fragment displays high transcriptional activity in all the different muscle 
cells, the larger CSRP3 fragment yields a more tissue restricted 
expression profile. The activity measured for the selected HSPB7 
promoter fragment did not rise significantly above that of the empty 
pGL4.10 control vector in any of the cell-lines tested. 
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Table 1. Promoter fragments 
 
HGNC 
symbol 
Promoter 
Regiona 
bp 
DBTSSb Refseqc Tata-boxd Previously 
described 
CSRP3 -4923 / +77  + + -
 -780 / +77 
FABP3 -1247 / +40 NM_004102 + mouse[13] 
HSPB7 -3888 / +392 + -
LOXL1 -4080 / +14 + rat[14], 
human[15] 
MYBPC1 -3068 / +72 + -
MYH6 -2028 / +30 NM_002471 human[16], 
rat,[6] 
MYL3 -1951 / +64 + NM_000258 -
MYL7 -1038 / +71 + NM_021223 + zebrafish[17] 
 -1038 / +329 
TCAP -637 / +23 + NM_003673 -
 
aPromoter regions incorporated in luciferase reporter vectors used in this study. b’+’ 
indicates where the selection of the TSS was supported by data from the DBTSS 
database. cWhen the selected TSS coincided with that of a known Refseq transcript, the 
corresponding Refseq ID is indicated. dBinding site matching TATA-box consensus 
sequence was present at -25 to -30 bp relative to selected TSS. 
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Figure 1. Transcriptional activity of promoter fragments.
Promoter reporter constructs derived from human promoter sequences were 
transfected into primary cultures of neonatal rat ventricular cardiomyocytes 
(NRVCM), mouse skeletal muscle myocytes (C2C12), rat aortic smooth muscle 
cells (A7R5) and human cervical cancer cells (HELA). Promoter activity was 
calculated on fold activation over the background obtained with equimolar 
amounts of the empty pGL4.10 reporter vector. 
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Discussion 
For many genes with a cardiac-specific expression little to none 
information is available on their promoter architecture. To assist in the 
advance on research on some of these genes we investigated the 5’-
flanking sequences and generated and validated a set of luciferase 
reporter vector constructs.  
We created a LOXL1 reporter construct that, unlike Csiszar et al, did 
not include the first intron.[16] Furthermore, the region we 
incorporated was 4 kb where Csiszar et al. included only up to -925 bp 
of the 5’-flanking region. The observed expression profile of the 
resulting LOXL1 promoter fragment corresponded to what is observed 
for the endogenous gene in for example the RefExA database. 
Interestingly, hardly any expression was observed in HELA cells while in 
the study by Csiszar et al. expression was observed in the osteosarcoma 
derived cell-line. The different origins of both cancer-cell lines as well as 
the difference in the selected promoter could be causative for this. 
Based on the gene expression databases we expected a strong 
enrichment of MYBPC1 expression in the skeletal muscle cells. The 
strongest activity of our luciferase reporter construct was however 
observed in A7R5 cells for which MYBPC1 expression was not expected. 
A recent study showed that MYBPC1 expression in cultured skeletal 
muscle cells was strongly down-regulated when compared to normal 
muscle tissue.[18] This explains for the low luciferase-levels in C2C12 
cells but not for the occurrence of expression in smooth muscle cells and 
cardiomyocytes. Possibly some sequences providing inhibitory activity 
within these tissues are located outside of the promoter region selected 
here. 
Like with many other cardiac-specific genes, relatively short 
stretches of the immediate 5’-flanking sequences appear to be sufficient 
for driving transcription in cardiomyocytes of CSRP3, MYL3, MYL7 and 
TCAP. The investigated fragment of MYL3 displays high levels of activity 
in cardiomyocytes and some activity in C2C12 cells. This corresponds to 
gene expression data from the endogenous human gene, which is known 
to be expressed in both heart and skeletal muscle (see for example the 
REFEXA database).  
For MYL7, so far, only the zebrafish promoter has been described 
before.[19] We began here to provide some functional data on the 
human promoter. Although MYL7 is principally expected to be a fully 
cardiac-specific gene, the selected MYL7 promoter fragment still 
displayed some residual activity in A7R5 cells while it did not display 
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any activity in C2C12 cells. This is somewhat remarkable since skeletal 
muscle cells, like cardiomyocytes, are striated muscle cells, and thus 
structurally and functionally more related.  
Additional studies would be required to verify whether these 
observations are resulting from differences in the endogenous 
transcriptional program between A7R5 cell cultures and the smooth 
muscle in vivo, or from regulatory elements located outside the 
promoter regions incorporated in this study. 
TCAP expression is normally observed in all three types of 
muscle.[20, 21] The selected promoter fragment indeed displayed 
activity in all three types of muscle cells, while at the same time no 
activity was observed in HELA cells. It therefore seems that a relatively 
short promoter fragment constitutes the expression profile observed in 
vivo. 
For FABP3, so far only the mouse promoter had been characterized in 
vitro.[22] Similar to what was found for the mouse promoter we found 
the investigated human FABP3 promoter-fragment to be active in both 
cardiomyocytes and C2C12 cells as well as smooth muscle. The 
promoter fragment thus yields an expression profile corresponding to 
what has been found for the FABP3 protein.[23]  
We found for CSRP3 that the larger promoter-fragment displayed 
much lower expression levels but at the same time led to a more tissue 
restricted expression profile. Although the gene has been found to be 
expressed in blood vessels we failed to detect promoter activity of the 
larger promoter fragment in cultured smooth muscle of aortic 
origin.[24] A possible explanation could be the influence of stretch. 
Campos and co-workers found that expression of CSRP3 was high in 
smooth muscle cells subjected to stretch, while no expression was 
detected when the cells were not subjected to stretching. Such a stretch 
dependent activation could also explain why the CSRP3 promoter 
activity was higher in the cardiomyocytes. Under the culture conditions 
employed in our study, the cardiomyocytes display frequent 
spontaneous contractions. It therefore could also well be that the 5kb 
CSRP3-promoter fragment becomes activated in A7R5 and C2C12 cells if 
these cells were to be subjected to stretch. If so, further investigation of 
this CSRP3 promoter fragment could provide valuable insights into the 
mechanisms underlying this response.  
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Conclusion 
We provided here for the first time information on the tissue-specific 
transcriptional activity of a number of genes expressed in 
cardiomyocytes, skeletal and smooth muscle. In general, the immediate 
conserved non-coding 5’-flanking sequences of genes with a cardiac-
enriched expression profile appear to represent the vast majority of the 
regulatory elements involved in the regulation of these genes. To 
confirm specificity for a specific type of muscle, in vitro models such as 
cultures of C2C12 and A7R5 cells can potentially provide valuable 
information. However, some limitations in using cell cultures for 
studying transcriptional mechanisms became apparent. The variations 
in expression of for example MYBPC1 and CSRP3 in cultured cells 
compared to the in vivo situation provided good examples for this. More 
definitive confirmation of the promoter fragments investigated here 
could come from in vivo studies. Alternatively, muscle cell cultures 
might be subjected to additional treatments such as exposure to stretch 
in order to make them a more representative and reliable model for 
transcriptional research in vitro. 
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generated of the human genomic sequences with those of mouse, rat 
and dog for up to 10kb 5’ upstream of the transcription start site.  
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Abstract 
The study of gene regulation in cardiomyocytes requires a reliable in 
vitro model. However, monolayer cultures used for this purpose are 
typically not being exposed to electric stimulation although this has 
been shown to strongly affect cardiomyocyte gene expression. Based on 
pacemakers for clinical use we developed an easy to use and portable 
system that allows the user to perform electro-stimulation of 
cardiomyocyte cultures in standard tissue incubators without the need 
of bulky equipment. In addition we present here a refined protocol for 
culturing highly pure cardiomyocyte cultures with excellent contractile 
properties for a wide variety of applications. 
Electrical stimulation of primary neonatal rat 
ventricular cardiomyocytes using pacemakers 
Monolayer cultures of primary neonatal rat ventricular 
cardiomyocytes (NRVCMs) are a frequently employed model to study 
transcription regulation or cardiac-specific genes like atrial natriuretic 
factor (Anf/ Nppa) and alpha myosin heavy chain (Myh6).[1-3] However, 
many of such studies pass over on the importance of electric stimulation 
of cardiomyocytes although it has been found that prolonged electric-
stimulation improves cardiomyocyte morphology and function and that 
electric pulsing directly increases transcript levels of cardiac-specific 
genes.[4, 5] 
Currently, in vitro stimulation of cardiomyocytes or engineered 
cardiac tissue is done using cardiac stimulators like those of Nihon 
Kohden (Tokyo) or Ion Optix (Milton, MA. U.S.A) with parameters 
varying between 2 to 4 ms, 5 to 11 V/cm and 1 to 3 Hz.[6-8] Such 
apparatuses have disadvantages: they require to be plugged into the 
power grid and their large dimensions make transport to other work 
areas for instance for microscope analysis cumbersome. Furthermore, 
the machines normally have to be placed outside the incubators since 
they were often not designed for use in incubators with high humidity 
and temperatures. As a result structural modifications to the incubators 
may be required or connecting cables have to run through door-
openings, potentially compromising sterility and culture conditions.  
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We hypothesized that employing cardiac pacemakers normally used 
for heart-patients would solve many of the aforementioned problems. 
These battery powered pacemakers are small and are completely closed 
so that the whole apparatus can be ethanol sterilized and placed inside 
incubators together with the cultures without the need for any 
modifications. Furthermore, the whole system together with cultures 
can easily be transported to any place and used there without 
interrupting the pulsing. 
We cultured NRVCMs in commercially available chamber-slides 
which can be used for a wide variety of purposes: live imaging, 
immunohistochemistry, reporter studies and a single chamber provides 
sufficient material for gene expression analysis. Reusable polycarbonate 
lids were designed to fit the chamber-slides and equipped with platinum 
electrodes running along opposite sides in each chamber. Small air 
channels in the lids enabled gas exchange (see figure 1). The electrode-
lids were connected to human pacemakers, models Kappa 931 and 401 
(Medtronic). The pacemakers were programmed using a Medtronic 
Vitatron 9790 programmer to give 7.5 V pulses (corresponding to 4.5 
V/cm) with a duration of 1.5 ms at 1 Hz, placing it in the same range as 
previous publications and resembling the levels required for exciting 
normal ventricular tissue.[7-9] New pacemakers and programmers can 
be costly and may not be feasible for all researchers. However, 
significant numbers of devices are explanted for various reasons. These 
explanted pacemakers can be obtained and programmed with the help 
of cardiologists and may still be able to stimulate for several years. 
The protocol employed for cardiomyocyte isolation and culture is a 
modified version of that described by Radisic et al..[9, 10] On day 1 
hearts were obtained from 0-3 day old Lewis rats locally bred at the 
animal facility of Maastricht University. The use of animals for this study 
was evaluated and approved by the institute’s animal ethical committee. 
On day 2 cardiomyocytes were pre-plated for 2 hours and subsequently 
plated at >30,000 cells/cm2 on plastic (Permanox®, Lab-Tek) chamber-
slides and incubated overnight in high serum medium supplemented 
with 10 µmol/L cytosine arabinoside (Ara-C) to further decrease the 
number of actively dividing (mostly non-myocyte) cells.[11, 12] The 
Permanox chamber-slides omitted the need for coatings since 
cardiomyocytes readily adhere to them. The culturing parameters were 
empirically determined through pilot experiments which revealed that 
the use of glass based chamber-slides with surface coatings like 
Histogrip™ (Invitrogen) and especially Matrigel™ (BD Biosciences) led 
to dramatic changes in cardiomyocyte cellular structure and function; 
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cardiomyocytes remained rounded, resulting in diminished intercellular 
connections and fewer contractions (data not shown). 
 
At densities lower than 30,000 cells/cm2 without electric stimulation 
the cells displayed no contractions, remained round and >50% of the 
cells died within 2 days of culture most likely because they were not 
able to form intercellular connections required for intercellular 
signaling. The resulting cultures consisted of >95% cardiomyocytes 
(purity of cultures can be observed from figure 2).  
 
 
Figure 1. System for culturing electro-stimulated cardiomyocytes. 
Top left panel: Human pacemaker Medronic model KAPPA 931 fixed to 
polycarbonate platform. Ventricular and atrial leads are connected to two 
separate pairs of sockets enabling electro-stimulation of 2 series with different 
pulse characteristics. Top right panel: Overview of pulsing system stimulation; 
Bottom panel: Polycarbonate reusable electrode lids designed to fit commercial 
dual chamber slides. 
77 
 
Figure 2. Gene expression in cultures of electro-stimulated 
cardiomyocytes. 
Confocal microscopy images of cardiomyocytes after three days of electric 
stimulation (A) and without stimulation (B). Cells were cultured and fixed on 
chamber-slides and stained with mouse antibody for rat cardiac troponin-I and 
FITC-labeled goat-anti-mouse. Actin was stained with Alexa- 494 labeled 
phalloidin and nuclei with DAPI. Scale bar indicates 10 µm. (C) Transcriptional 
activity of a 2kb human MYH6 promoter fragment in cultures with and without 
stimulation 3 days post-transfection. Cells were transfected with equal molar 
amounts of reporter plasmids and 10 ng of pGL4.75 CMV-Renilla luciferase 
reporter vector.  
 
 
On day 3 the medium was replaced with Ara-C-free high serum 
medium since Ara-C was shown to directly interfere with contractile 
activity. For transfection studies, cells can be transfected at this time. 
We obtained reproducible results for luciferase reporter constructs with 
the transfection reagent Fugene HD (Roche) using the manufacturers 
protocols when transfecting cells in high serum medium.  
In our studies we employed transfection studies to examine the 
promoter sequences of cardiac genes. A Myh6 promoter luciferase-
reporter construct was transfected into cardiomyocytes which 
subsequently were electro-stimulated (figure 2). The behavior of the 
luciferase reporter construct is similar to that of the endogenous Myh6; 
the activation observed in figure 2 is believed to be electric pulsing-
dependent.  
Typical spontaneous contractions normally observed in 
cardiomyocytes became visible on day 4, also in absence of electric 
stimulation. From day 4 onwards, culture medium was refreshed every 
24 hours with differentiation medium (DMEM, 2% horse serum, 1% 
HEPES, gentamycin 0.10 mmol/L, Fungizone 0.22 nmol/L) to avoid 
starvation of the cells. Serum concentration was shown to directly affect 
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formation of sarcomere structures and contractile activity. This was to 
be expected since serum levels directly modulate Serum Response 
Factor, a key cardiac transcription factor.[13, 14] Empirically we found 
normal differentiation and frequent spontaneous contractions in 
stimulated and non-stimulated cultures to be maintained at serum 
levels of 2% even after several days of culture. The best results for 
electro-stimulation were obtained when starting stimulation on day 4 
together with the first addition of differentiation medium, thereby 
allowing for a recovery time of several days similar to previously 
described.[6]  
In short, we present here a refined protocol for culturing NRVCMs 
and a pacemaker-based pulsing system which inherent characteristics 
renders it possible to place the whole system inside any standard 
incubator, making it much more convenient in use than conventional 
equipment. The electro-stimulated NRVCMs can be used for a many 
applications including reporter-assays, an interesting combination 
which to our knowledge remained un-investigated so far. 
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Abstract 
Cardiomyocytes in vivo are continuously subjected to electrical 
signals that evoke contractions and instigate drastic changes in the cells’ 
morphology and function. Studies on how electrical stimulation affects 
the cardiac transcriptome have remained limited to a small number of 
heart-specific genes. Furthermore, these studies have ignored the 
interplay between the electrical excitation and the subsequent 
contractions. We carried out a genome-wide assessment of the effects of 
electrical signaling on gene expression, while distinguishing between 
the effects deriving from the electrical pulses themselves and the effects 
instigated by the evoked contractions. The changes in gene expression 
in primary cultures of neonatal ventricular cardiomyocytes from Lewis 
Rattus norvegicus were investigated using micro-arrays and RT-QPCR. A 
series of experiments was included in which the culture medium was 
supplemented with the contraction inhibitor blebbistatin to allow for 
electrical stimulation in the absence of contraction. Electrical 
stimulation was shown to directly enhance calcium handling and induce 
cardiomyocyte differentiation by arresting cell division, and activating 
key cardiac transcription factors as well as additional differentiation 
mechanisms such as Wnt-signaling. Several genes involved in 
metabolism were also directly activated by electrical stimulation. 
Furthermore, our data suggest that contraction exerts negative feedback 
on the transcription of various genes. Together, these observations 
indicate that intercellular electric currents between adjacent 
cardiomyocytes have an important role in cardiomyocyte development. 
They act at least partially through a pulse-specific gene-expression 
program that is activated independently from the evoked contractions. 
Introduction 
Electrical pulses are essential for a normal functioning heart. They 
regulate the rhythm of contractions of cardiomyocytes. Together with 
the induced contractions, they are also crucial for maintaining the 
normal cellular structure and functioning of the individual 
cardiomyocytes. Cultured adult cardiomyocytes display better 
contractile activity when the cells have been subjected to continuous 
electrical pulsing. Several studies have shown that the sarcomere 
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structure and intercellular structures such as gap junctions of 
cardiomyocytes are maintained when subjected to extracellular 
electrical stimuli, while in their absence, these structures are 
disrupted.(3, 13, 18, 20) A similar response to electrical pulsing was 
observed for skeletal myocytes. For these cells it was found that the 
changes in sarcomere organization were not caused by the higher 
expression levels of various main structural proteins.(9) However, the 
expression levels of the structural proteins myosin heavy chain 7 
(Myh7) and myosin light chain 2 (Myl2) were both found to be elevated 
by electrical stimulation in cardiomyocytes.(18, 25) The increased 
expression of Myl2 appeared to be mediated by voltage-gated calcium 
channels and calmodulin, indicating the direct involvement of calcium 
handling.(18) 
The heart-specific hormone atrial natriuretic factor (ANF), encoded 
by the gene natriuretic peptide precursor A (Nppa), displayed a pulse-
dependent increase in expression similar to Myl2.(18) However, ANF-
levels also increase when cells are passively stretched, indicating that 
increased ANF expression could well be the result of the increased 
contractions induced by electrical stimulation and not by the increased 
electrical signaling itself.(14) In other studies it was found that 
mechanical stretching itself leads to changes in morphology, and 
differential RNA and protein synthesis. Furthermore, stretching was 
also found to affect intracellular calcium signaling in ways similar to 
electrical stimulation.(8, 15, 16, 25) A genome-wide analysis of 
mechanically induced changes in cardiomyocyte gene expression was 
undertaken by Frank and co-workers.(8) They postulated that the 
changes in gene expression that were observed in mechanically 
stretched cultures but not in phenylephrine-treated cultures or 
untreated controls were elicited by a stretch-specific gene program. A 
genome-wide study of the role of electrical signaling in the regulation of 
the cardiomyocyte transcriptome is currently lacking.  
In this study we provide a genome-wide analysis of the electrical 
pulse-induced changes in gene expression, in neonatal rat ventricular 
cardiomyocytes, which are frequently used as a model in cardiac 
research. In order to distinguish between the responses to the pulse-
induced calcium oscillations and subsequent contractions we employed 
the contraction inhibitor blebbistatin. We found that, independently 
from contraction, electrical signals directly affect the transcript levels of 
genes involved in a wide variety of processes including metabolism, 
cardiomyocyte differentiation and calcium handling, thus showing that 
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electrical signals by themselves play a crucial role in cardiomyocyte 
development and function. 
Materials and methods 
Cell culture 
Hearts were obtained from 0–3-day-old male and female Lewis rats 
from the experimental animal facility of Maastricht University. The use 
of animals for this study was evaluated and approved by the Maastricht 
University animal ethical committee. Procedures were in accordance 
with institutional guidelines. Cardiomyocytes were isolated and 
cultured as described previously.(17) After pre-plating, cells were 
plated in Permanox chamber slides (Lab-Tek) at 50,000 cells/cm2. When 
applicable, cells were electrically stimulated for 3 days starting when 
the differentiation medium was first applied. For contraction inhibition 
the ‘differentiation’ medium was supplemented with 10 µmol/L 
blebbistatin (Sigma-Aldrich, St. Louis, MO, USA). For stimulation of 
contraction in the absence of electrical stimulation, phenylepinephrine 
(Sigma-Aldrich) was added to 50 µmol/L.  
Immunohistochemistry 
Cardiomyocytes grown on Permanox chamber slides (Lab-Tek) were 
washed briefly 2X with HBSS. Cells were fixed for 20 minutes in 3.7% 
paraformaldehyde in PBS (Invitrogen) pH 7.5. After washing three times 
briefly with PBS the cells were incubated for 45 minutes in blocking 
solution: 1% bovine serum albumin in PBS. Incubation with primary 
mouse monoclonal antibody to cardiac troponin I (Abcam, Cambridge, 
UK) was carried out in 1% BSA and 0.1% Tween-20 in PBS for 45 
minutes. After three washes with 0.05% Tween-20 in PBS, samples were 
incubated for 30 minutes with the FITC-labeled goat-anti-mouse 
secondary antibody (Southern Biotech, Birmingham, AL, USA) and 
Phalloidin-alexa 595 (Invitrogen, Paisley, UK) in PBS containing 1% BSA 
and 0.1% Tween-20. Samples were then washed three times with 0.05% 
Tween-20 in PBS, twice with PBS, and mounted in 90% glycerol, 
containing 20 mM Tris-HCl pH 8.0, 0.2% NaN3, and 2% 1,4-di-
azobicyclo-(2,2,2)-octane (DABCO; Merck, Darmstadt, Germany). Nuclei 
were counterstained using 0.5 μg/ml diamidino-2-phenylindole (DAPI; 
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Sigma-Aldrich). Images were obtained using a Leica TCS SPE confocal 
laser scanning microscope system with a DMI 4000B inverted 
microscope. Cell diameter measurements were performed using ImageJ 
(NIH, USA). 
Live imaging 
Films were made using a Leica DMRIBE microscope equipped with a 
Hamamatsu digital camera (type C4742-95). The individual images, of 
which the films were composed, were recorded using a 10X 
magnification and an exposure time of 0.1 seconds. The final movies 
displayed the cells in real time. Open Lab version 2.2.5 (Improvision, 
Waltham, MA, USA) software was used. Using a Thermoplate (Tokai HIT, 
Shizuoka-ken, Japan), the mean temperature was maintained at 37 °C. 
RT-QPCR 
RNA was isolated using Trizol reagent (Invitrogen, Paisley, UK). First 
strand cDNA was made using M-MLV reverse transcriptase (Finnzymes, 
Espoo, Finland) starting from 1.0 µg of total RNA. QPCR was performed 
using a qPCR SYBR-Green master mix (Eurogentec, Liège, Belgium) in 
10-µl reactions on an ABI7900 (Applied Biosystems, Foster City, CA, 
USA). In all experiments peptidylprolyl isomerase-A (Ppia) was used as 
the reference gene. The oligonucleotide sequences are provided in the 
supplementary data. 
Expression arrays 
For each array, two separate samples from one series of either pulsed 
or non-pulsed cells were pooled. RNA quantity and quality were 
checked using Bioanalyzer RNA nano chips (Agilent, Santa Clara, CA, 
USA). One µg total RNA was taken from pooled RNA samples and 
processed using an Affymetrix One-Cycle cDNA synthesis kit 
(Affymetrix, Santa Clara, CA, USA). Samples were applied to a GeneChip 
Rat Expression Set 230 (Affymetrix) and processed according to the 
manufacturer’s instructions. CEL-files were transformed using the 
PLIER-algorithm. Analyses for differentially expressed genes were 
performed using BRB-Array Tools version 3.7.0 
(http://linus.nci.nih.gov/BRB-ArrayTools.html). In short, the array data 
were normalized using the housekeeping gene normalization option in 
86 
BRB-Array tools. For housekeeping genes we selected the rat orthologs 
of the housekeeping genes of the Affymetrix HG-U133 plus 2.0 arrays 
(the list of housekeeper probe sets is provided in the supplementary 
data). The resulting data were analyzed for differential expression of 
genes through class comparison of three separate series of experiments 
with arrays paired by experimental series (by batch of cardiomyocytes). 
To identify the affected biological processes, genes that were 
significantly differentially expressed between groups (p<0.05) were 
classified using DAVID (Database for Annotation, Visualization and 
Integrated Discovery).(7) We listed the clusters with an enrichment 
score (–log10p) corresponding to p<0.05. The microarray data discussed 
in this publication were deposited in NCBI's Gene Expression Omnibus 
and are accessible through GEO Series accession number GSE15856:  
http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE15856.(1) 
RESULTS 
Microscopic analysis of cell morphology and contractile activity. 
In our cell culture procedure the cardiomyocytes first underwent 
partial de-differentiation during which sarcomeric structures 
diminished and cells decreased in size. We found this to be the result of 
the low temperature (4 °C) at which the overnight incubation was 
performed (data not shown). In the initial recovery phase, upon plating, 
the cells increased in size again, formed cell–cell connections and 
eventually displayed the characteristic frequent spontaneous 
contractions. We performed a more detailed analysis of the influence of 
electrical stimulation on cardiomyocyte cell morphology using 
immunohistochemistry and confocal microscopy (figure 1). Cultures 
were fixed and stained after 3 days of culture in low serum 
differentiation medium with or without electrical stimulation. In 
addition, we included a series of non-stimulated cells that were 
supplemented with epinephrine. 
A difference in the overall shape of the cells was observed between 
electrically pulsed and non-pulsed cells. Non-pulsed cells displayed a 
somewhat fibroblast-like elliptical shape while the electrically pulsed 
cells were more ‘straight/rectangular’ over their whole length, similar to 
the cardiomyocytes in the native heart. The epinephrine-stimulated cells 
showed the typical appearance of hypertrophy, characterized by the 
increased width of the cells (quantified and depicted in Figure 1J). 
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Striation patterns originating from stained sarcomere protein structures 
were visible in all samples, although the epinephrine-treated cells 
showed a more diffuse pattern when compared to the electrically 
stimulated cells. Separate myofibrils remained clearly visible in the non-
pulsed cardiomyocytes. In electrically stimulated cardiomyocytes and 
those treated with epinephrine the myofibrils were packed closely 
against each other over the whole width of the cell with no visible 
spaces in between.  
The contractile activity of living cardiomyocytes in pulsed and non-
pulsed cultures was visualized and recorded using light microscopy. 
Movies displaying the contractions in real time are available as on-line 
supplementary data. As shown in these movies, the cardiomyocytes that 
were subjected to electrical pulsing displayed more constant and 
frequent contraction when compared to non-stimulated cells. The rapid 
synchronized contractions occurred more frequently than those at the 1 
Hz at which the pacemaker was programmed. We believe that this was 
the result of spontaneous contraction of the cardiomyocytes themselves, 
because the contractile activity continued when stimulation was 
temporarily halted (results not shown). 
Pulsing induced changes in gene expression. 
We evaluated the effect of extracellular electrical stimulation on the 
expression of gap junction protein alpha 1/connexin-43 (Gja1/Cx43), 
myosin heavy chain 6 (Myh6), myosin heavy chain 7 (Myh7) and Nppa in 
cardiomyocytes at different cell densities using RT-QPCR analysis. In 
these preliminary experiments we observed that some of the pulse-
induced changes were diminished at higher cell densities (>100,000 
cells/cm2, see Figure 2). Microscopic inspection of living cells at those 
higher cell densities revealed no difference in contractile activity, and 
both pulsed and non-pulsed cultures displayed contractions at 
frequencies higher than 1 Hz. We suspected that at higher cell densities 
depolarization waves originating from the spontaneous contractions 
overpowered the pulses supplied by the pulsing system. In order to 
detect as much pulse-related change as possible we used a seeding cell 
density of 50,000 cells/cm2 in all subsequent experiments. The 
frequencies at which the employed pacemakers can pulse are limited to 
those found in the human in vivo situation. Therefore we kept the 
pulsing frequency at 1 Hz although the intrinsic rhythm of neonatal 
heart-beat frequency is higher than 1 Hz. In preliminary experiments we 
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found that significant changes in cell morphology and gene expression 
were observed even at this frequency. 
 
 
Figure 1. Effect of extracellular applied electrical pulsing on 
cardiomyocyte morphology.  
Cardiomyocyte cultures were fixed and stained after 3 days of culture in low-
serum medium, and were non-pulsed (A–C), pulsed (D–F) or non-pulsed but 
supplemented with phenylepinephrine (G–I). The structural proteins actin 
(A,D,G) and the cardiac-specific troponin-I (B,E,H) were detected using 
phalloidin and TNNI3-specific antibody staining. An overlay shows DAPI-
stained nuclei (C,F,I). Scale bars indicate a length of 10 µm in the overview 
pictures and 4 µm in the enlarged views.  
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J 
 
           
Figure 1. Continued from previous page
To compare cell diameter, an indicator for hypertrophy, cellular diameters 
were measured at the site of the nuclei and average values were calculated (J). * 
Indicates a significant difference (p<0.006) according to the t-test.
 
 
Figure 2. Susceptibility to electrical pulsing at different cell densities.  
Samples from cultured extracellular electrically stimulated (3 days of 
stimulation) and non-stimulated cardiomyocytes were subjected to RT-QPCR 
analysis for the genes, Csrp3, Gja1/Cx43, Myh6, Myh7 and Nppa. Changes in gene 
expression are expressed as the fold change of stimulated cultures over non-
stimulated cultures of the same cell density. 
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To obtain an integral overview of differentially expressed genes as a 
result of electrical stimulation we performed gene-expression 
microarray analysis. Differentially expressed genes were identified by a 
pair-wise comparative analysis using BRB-Array Tools. Probe sets with 
p<0.05 were considered to be significantly differentially expressed. Out 
of the 2474 differentially expressed probe sets, the vast majority (1948) 
was up-regulated (see supplementary data). Differentially expressed 
genes were analyzed through gene ontology to identify the biological 
processes, cellular compartments and molecular functions in which the 
genes were enriched (Table 1).  
 
 
Table 1: Gene ontology clusters enriched with genes differentially 
expressed in electrically stimulated cardiomyocytes. 
 
Cluster Sub-cluster Up-
regulated 
Down-
regulated 
Biological process Apoptosis 1 
 Cyclase activity positive 
regulation  
4  
 Differentiation / 
morphogenesis 
6  
 Heart rate, positive regulation 3  
 Transcription regulation 1  
 Transcription, negative 
regulation 
5  
 Transcription, positive 
regulation 
7  
 Vasculature development 2 2 
   
Cellular compartment Mitochondrion 2  
 Myosin filament 3  
 Sarcomere 1  
   
Molecular function Ion channel activity 1  
 
Genes differentially expressed (p<0.05) by electrical pulsing were functionally 
annotated through clustering based on gene ontology terms using the DAVID 
program. Annotated clusters are ranked alphabetically within their category. 
Numbers refer to the ranking of the enrichment score, 1 being the most 
enriched. The DAVID program does not supply cluster names; therefore we 
supplied our own cluster names reflecting the elements of the clusters.  
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Hallmarks among the biological processes affected by electrical 
pulsing were the up-regulated ‘differentiation/ morphogenesis’ and 
‘positive regulation of heart rate’. Apoptosis was found to be down-
regulated by electrical pulsing. Furthermore, we observed the increased 
expression of genes encoding components of the cardiomyocytes’ 
sarcomeres and ion-channels. In Table 2 we provide the gene-
expression data for a selection of genes within these groups. For a 
number of genes we verified gene expression using RT-QPCR (Figure 3). 
Although the changes observed in the RT-QPCR were much stronger, the 
overall changes followed the same pattern. 
 
 
 
 
Figure 3. Electrical stimulation affects transcription independently from 
contraction.  
Graph depicts fold changes of gene expression as determined through RT-QPCR 
analysis on samples from cultured extracellular electrically stimulated (3 days 
of stimulation) and non-stimulated cardiomyocytes. White bars: comparing 
electrically stimulated to non-stimulated. Black bars: comparing blebbistatin-
supplemented electrically stimulated to normal stimulated. Grey bars: 
comparing blebbistatin-supplemented non-stimulated to normal non-
stimulated. 
 * indicates significant (p<0.05) differential expression. ** indicates a significant 
difference (p<0.05) between the two series. 
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Blebbistatin supplementation reveals a stretch-independent gene 
expression program.  
The observed changes in gene expression induced by electrical 
stimulation were to some extent the result of increased contractile 
activity. In order to identify which of the changes in the gene expression 
program arose specifically by pulsing, independently from contraction, 
we supplemented electrically pulsed cardiomyocyte cultures with the 
contraction-blocking agent blebbistatin. In Table 2 the ratios of fold 
changes determined via microarray analysis are given as indicators of 
the changes in expression between matching pairs of experiments. For 
many genes, supplementation with blebbistatin did not lead to a 
significant change in expression levels, indicating that the increase 
observed in the pulsed cultures (compared to non-pulsed) resulted only 
from electrical stimulation. A few genes, including triadin (Trdn), Myh6, 
myosin light chain 7 (Myl7), carnitine palmitoyltransferase 1b (Cpt1b) 
and hydroxyacyl-Coenzyme A dehydrogenase (Hadh) displayed an even 
further increase in expression. Through RT-QPCR, we confirmed this for 
Myh6 (Figure 3). When considering the effects of pulsing and 
blebbistatin supplementation of the pulsed cells, the cumulative changes 
in gene expression of some of the genes indicated in Table 2 differed by 
more than three-fold compared to non-pulsed cells. 
To investigate the possible effect of blebbistatin addition itself on 
gene expression we compared the expression levels of selected genes in 
non-stimulated cultures with and without blebbistatin supplementation 
(Figure 4). In the absence of external stimulation, the addition of 
blebbistatin led to a decrease in the expression of Myh6 and Atp2a2. 
Although not reaching significance, the cardiac-specific genes Myl2, 
Nppa and Tbx5 also displayed an overall trend in down-regulation. 
Discussion 
Using a pulsing system based on human pacemakers, we carried out 
a genome-wide assessment of the effect of electrical stimulation on the 
transcriptome of cultured primary neonatal rat ventricular 
cardiomyocytes.(17) Immunohistochemistry and imaging of living cells 
in culture showed that electrical stimulation appeared to enhance (re-
)differentiation. This proposed increase in differentiation was 
confirmed by gene-expression analyses. We found that electrical 
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stimulation led to the increased expression of cardiac-specific genes 
such as Myh6, Gja1 and the cardiac-specific isoform of troponin-T 
(Tnnt2). At the same time, myosin light chain 1(Myl1) and troponin-C 2 
(Tnnc2) were down-regulated. Both these genes are known to have a 
more skeletal muscle-restricted expression profile. The cells thus 
deviated more from a common striated muscle phenotype. With regards 
ion channels, we observed increased expression of cardiac-specific 
transcripts, amongst them sarcoplasmic calcium channel Atp2a2 and the 
cardiac ventricle L-type Ca2+ channel isoform Cacna1c.(11) 
Activation of the cardiac-specific transcription program was further 
demonstrated by the differential expression of several key cardiac-
enriched transcription factors. Increased expression was observed for 
T-box 5 (Tbx5), myocardin (Myocd) and myocyte enhancing factor C 
(Mef2c). All are involved in cardiogenesis and regulation of the 
transcription of heart-specific genes in later stages of life.(4, 22) 
Meanwhile, expression of the twist homolog Twist1, a negative regulator 
of cardiac-specific gene transcription, was decreased.(10) The increased 
differentiation was also apparent from the increased expression of some 
of the more ubiquitously expressed genes: increased levels of the cyclin-
dependent kinases Cdkn1c and Cdkn2b, both of which augment the 
arrest of cell division, showed that the cells exit from a proliferative 
state and attain a more differentiated state. Activation of Van Gogh-like 
2 (Vangl2) and low density lipoprotein 6 (Lrp6) indicated activation of 
Wnt-frizzled signaling.(19, 23)  
The accelerated differentiation due to the application of externally 
generated electrical pulses was only observed in cardiomyocytes 
cultured at low densities (≤ 50,000 cells/cm2). It seems likely that in 
cardiomyocyte cultures at lower cell densities the extracellular electrical 
pulses functionally compensate for the lack of electrical stimuli normally 
obtained from the surrounding cells. Once the cultured cardiomyocytes 
develop further and form more intercellular connections, the cells can 
take over some of the pacemaker pulsing activity through their 
spontaneous contraction and provoke contractions in neighboring cells. 
This in itself also demonstrates that electrical signals transmitted by the 
cells themselves are important in cardiomyocyte development. 
Furthermore, these observations concur with the accelerated 
differentiation of mesenchymal stem cells to cardiomyocytes at higher 
cell densities, independently of extra electrical stimuli, and the 
improvement in cardiomyocyte function at higher cell densities.(6, 24)  
At higher cell densities, the expression levels of Myh6 were still 
increased as a result of electrical pulsing, suggesting a similar ability in 
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vivo. In a recent study on human heart failure patients, expression of 
MYH6, together with that of ATP2A2, was indeed increased in hearts 
receiving electrical stimulation.(5) In addition, our data showed that 
electrical pulsing leads to the down-regulation of genes involved in 
apoptosis, thus providing an additional explanation for the observed 
beneficial effect that electrical stimulation has on the failing heart. 
Contrary to previous publications, we did not observe increased 
expression of Nppa in electrically stimulated cardiomyocytes.(18) 
Besides the unchanged expression of Nppa, the expression of the 
hypertrophy mediators Mapk1 (ERK2), Mapk3 Map2k5 (ERK1) Map2k5 
(MEK5) and v-akt murine thymoma viral oncogene homolog 1 (Akt1) 
also remained unchanged by electrical stimulation.(2) In addition to this 
we found the expression of Trdn to be increased by pulsing while in PE-
stimulated cells, a model for hypertrophy, a significant decrease has 
previously been observed.(8) Besides supporting the proposed absence 
of hypertrophy this shows that epinephrine and electrical stimulation 
activate very distinct mechanisms in gene expression regulation.  
To distinguish between transcriptional responses to electrical 
currents and stretching, the contraction inhibitor blebbistatin was 
employed. For genes in which expression in pulsed cells was not altered 
by blebbistatin supplementation, it is likely that their observed up-
regulation by electrical stimulation resulted from the electrical signaling 
and not from the subsequent contractions. Tbx5 and Mef2C, encoding 
two key cardiac transcription factors, were among these genes, as well 
as glycerol-3-phosphate acyltransferase (Gpam) and alpha-branched 
chain ketoacid dehydrogenase (Bckdha), both of which are involved in 
ß-oxidation. 
Blebbistatin supplementation of electrically stimulated cultures led to 
an even further increase in the expression of several genes, e.g. Myh6, 
Trdn, Cpt1b and Hadh when compared to normal pulsed cultures. The 
latter two are also involved in ß-oxidation and Hadh was previously 
described to be up-regulated during increased muscle activity.(21) This 
suggests that pulsing, independently from contraction, affects the 
expression of genes involved in physiological processes.  
The down-regulation of Myh6 in control experiments, with 
blebbistatin supplementation of non-stimulated cells, suggests that the 
increase in Myh6 expression in the electrically stimulated cultures was 
not caused by a side effect of blebbistatin, but by the occurrence of a 
negative transcription regulatory mechanism exerted by stretching. 
Indeed, in the data from the stretch study by Frank et al., Myh6 
displayed a clear trend towards being down-regulated by stretching.(8) 
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A likely explanation for the down-regulation of Myh6 and Atp2a2 by 
blebbistatin in non-stimulated cultures is that overall cardiomyocyte 
development and function were seriously hampered when contraction 
was blocked in the absence of external electrical stimuli. It thereby 
affected the cardiomyocyte transcriptome as a whole. 
The increase in expression of Atp2a2, Cacna1c, Trdn and Hrc and the 
down-regulation of the Ca2+ oscillation antagonist type 3 inositol 1,4,5-
triphosphate receptor (Itpr3) suggest that calcium handling is activated 
in a similar way to that described in earlier publications.(12, 13) In 
conjunction with this we found that the activation of several genes 
persisted in blebbistatin-supplemented cultures. This affirmed that 
calcium cycling continued in the absence of contractions.  
In addition to the identification of pulse-specific genes, the blocking 
of contraction by blebbistatin also revealed that several genes are to 
some extent activated by stretching. One such stretch-dependent gene is 
Myh7, although it was not identified as such in the mechanical stretch 
study by Frank et al.(8) Differences in cell density and the spontaneous 
contractions of cardiomyocytes are a likely cause of this. In their 
mechanical stretch study, Frank et al. used a cell density of 175,000/cm2 
while in our experiments cell density was typically 50,000/cm2. At 
higher cell densities, cells can more easily excite each other electrically 
and induce deformation of the surrounding cells, thereby triggering the 
stretch-related gene expression program. Although not reaching 
significance, Nppa also displayed a slight trend for being down-
regulated by blebbistatin supplementation. This supports the findings of 
Kinunnen et al., who reported Nppa to be activated by stretching.(14) 
However, the use of neonatal myocytes at the low densities in this 
study brings with it some limitations for making comparisons to the in 
vivo situation of the (adult) heart. Pulse-induced changes in gene 
expression would have to be studied at higher cell densities (>100,000 
cells/cm2) to obtain more representative information on the role of 
electrical signaling in vivo.  
Nevertheless, the processes activated by electrical stimulation in the 
absence of contractions are also likely candidates for being induced by 
pulsing in vivo. Based upon our findings and the previously described 
activation of for example ATP2A2 by electrical pulsing in vivo, we believe 
that pulse-dependent activation of calcium handling, as observed in our 
study, also occurs in vivo, and with it the fundamental effects that it 
exerts on the cardiomyocyte transcriptome.(5) Electrical signaling, by 
itself, is therefore also likely to provide an additional mechanism along 
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with contraction, through which the cardiomyocyte transcriptome 
reacts to alterations in heart activity. 
We thus showed that aside from initiating contractions, electrical 
signals activate a unique and contraction-independent gene expression 
program. This program is important in cardiomyocyte development and 
function and acts through mechanisms that differ from those activated 
by mechanical stretching or epinephrine stimulation. 
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Abstract 
Of only a few cardiac genes the promoter architecture and associated 
transcriptional regulation have been investigated into great detail. 
However, for most of the cardiac genes there still remain many 
questions on the fundamentals of their transcriptional regulation. We 
screened the immediate 5’ flanking promoter regions of cardiac genes 
for regulatory motifs and modules involved in obtaining cardiac-specific 
expression, and in addition for elements involved in the transcriptional 
response to electric stimuli. Similar to others, we found the elements for 
serum response factor (SRF), myocyte enhancer factor 2 (MEF2) and 
SP1 to be involved in obtaining cardiac specificity. Our screening for 
elements mediating the transcriptional response to electric stimulation 
revealed an enrichment of binding sites for transcription factors known 
to act in hypertrophy, TBX5, MEF2, GATA1, and LEF1. Through 
experimental validation we show that in the cysteine and glycine-rich 
protein 3 (CSRP3) promoter TCF7L2 binds to a predicted LEF1 site. 
While β-catenin signaling has been previously found to be involved in 
activity induced changes in gene-expression, we show that the binding 
sites involved, are enriched in the promoters of genes responding to 
pulsing in the absence of contraction. 
Introduction 
With the human genome sequence known, one of the challenges 
remaining is to determine which of the billions of base pairs in the DNA 
are involved in regulating the transcription of the more than 20 
thousand genes encoded within the human genome. To circumvent the 
laborious research on the transcriptional regulation of individual genes, 
bioinformatics analyses are performed on sets of genes that respond in 
parallel to specific stimuli or display similar spatial and or temporal 
expression profiles. The underlying hypothesis is that regulatory 
elements responsible for this shared transcriptional activity are 
enriched within the promoter sequences of such a set of genes.[1-3] 
Within the genes, these searches for the regulatory elements are often 
limited to the conserved non-coding sequences (CNS), which although 
comprising only 1-2% of the genome are apt to contain sequences 
involved in transcription regulation.[3-7] Several studies have already 
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been undertaken to identify motifs involved in tissue-specific gene 
expression.[8-10] However, many of these studies only involved in silico 
(computer) analysis and provided no experimental validation. The 
necessity for some sort of ‘wet-bench’ derived supportive data however 
becomes apparent from studies like those of Bajic et al., who found that 
some of the programs in use perform even worse than random 
guessing.[11] 
In our study we first searched for transcription factors and cis-
regulatory modules responsible for restricting gene expression to the 
heart’s unique muscle cells, the cardiomyocytes. Secondly, we 
performed a search for transcriptional elements involved in a process 
that is a unique characteristic for the cardiomyocytes, the response to 
continuous electric stimulation. For several known cardiac-specific 
genes it is known that a relative short stretch of 5’-flanking sequence is 
sufficient to drive cardiac-specific expression. Often, a few hundred base 
pairs are enough to restrict their expression to the heart.[12-15] 
However, there are instances known of key cardiac enhancers located 
further upstream. Restriction of ACTC1 expression to the heart depends 
for example on an enhancer located 2 kb upstream of the TSS.[15] 
Taking this into account, we focused our search for regulatory elements 
at first on the region stretching up to 2 kb directly upstream of the TSS. 
Previously we investigated genome-wide the effects of electric 
stimulation on gene expression and showed that several cardiac-specific 
genes are activated by electric pulsing independent from 
contractions.[16] The identification of cis-regulatory elements and 
proteins involved in mediating the response of the cardiac 
transcriptome to electric signaling will bring valuable information on 
one of the basic mechanisms contributing to the formation and 
maintenance of the heart. We hypothesized that a shared regulatory 
mechanism at the transcription level could be underlying the increase in 
gene expression of pulsing-responsive genes. Using the aforementioned 
approach for finding regulatory motifs responsible for a shared 
transcription program could thus potentially also provide valuable 
insights in the heart’s response to electric signals. 
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Materials and methods 
Data collection and preprocessing 
Based on the gene expression databases of SYMATLAS/BioGPS and 
REFEXA (http://157.82.78.238/refexa/main_search.jsp), we composed 
5 sets of human genes, expressed specifically in either, adipocytes, 
endothelium, heart, skeletal or smooth muscle.[14] An additional sixth 
set was composed, consisting of 500 random human genes. The 
composed sets of tissue-specific genes are supplied as supplementary 
data (supplementary file 1). For the tissue-specific genes and their 
corresponding mouse orthologues, we downloaded from the 
ENSEMBL35 database the genomic sequence of the entire gene, plus 
10kb up- and down-stream of the gene.[17] The human and mouse 
sequences were pair-wise aligned with AVID and regions were 
considered to be conserved when more than 75% was identical within a 
sliding window of 100bp.[18] Further analysis was restricted to the 
genomic sequences and conserved regions located within 2kb up- and 
0.5kb down-stream of the transcription start site, an approximation of 
the promoter (supplementary file 2). Moreover, parts that overlapped 
with adjacent genes were discarded. 
Selection of regulatory motifs 
Known motifs - For the detection of ‘known’ motifs we used the 
positional weight matrices (PWMs) of the TRANSFAC Pro 9.3 collection, 
thereby only employing the 557 PWMs for vertebrate factors.[19, 20] As 
background model for motif searches we used the third-order Markov 
chain background model (BG), supplied by the developers of 
MOTIFSCANNER[21] This model was computed using the sequences 
between −2000 bp and +200 bp relative to the TSS of all human genes 
deposited in ENSEMBL. An intermediate set (Set 1) of TRANSFAC-
derived PWMs was assembled by selecting those that had an occurrence 
within the CNS according to MOTIFSCANNER (prior=0.2, double 
strand=yes, background=BG).  
De novo motifs - Potential de novo PWMs/ motifs within the CNS 
were searched for using the Gibbs sampling tool MOTIFSAMPLER 
(prior=0.2, double strand=only forward, background=BG, number 
motifs=1, number runs=100, width= 3-12bp).[21] Per tissue, PWMs 
were clustered based on width and one representative PWM was 
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preserved. Clustering and selection was then repeated for all the 
preserved PWMs for each tissue. For the PWM-clustering we used 
graph-based clustering with MCL (I=2.2) and Kullback-Leibler, 
computed with MOTIFCOMPARISON (threshold=5, maximum allowed 
shift=0) from the INCLUSIVE software package, as measure of 
divergence.[22, 23] The obtained motifs of this clustering were 
assembled in a second intermediate set of motifs (Set 2). 
Computational identification of tissue-specific motifs 
Using MOTIFSCANNER (prior=0.2, double strand=yes, 
background=BG) we calculated for each PWM in Set1 and Set2 the 
number of instances in the CNS. Then we analyzed per list of tissue-
specific genes whether the frequency was significantly larger than one 
would expect based on the results for the list of random genes. All 
PWMs from Set1 and Set2 with a statistically over-represented (SOR)-
score <= 0.1 were merged into a combined set (Set3). To remove 
redundant motifs a final list (Set4) was created by discarding de novo 
PWMs from Set3 that matched with the prior selected TRANSFAC PWMs 
(Set1). A de novo PWM was considered as matching a TRANSFAC PWM 
based on 3 criteria: (1) the de novo PWM had an instance that 
overlapped at least for 75% with an instance of the TRANSFAC PWM, (2) 
the Kullback-Leibler divergence between the PWMs as computed with 
MOTIFCOMPARISON (threshold=0.5, maximum allowed shift=2), was 
less than 0.5 and (3) the logos of the PWMs looked similar after visual 
inspection. 
Computational identification of binding sites and cis-regulatory 
modules  
Binding sites for PWMs in the list of Set4 were located in the 
complete sequences (irrespective of conservation) using 
MOTIFSCANNER (prior=0.2, double strand=yes, background=BG). Again 
the observed number of instances per tissue was compared with the 
number expected based on the results for the set of random genes. For 
each tissue only the binding sites of PWMs with a SOR <= 0.1 were 
retained. The predicted binding sites were used to identify cis-
regulatory modules. Therefore, we constructed a co-localization 
network G=(N,E) where N is the set of PWMs and E is a set of weighted 
edges between them. The weights were computed from the 
MOTIFSCANNER results per tissue as the probability that the two PWMs 
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have an instance within 200 bp of each other. Clusters in this network 
are identified by graph-clustering with MCL (I=1.6). Retained were the 
heterogeneous clusters that grouped together 2-7 distinct PWMs and for 
which we could confirm a clustering of the associated binding sites after 
visual inspection of the MOTIFSCANNER results with TOUCAN[21] Cis-
regulatory modules could then be identified as regions in the genomic 
sequences that were densely populated by instances of the PWMs in one 
of such PWM clusters. 
Computational identification of pulse-responsive regulatory motifs  
To identify cis-regulatory elements with a potential role in the 
transcriptional response of the heart muscle to electric stimulation, we 
employed the microarray-data from our study in cultured 
cardiomyocytes.[16] This dataset is accessible under NCBI GEO series 
accession number GSE15856.[24] 
First genes were selected that were up-regulated in cells exposed to 
electric pulsing. To allow for a larger number of cardiac genes, genes 
with p > 0.1 were selected. Next all genes were filtered out that were 
down-regulated by addition of blebbistatin. The up-regulation of these 
genes in the pulsed samples may have been the result from an increase 
in stretch activity and not from the electric pulses themselves. The 
reference set was composed of genes of which the expression was not 
increased by pulsing. From both gene-sets we selected the cardiac-
specific genes by comparing the gene-expression levels in human 
cardiac ventricle with that in a set of 64 other human tissues.[25] By 
using this dataset we incorporated the assumption that overall tissue-
specificity of genes in human and rat is comparable. Tissue specificity is 
expressed as the entropy value (Q).[26] Genes with an entropy value 
(Q)<5 were considered heart-specific (supplementary file 3). Genes that 
occurred in both sets due to results from different probe-sets were 
omitted from analysis. Similar to the previous analyses overrepresented 
TRANSFAC motifs within the promoter region -1 kb to +500 bp were 
identified using MOTIFSCANNER (prior 0.2, both strands). In this 
analysis rat promoters were investigated. Of the available species for 
which models are available in MOTIFSCANNER, mouse is the most 
similar to rat. For this, the third-order model of 1 KB mouse ENSEMBL 
promoters, provided by the MOTIFSCANNER program was chosen. 
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Plasmids and constructs 
Promoter fragments were obtained through PCR on human genomic 
DNA. Resulting promoter fragments were cloned into the luciferase 
reporter vector pGL4.10 (Promega) using standard molecular biology 
techniques. The promoter fragments used were, CSRP3[-458/+77], 
MYH6 [-2048/+25] and HRC [-965/+73] The human genomic sequences 
of the selected promoter regions are provided in supplementary file 10. 
Mutant constructs were generated using the QuickChange II site-
directed mutagenesis system (Stratagene, La Jolla, CA USA).  
Cell culture and transfection 
Cultures of primary neonatal rat ventricular cardiomyocytes were 
prepared and maintained as described earlier.[27] Transfections were 
performed using FugeneHD (Roche Applied Biosystems) according to 
manufacturer’s instructions. 
Luciferase assays 
Luciferase was measured 3 days post transfection using the Dual-Glo 
reagent (Promega, Madison WI U.S.A.) on a Glomax 96 well luminometer 
(Promega, Madison WI USA). 
Electrophoretic mobility shift assay (EMSA) 
EMSA was performed using biotin labeled probes (Eurogentec, Liege 
Belgium) and a LightShift chemiluminescence EMSA kit (Thermo 
Scientific, Rockford IL USA). Oligonucleotide sequences of the probes 
used for EMSA are listed in supplementary file 4. 
Results 
Predicted cis-regulatory elements and modules 
Based on gene-expression data from publicly accessible databases, 
lists were composed consisting of genes which’ expression is restricted 
to either cardiomyocytes, skeletal muscle, smooth muscle, endothelial 
cells or adipocytes (supplementary file 1). Smooth muscle and skeletal 
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muscle were included in the analyses in order to distinguish 
cardiomyocyte-specific elements from those associated with muscle-
tissues in general. 
Through a computational procedure (see materials and methods) we 
derived from human-mouse conserved non-coding sequences (CNS) in 
the promoter regions of the genes some patterns that characterize the 
DNA-binding preferences of relevant trans-regulatory elements. The 
patterns – called positional weight matrices (PWMs) – were selected 
from an existing database (TRANSFAC) or modeled from scratch. The 
names of the final selection of TRANSFAC PWMs are available in 
supplementary file 5. The de novo PWMs were predicted by scanning the 
sequences with MOTIFSAMPLER. We chose for a single-stranded search, 
since a double-stranded search showed a bias toward palindrome-
motifs. Out of the 413 de novo PWMs that we identified in the CNS, 123 
were retained after evaluation of their statistical overrepresentation. 
The majority of identified de novo PWMs have a width of 6 to 9 bp, 
enabling the complete binding site to be located inside the major groove 
of the DNA helix for better accessibility to binding proteins. With the 
employed filtering procedures, we were able to eliminate some of the 
similar de novo PWMs, but not all of them. Some redundancy remained 
among the de novo PWMs. Patterns that repeatedly can be observed 
among the cardiac-specific de novo PWMs are for instance ’GCAGG’, 
‘GGGNN(N)GGG(G)’ and their reverse complement. Matching of de novo-
PWMs with known (TRANSFAC) PWMs, revealed that 28 ‘de novo’ 
PWMs (23%) correspond to 8 well-known transcription factors, MAZ, 
UF, NF-kappa, CHCH, SP, MZF, AP and E2F. The matrices of the final 
selection of de novo PWMs are available in supplementary file 6. 
The identified PWMs were used to predict the location of cis-
regulatory elements in the ‘complete’ promoter sequences, -2 kb to + 0.5 
kb of the TSS, including non-conserved regions. The computational 
procedure (see materials and methods) yielded a catalogue consisting of 
5,278 binding sites for 135 different PWMs (supplementary file 7). We 
searched in more detail for transcription factors with binding sites that 
repeatedly appear in close proximity of one another within the 
promoter set of a certain tissue. Clusters of such transcription factor 
binding sites are candidate cis-regulatory modules. After graph-
clustering and filtering (see materials and methods), we found 10 
groups of motifs with clustered binding sites in heart, smooth muscle 
and endothelial tissue (supplementary file 8). Most groups contain a 
mixture of known and de novo PWMs.  
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Regions 0.5kb proximal to the TSS appear to be enriched both with 
CNS and cis-regulatory elements (see figure 1). Sequence alignment of 
the tissue-specific genes with their mouse orthologues revealed that 
CNS make up for 13 percent of the sequence between – 2kb to +0.5 kb of 
the TSS and most of these CNS are located within 500 bp of the TSS. The 
alignment approach selected genomic regions that are slightly enriched 
with regulatory elements. Depending on the tissue, 15.92 ± 2.42 percent 
of the binding sites of known transcription factors (PWM set S1, see 
methods) fall within a predicted CNS according to MOTIFSCANNER. A 
one-sided Wilcoxon signed rank test confirmed that this percentage is 
significantly larger than the expected 13 percent (p-value=0.03). 
Moreover, the enrichment increases with 3.42 ± 0.79 percent when only 
binding sites on the 5’-3’ strand are considered. This increase is also 
statistically significant according to a one-sided Wilcoxon signed rank 
test (p-value=0.03). 
Comparison of predicted tissue-specific regulatory programs 
Comparison of the motif-scanning results of the complete sequences 
(i.e. including the non-conserved regions) for the 5 tissues, revealed 
similarities between heart, skeletal- and smooth-muscle. SRF emerges 
strongly across the various types of muscle. HEN1, which is predicted to 
play a role in transcription of heart genes, represents an E-box binding 
protein. Such E-boxes can however be targeted by a wide variety of 
factors. Analogous to the foregoing, endothelial and adipocyte tissues 
share fewer factors with the other tissues we investigated here, the 
muscles. Known motifs that seem to be more typical for the heart are 
NMYC - associated with N-Myc - and muscle initiator sequence 19 - 
associated with yet unidentified transcription factor(s). Other known 
factors with binding sites that are shared between heart and the other 
tissues are AP2α, AR, E2A, GLI, HIF1, LBP1, MAZR, MEF2, MEF3, MYOD, 
MZF1, NFκ-B, RSRFC4, SMAD3, SMAD4, SP1 and TAL1.  
The analysis of clustered binding sites revealed in all muscles a 
grouping of many versions of the PWM of SRF. Skeletal tissue also has a 
grouping with many versions of the PWM of PPARG. All muscle tissues 
contain a large cluster that includes SP1/TAL1/MYOD. This combination 
thus seems to be representative for a general muscle program. Both 
striated muscles, heart and skeletal, contain a cluster including MEF2 
and RSRFC4. Heart tissue has an interesting specific cluster, which 
includes muscle initiator sequence 19 (a motif that was only included in 
the cardiac-specific list).  
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Figure 1. Enrichment of conserved non-coding sequences and 
transcription factor binding sites in the region surrounding the TSS. 
(A) Genomic DNA sequences between -2kb and +0.5 kb of the TSS of human 
genes and their mouse orthologues were aligned with a sliding window of 100 
bp. Sequences not encoding for proteins with >75 percent identity between 
human and mouse were scored as conserved non-coding sequences (CNS). The 
number of CNS for each position, normalized over the 2.5 kb region was 
plotted. The smoothened line depicts the overall trend fitted through all data 
points. (B) A catalogue was composed of 6,235 computationally predicted 
binding sites within -2kb and +0.5kb from the TSS of the investigated genes 
(including non-conserved regions). The graph describes the number of 
predicted binding sites that cover each position, computed over all sequences 
and normalized over the 2.5kb region. The trend is indicated by a smoothed 
line that was fitted through all data points.  
A 
B 
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Predicted pulse-responsive regulatory program 
Based on previously generated micro-array data we selected a set of 
12 cardiac-specific genes that were specifically activated by electric 
stimuli, independent of contraction (supplementary file 2).[28] Using 
the TRANSFAC matrices, we detected the potential TF-binding sites 
within the human/rat CNS between 1 kb upstream and 500 bp 
downstream of the TSS. As a control set, we selected cardiac-specific 
genes displaying no specific response to electric stimuli. 
Overrepresentation of known motifs was again determined using a 
binomial distribution. Motifs identified as being enriched in promoters 
of pulse-responsive genes are listed in supplementary file 9. The top-
ranking motif is E-box 47. Amongst the other motifs identified are 
several well-known key cardiac transcription factors, GATA, TBX5, 
MEF2 and MYOG. Especially of the latter a high number of occurrences 
were found. Interestingly, amongst the motifs identified was also YY1, a 
factor known to act as a transcriptional inhibitor in muscle.[29] In our 
analysis we also found LEF1 to be enriched in pulse responsive genes. 
LEF1 binding sites can be targeted by TCF7L2 the final actor of many 
pathways leading to the activation of β-catenin that acts in concert with 
TCF7L2. Due to the limited number of genes available in the set of pulse 
responsive genes, a prediction of cis-regulatory modules was not 
attempted.  
In vitro verification of identified motifs 
In addition to investigating the effects of electric stimuli on the 
endogenous rat genes, we also performed studies on the effects of 
electric stimuli on the transcriptional activity of human promoters. For 
this, neonatal rat cardiomyocytes were transiently transfected with 
luciferase reporter constructs containing human promoter fragments. 
Both a -780/+77 promoter fragment of cysteine and glycine rich protein 
3 (CSRP3) and a -2028/+30 promoter fragment of alpha myosin heavy 
chain (MYH6) were found to be strongly activated by electric 
stimulation (figure 2).  
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Figure 2. Human promoter fragments of CSRP3 and MYH6 are activated by 
electric stimulation. Primary cultures of neonatal rat ventricular myocytes 
were transfected with firefly luciferase reporter constructs baring the human 
promoter fragments CSRP3[-758/+77], MYH6 [-2048/+25] and HRC [-
965/+73]. After transfection, cultures were maintained for 3 days with and 
without electric stimulation (1 ms pulses of 1 Volt/cm at 1 Hz). Signals are 
normalized to 10,000 counts/s of activity from co-transfected CMV-Renilla 
luciferase. 
 
Using the CSRP3-reporter construct we verified in vitro the relevance 
of the motifs identified in the bioinformatics screening. All the promoter 
elements that we investigated in vitro are conserved across species 
(figure 3). Using site directed mutagenesis the TFBSs were mutated in 
separate constructs. Care was given to avoid the introduction of any 
potential new TFBSs as a result of the mutagenesis. The effect of these 
mutations is displayed in figure 4. From figure 4 can be seen that 
transcriptional activity of the CSRP3 promoter decreases about 10 fold 
when disrupting the myogenin site. Mutation of either the TCF7L2 or 
Sp1 site completely abolished transcriptional activity. 
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          -465      -458 
Hs  TTTTTTCTCC CAAGCT.TCT TTGAAGAGAT TATCTAAGTA 
Mm  CACCTCCCCA CACGCCCTCC TTGAAGAGAT TAGTTAAGTG 
Rn  CTTCAGGGTC TGAACC.TAT TTGTTGAGGG TGGCCATTTG 
Cf  TTTCTTTCCC CAAGTT.TCT TTGAAGAGAT TATCTAAGTA 
Bt  CTTATTTTCC CAAGCT.GCT TTGAAGAGAT TATCTAAGTA 
 
 
 
         -285      -276 
Hs  ......AGGT C..AGTGGGG TGGGGGCCTG GAGAAATGAT 
Mm  GGC...AGGG C..ATGGGGG TGGGGGTGTG TGGAAGGGAG 
Rn  TTCACCATGC CGAACTGGGG TGGAGGTGCA AAATGTGGAG 
Cf  ......AGGT C..AGGGGAG TAGGAGCCTG GAAAAATGAT 
Bt  ......AGGT C..AGGGGAC TGAGAGCCGG GAAAAATGAT 
 
 
 
   -51    -45 
Hs  TTTCAGCCCC TGATAGCAGT TGTGTTACTC ACGTCTCATT 
Mm  TTT....... ...TGGCAAT TGTGTTACTC GTGTCTTATT 
Rn  GAGAAA.... TGCTACCAGT GGACTC.CAC GAGGATCAGG 
Cf  TTTCAGCCTC TGATAGCAGT TGTGTTACTC ATGTCTCATT 
Bt  TTTCAGCCTC TGATAGCAGT TGTGTTACTC ATGTCTCATT 
 
 
Figure 3. Conservation of TFBSs in CSRP3 promoter across mammalian 
species. Alignment of CSRP3 5’-flanking promoter sequences for human (Hs), 
Mouse (Mm), Rat (Rn), Dog (Cf) and cow (Bt). Highlighted are the TFBSs for 
myogenin, SP1 and TCF7L2. Numeric values indicate distance in base pairs to 
TSS. 
 
While myogenin and SP1 had both been previously described to play 
a key role in the transcription regulation of cardiac genes, no similar 
findings had been done for TCF7L2.[30, 31] To verify whether TCF7L2 
indeed binds to the proposed binding site within the CSRP3 promoter 
we performed an electrophoretic mobility shift assay (EMSA) (figure 5). 
Biotin labeled probes corresponding to the human genomic sequence 
containing the TCF7L2 binding site were mixed with nuclear extract 
from human heart. To verify specificity of binding mutant probes were 
used, containing the site mutation identical to that of the mutant 
luciferase construct. In addition a series was included where an 
MYOGENIN
SP1
TCF7L2
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antibody specific for TCF7L2 was added. At the time of performing the 
experiments the only available antibody was one that binds to TCF7L2 
at the region required by the protein to bind to the DNA. As a result, a 
super-shift could not be detected. However, addition of the antibody 
resulted in reduced protein binding to the wild type probe, indicating 
that the binding factor is indeed TCF7L2. 
 
 
 
 
 
 
 
 
 
Figure 4. TCF7L2, Sp1 and MYOG binding sites are essential for CSRP3 
transcription. 
 A: Proposed TFBSs were mutated as indicated in the pGL4.10 firefly luciferase 
reporter vector containing the wild type CSRP3-promoter sequence from -780 
to +77 relative to the TSS. The myogenin site partially overlaps with a predicted 
binding site for GATA factor, the latter was left intact by the mutagenesis.-B: 
Promoter activity in cardiomyocytes, of pGL4.10 -derived reporter vectors co-
transfected with Renilla luciferase (Rluc) vector baring a CMV promoter. Bars 
indicate the activity of the wild type (wt) promoter, the three separate mutants 
and the empty pGL4.10 vector. Signals were normalized to 10,000 Rluc 
counts/s. 
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Lane 1 2 3 4 5
Labeled probe wt wt wt mt wt
nuclear extract - + + + +
unlabeled 
probe 
- - ++ - -
Antibody  
  α-TCF7L2 
- - - - +
                               
 
 
 
 
 
 
 
Figure 5. EMSA.  
Binding of TCF7L2 to the proposed binding site in the human CSRP3 promoter 
was investigated with an electrophoretic mobility shift assay (EMSA). 
Oligonucleotide probes were generated based on the CSRP3 promoter region -
476/-447 bp containing the TCF7L2 binding site. Where indicated, unlabeled 
probe with the wild type sequence was applied in 200 fold the amount of the 
labeled probe. Graph on the right displays quantification of the indicated band 
corrected for the background of the individual lanes. 
 
 
Discussion 
In the first part of this study we performed a range of in silico 
analyses to identify motifs and modules involved in orchestrating 
transcription in a tissue-specific manner. One of the observations we 
made was that bases in the immediate proximal region of the TSS were 
the most likely to be part of a conserved non-coding sequence. The 
observed positional bias is unlikely an artifact of the methodology. Only 
to a very limited extent, it can be explained by the exclusion of regions 
116 
that overlap with adjacent genes: of the 137 2.5kb sequences for the 
tissue-specific genes, only 15 had an upstream gene that overlapped 
with the 2.5kb and were henceforth trimmed. The bias was also 
somewhat to be expected since this is the region closest to the coding 
sequences which on themselves are in general strongly conserved 
across species. When screening the sequences, both conserved as well 
as non-conserved parts, for binding sites, we found an enrichment of 
regulatory elements within this immediate proximal region. The 
positional bias of regulatory elements is partially implicated by the use 
of motifs that were derived from the conserved non-coding sequences. 
For a large part, our screening based on matrices for known 
transcription factors did not reveal much new information on tissue-
specific elements. Many of the motifs we identified had already been 
identified in other studies.[3, 8, 9] The de novo matrices that we 
identified seem to be especially important for regulation in smooth 
muscle and endothelial tissue, as is indicated by the motif-groups that 
we found for these tissues which consist of only de novo motifs. Since 
our primary interest was in the heart we did not follow up on 
investigating the functionality of these proposed motifs and modules.  
In addition to identifying regulatory elements involved in tissue 
specificity we also investigated which cis-regulatory elements could be 
involved in the transcriptional response to electric stimulation.[16] 
Amongst the motifs identified were E-box47, TBX5, MEF2, GATA1, 
MYOGENIN, YY1 and LEF1. The function of an E-box 47 site in the MYH6 
promoter has been studied in detail by Ojamaa et al.[32] In their study, 
Ojamaa et al., reported MYH6 to be activated by stretch, based on an 
absence of contraction due to the addition of 2,3-butanedione 2-
monoxime (BDM) or verapamil.[32] However, both verapamil and BDM 
are known to strongly affect calcium.[33] This together with the 
observations from our previously reported array study and the fact that 
MYH6 was found to be not affected by the application of mechanical 
stretch, lead us to suspect that Ojamaa et al., were in fact looking at a 
mechanism not resulting from stretch but from an altered calcium 
signaling such as that induced by electrical pulsing.[34] Many of the 
motifs identified as being involved in the pulsing response, have also 
been found to be implicated in hypertrophic responses[35, 36] 
However, as we reported earlier, we believe that the responses to 
electrical pulsing and for example phenylephrine induced hypertrophy 
are quite distinct.[16] 
Several findings of the in silico analysis are in agreement with 
literature, but a definite statement about the confidence in the 
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prediction results should be accompanied by further biological 
verification, by verification with other tools on the same input data and 
by verification of our methodology on other input data. The latter will 
provide an idea about the sensitivity of the methodology to random 
variations in the inherently incomplete input data, such as the choice of 
the genes in the random list, choice of the genes in the tissue-specific 
lists, decision on sequence boundaries, selection of known PWM 
database (TRANSFAC versus JASPAR) and use of a particular 
background model. A reliable background model is for instance of 
uttermost importance.[46-47] The genomic region within 0.5kb from 
the TSS is rich in G/C content and will naturally be seen as ‘awkward’ by 
a background model that is computed from sequences with only normal 
G/C content.[48] Possibly, the methodology can be made more robust to 
random variations by controlling the false discovery rate when 
classifying multiple PWMs as statistically overrepresented, using 
Benjamini-Hochberg’s method.  
Next to sensitivity to input data, we should discuss another 
shortcoming of the in silico analysis: the identified regulatory programs 
are definitely incomplete. Cooperative binding and the role of co-factors 
were neglected in this study[34] Binding sites for the more ubiquitous 
expressed SRF emerged from our analyses as being enriched in the 
promoters genes of ‘muscle genes’. For its activity however, SRF often 
requires the actions of additional factors such as GATA4 and Nkx2-5 in 
heart and myocardin in heart and smooth muscle.[35-37] GATA4 and 
especially NKX2-5 are more cardiac-restricted, and expressions of 
isoforms of myocardin are limited to smooth muscle or 
cardiomyocytes.[38] Thus although SRF does not directly provide tissue 
specificity on itself, it can be the key docking site for factors bringing 
about the eventual tissue specificity. Further limitations of the in silico 
analysis become apparent when one realizes that in cardiomyocytes, the 
highly cardiac-specific transcription factor Nkx2-5 can also bind to some 
of the SRF binding sites.[39] This implies that the enrichment of SRF in 
heart could also be an indication for an increased involvement of NKX2-
5. 
In the process of verifying in vitro the importance of identified motifs 
in cardiomyocyte transcription we verified for the first time the role of 
several transcription factors in the transcriptional regulation of the 
human CSRP3 promoter. While SP1 and myogenin have both been 
implicated previously to have a direct role in transcriptional regulation 
of cardiac-specific genes, this has not been the case for TCF7L2. We 
show here that a mutation of a TCF7L2 binding site within the CSRP3 
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promoter completely abolished its transcriptional activity in 
cardiomyocyte cultures. These observations by themselves did not 
directly confirm a role of TCF7L2 in mediating the transcriptional 
response to electric stimuli, but even so interesting, they did reveal that 
TCF7L2 is a key transcription factor for CSRP3 and possibly more genes 
with a cardiac-enriched expression profile. 
Overrepresentation of the TCF7L2 binding site motif was previously 
found to be correlated to responsiveness to WNT-signaling.[40, 41] In 
relation to the heart Wnt/ß-catenin signaling plays a dual role. From 
experiments in Xenopus, Afouda et al. found that Wnt/ß catenin 
signaling could inhibit cardiogenesis by inactivating GATA4, while 
GATA4 dependent activation of Wnt11 activated cardiogenesis.[42] 
Cardiogenesis can be stimulated by Wnt/ß-catenin through Wnt3a and 
Wnt3 or co-expression of ß-catenin and Lef1.[43] In another study, it 
was shown that exercise training of rat skeletal muscle led to an 
activation of ß-catenin through inactivation of GSK-3ß, via activation of 
Dvl and Akt.[44]  
Taking the aforementioned into consideration, it appears that ß-
catenin/TCF7L2 signaling, can be activated by fluxes in the electrical 
potential of cells and still occur in absence of the normally evoked 
mechanic stretch activity. It should be noted however, that a 
LEF1/TCF7L2 site was not detected in the promoters of all the pulse-
responsive genes. For a complete understanding of the role of 
LEF1/TCF7L2 and the other pathways involved, a full study would be 
required to elucidate the mechanisms of the interplay between electric 
signaling and the mechanic process of contraction.  
Although a broad genomics-based analysis as we performed here 
provides useful insights, it has some serious limitations. Our 
investigation shows once more that transcriptional regulation is a very 
intricate process, varying strongly from gene to gene and involving 
many proteins acting via highly dynamic networks of interactions. In 
order to fully understand regulatory programs at the transcriptional 
level, extensive proteomic studies will have to be involved. Large scale 
studies on co-regulation of genes and protein-protein interaction 
between transcription-factors are well on the way, but genome wide 
studies combining proteomics and genomics with resolutions on the 
individual promoter scale are still yet to come.[45, 46] 
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Supplementary data 
Supplementary file 1. List of genes used for identifying tissue-specific 
motifs. 
Supplementary file 2. Promoter sequences-2000bp to +500 bp of genes 
used in identifying tissue-specific motifs. 
Supplementary file 3 List of genes up-regulated by electric pulsing 
Supplementary file 4. EMSA probe sequences 
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Abstract 
The Wnt/Frizzled signal transduction pathway is implicated in 
development and disease. It has already been extensively proven that 
the Wnt/Frizzled pathway can promote cardiogenesis. Additional 
preliminary experiments indicate that β-catenin dependent Wnts can 
promote expansion of cardiac progenitors and differentiation of 
cardiomyocytes. Based on previous studies we anticipated an 
involvement of ß-catenin signaling in the transcriptional response of 
cardiomyocytes to electric pulsing. Here, we addressed the role of the 
Wnt/Frizzled signal transduction cascade in the response to electric 
signals. We show that the transcriptional response to electric signaling 
is activated by a ß-catenin dependent pathway, which to some extend 
overlaps with Wnt/Fzd signaling initiated by Wnt5a.  
Introduction 
The cardiac muscle is one of the three muscle types in the body. 
Many factors controlling transcription in skeletal and smooth muscles 
also play a pivotal role in the cardiac muscle. The cardiac muscle, 
however, is much more difficult to study in vitro, because adult 
cardiomyocytes do not proliferate. In order to approach in vivo settings 
as close as possible, the cardiomyocytes need to align and couple, 
forming an interlinked electrophysiological syncytium[1] Cultured 
cardiomyocytes subjected to electric stimulation display increased 
differentiation associated with a higher degree of organization of 
sarcomere structures and improved contractile properties[2-5] In the 
past, many researchers observed that the expression of genes involved 
in the fetal/hypertrophic program, such as c-FOS, c-JUN, atrial 
natriuretic factor (NPPA) and brain natriuretic protein (NPPB) were 
influenced after electrical stimulation.[6, 7] The response of some, 
however, might be arising from the increased consequential 
contractions and not the electric stimuli themselves.[8, 9] 
Previously, we investigated the genome-wide changes in gene-
expression induced by electric stimulation and found that certain 
cardiac-specific genes were activated solely by electric signals.[3] In a 
subsequent study, we analyzed the promoters of pulsing-responsive 
genes to identify regulatory mechanisms underlying the transcriptional 
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response to electric stimulation. We found that the proximal promoters 
of genes activated by electric stimuli, independent from stretch, were 
enriched with target sequences for transcription factors involved in the 
hypertrophic response such as: MEF2, GATA and TCF/LEF.[10]  
TCF/β-catenin signaling becomes activated in several ways. In 
response to increased activity and hypertrophy, it is shown to be 
activated downstream of PKB and Akt-signaling[11]. However, TCF/LEF 
is also known to be involved in Wnt/Fzd signal transduction cascades, 
which play an important role in cardiovascular and nervous 
systems.[12, 13] Interestingly, earlier findings indicated increased 
expression of several elements of the Wnt-signaling cascade in response 
to electrical stimulation.[3] The Wnt/Fzd signaling pathway can be 
divided into the β-catenin dependent pathway and the a-specific or β-
catenin-independent pathway. The β-catenin independent pathways 
consist of a planar cell polarity pathway and can signal through cGMP 
phosphodiesterases which reduces cGMP, or calcium and a 
phospholipase-C recruiting NFAT and CamKII.[14] In the β-catenin 
dependent pathway, binding of Wnt ligands to Frizzled (Fzd) lead to an 
activation of the protein disheveled which on its’ turn inactivates GSK3-
β. The decrease in active GSK3-β leads to more β-catenin being 
translocated to the nucleus and eventually stimulates gene transcription 
in conjunction with TCF. So far, 19 different Wnts have been identified. 
They can be subdivided into two classes; the Wnt5a class, which signals 
via the second messenger calcium and the Wnt1 class, which induces 
second axis formation and signals via the second messenger β-
catenin.[15, 16] 
Here, we investigated the role of Wnt/Fzd signaling in the 
cardiomyocytes’ response to electric stimulation. In the model 
employed, the cells undergo an initial (partial) de-differentiation before 
(re-)differentiating again to cardiomyocytes displaying the 
characteristic frequent spontaneous contractions and expressing 
cardiac-specific proteins.[3] This provides us with an excellent tool to 
study Wnt/Fzd related interventions and examine their effect on the 
differentiation of cardiomyocytes and on their contractile activity. 
Modifying the Wnt/Fzd signal transduction cascade may provide a tool 
for ameliorating synchronicity and frequency of beating of the 
cardiomyocytes, which could be beneficial for therapy with stem cells.  
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Materials and Methods  
Cell culture  
Primary cultures of neonatal rat ventricular cardiomyocytes were 
prepared and grown on Permanox chamberslides (Nunc, Langenselbold, 
Germany) as described earlier.[4] In short; tissue was digested 
overnight with trypsin at 4°C and the next day with collagenase at 37°C. 
After preplating, cells were plated at a density of 50,000 cells/cm2 in 
high serum medium supplemented with Ara-C to remove remaining 
non-myocytes. After another 24 hour incubation in high serum without 
Ara-C, cells were maintained in low serum differentiation medium, 
containing 2% horse serum. Where applicable, conditioned media were 
applied at the time when differentiation medium was applied. The 
conditioned media were prepared by adding the following supplements 
to the differentiation medium at the indicated concentrations; verapamil 
hydrochloride at 1 µM (Sigma-Aldrich, Saint Louis, USA), BayK8644 at 
10 µM (Bayer, Mijdrecht, The Netherlands). Wnt3a and Wnt5a 
conditioned media were prepared as described previously, with the 
difference that cells were maintained in 2% horse serum.[18, 30, 31] 
Culture media were refreshed every 24 hours. Were indicated, electric 
stimulation was performed as described earlier.[32] In short; using 
pacemakers, cultures were exposed to electric pulses at 1Hz and 2 V/cm 
bipolar. Electrical stimulation was started at the moment of applying 
differentiation medium.  
Recording of contractile activity 
Films were made using a Leica DMRIBE microscope equipped with a 
Hamamatsu digital camera (type C4742-95). The individual images, of 
which the films were composed, were recorded using a 10X 
magnification and an exposure time of 0.1 seconds. The final movies 
displayed the cells in real time. Open Lab version 2.2.5 (Improvision, 
Waltham, MA, USA) software was used. Using a Thermoplate (Tokai HIT, 
Shizuoka, Japan), the temperature of the culture medium was 
maintained at 37 °C. 
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RT-QPCR 
After 3 days in differentiation medium RNA was isolated using the 
Trizol method (Invitrogen, Merelbeke, Belgium). RNA quantity and 
quality were analyzed using Nanodrop (Thermo Fischer, Waltham MA 
USA). First strand cDNA was made using M-MLV reverse transcriptase 
(Finnzymes, Espoo Finland) starting from 1.0 µg of total RNA. QPCR was 
performed with qPCR master mix for SYBR Green (Eurogentec, Liège 
Belgium) in 10 µl reactions in 384 well format on an ABI7900 (Applied 
Biosystems, Melbourne Australia). Rat peptidylprolyl isomerase-A 
(Ppia) served as the reference gene. Primer sequences for all genes 
investigated are supplied in the supplementary data table. 
Statistical analysis 
All values are shown as mean ± S.E.M. Differences between groups 
were examined for statistical significance using one-way ANOVA with 
the Bonferroni post-test (Graph Pad Prism). A p-value of less than 0.05 
was considered to indicate a statistically significant difference. 
Results 
Effects of Wnt3a and Wnt5a on cardiomyocyte beating frequency 
Electrical pulsing enhances the (re-)differentiation of cultured 
neonatal cardiomyocytes.[2, 3] To study a the role of Wnt/Fzd signaling 
in this enhanced differentiation upon pulsing, we cultured neonatal rat 
ventricular cardiomyocytes (NRVCMs) in various types of media, a 
standard control medium and media supplemented with either Wnt3a, 
Wnt5a, the calcium agonist BayK8644, or the calcium antagonist 
verapamil. Verapamil is used to treat arrhythmias. Irregular occurring 
depolarisations are counteracted while constant sinus rhythm is still 
sustained.[17] BayK8644 acts oppositely, it prolongs the time that the L-
type calcium channels are opened and with it, the time that the system 
remains insensitive to new incoming depolarization signals.[17] 
The conditioned media containing Wnt3a or Wnt5a, have been tested 
extensively using our standard testing protocols and proved to exhibit 
the same results as the recombinant proteins.[18] In addition, series 
were included in which ß-catenin was over-expressed using transient 
transfection of a ß-catenin expression vector.  
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We observed that the addition of the Wnt conditioned media had a 
strong effect on the beating frequency of the cardiomyocytes, as seen 
under a light microscope. Cardiomyocytes maintained in standard 
medium, contracted with a frequency of around 16 beats per minute 
(figure 1). This frequency was significantly augmented by addition of 
Wnt5a, to 44 beats per minute (bpm) and even up to 55 bpm by Wnt3a. 
In both cases the change in contraction occurred within seconds after 
adding the Wnt conditioned media. 
 
 
Figure 1. Effect of Wnt proteins on the beating frequency of cultured 
cardiomyocytes. 
Using light microscopy, the contractions of cardiomyocytes were recorded. The 
cells were maintained medium supplemented with either control, Wnt3a or 
Wnt5a conditioned medium. The results are represented as a mean of eight 
independent measurements with SEM (Π P<0.05 and  # P<0.01). 
Gene expression analysis 
For a few selected genes, we investigated whether the use of different 
media affected their expression at the mRNA-level. The selected genes 
were those encoding the key cardiac transcription factor GATA4, 
connexin 43 (Cx43/Gja1), which plays a central role in conducting the 
action potential between cardiomyocytes, alpha myosin heavy chain 
(Myh6) and cysteine and glycine rich protein 3 (Csrp3). In our earlier 
studies we found that transcriptional activity of fragments of the human 
promoter sequences of MYH6 and CSRP3 was markedly increased in 
response to electric stimuli. Furthermore, we showed that a TCF/LEF 
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binding site in CSRP3 is targeted by TCF7L2 and that this site is crucial 
for CSRP3 expression in cardiomyocytes.[4, 8, 10]  
Using RT-QPCR we found that the expression of the cardiac-specific 
genes Myh6 and Gja1 as well as that of the heart-enriched Gata4 and 
Csrp3 was increased by electric stimulation. Interestingly, 
supplementation of the medium with Wnt5a resulted in an increased 
expression of these genes in both the pulsed and non-pulsed cells. The 
effects of pulsing and Wnt5a appear to be cumulative, the increase in 
expression of the two combined is comparable to the rise in expression 
caused by pulsing and Wnt5 individually. Supplementation of the 
medium with Wnt3a attenuated the expression of all 4 genes in both the 
pulsed and non-pulsed series. The addition of verapamil led to an 
increased expression of Gja1, Csrp3, Gata4 and Myh6. Similar to the 
observations with Wnt5a, the effects of pulsing and addition of 
verapamil also seem cumulative. In pulsed cultures containing 
BayK8644, the expression of all these genes was strongly decreased 
while in the non-pulsed cells BayK8644 had little to no effect.  
Based on our previous research, we anticipated the genes Csrp3 and 
Myh6 to be activated by Wnt/ß-catenin dependent signaling. Indeed, the 
transcript-levels of both genes were increased as a result of the 
transient over-expression of ß-catenin within the cells. In addition to the 
aforementioned genes, we also studied the effects of the various 
conditions on the expression of the hypertrophy markers Nppa and 
Nppb. Both genes have been reported to be activated upon pulsation.[6] 
However, at least for Nppa, this activation is likely to be related to the 
contractile activity and not to the electric stimulation itself.[3, 19] The 
data of the non-pulsed cells, showed increased expression of Nppa and 
Nppb after supplementation with Wnt5a, but decreased Nppa and Nppb 
expression after Wnt3a administration (figure 2). 
Determination of the Wnt/Fzd signal transduction cascade 
components 
Apart from studying differentiation, we also analyzed the 
transcription levels of the Wnt receptors. It is known that Wnt3a and 5a 
are the ligands for Fzd-1 and -2.[20] Figure 3 shows the expression 
levels for endogenous Fzd-1 and -2. The expression pattern that was 
observed is similar to that of the differentiation markers (Fig. 2). The 
relative decrease or increase is more pronounced after pulsation, but 
the pattern of expression remains the same. Furthermore, Fzd-1 and 
Fzd-2 also display a similar expression profile. 
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Figure 2: Gene expression analysis (continued on next page) 
Left panel are non-pulsed cardiomyocytes and the right panel pulsed. All 
data are represented as means of six independent measurements and 
with SEM (* p<0.001 if significantly different from control and ● 
p<0.001 if significantly different from non-pulsed cardiomyocytes). 
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Figure 2: Gene expression analysis (continued) 
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Figure 3: Components of the Wnt/Fzd pathway under different conditions.  
Left panel are non-pulsed and right panel are pulsed cardiomyocytes. The 
results indicate means of six independent measurements with SEM. (Π p<0.05 
and * p<0.001) 
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Discussion 
The heart consists of different cell types, wherein the fibroblasts, 
endothelial cells and the cardiomyocytes are the central players. The 
main functions of the cardiomyocytes are to provide conduction of the 
action potential and contractile force of the heart. To study the 
cardiomyocytes in vitro, the natural environment of the heart has to be 
mimicked in the petridish. Cardiomyocytes in culture typically display 
spontaneous contractions. However, when cardiomyocyte cultures are 
maintained for longer periods without electric stimulation the 
contractile activity will be abrogated.[21] Eventually the cells’ 
morphology will change, cells will start to detach and cell death will set 
in.[22] Therefore, to study cellular mechanisms in the heart, cells have 
to be pulsed. Previously, we performed in depth studies on the effect of 
electric stimulation on cardiomyocytes in culture.[3, 10] Similar to 
others, we found that exposure to electric stimulation enhanced 
differentiation and improved contractile activity. In this article, we 
revealed that pulsing activates elements of the Wnt-signaling pathway 
and the involvement of the TCF/ß-catenin signaling in transmitting the 
electrical signaling to the transcriptional program. 
Here, we found that Wnt5a enhances cardiomyocyte differentiation. 
Supplementation of culture media with this Wnt activated transcription 
of genes with a more cardiac-enriched expression profile such as 
Cx43/Gja1, Csrp3, Gata4 and Myh6. Moreover, the expression profile of 
Myh6, a known GATA4 target, correlated with that of GATA4.[7] 
Wnt3a supplementation, reduced expression of all genes investigated 
in this study. A similar response for Wnt3a was observed by Liu et 
al..[23] They found that in later stages of cardiogenesis Wnt3a 
attenuated differentiation through the inactivation of Nkx2-5 via 
activation of HDAC1, while in the early stages of cardiogenesis the 
Wnt3a acted in the opposite way. At the moment when the conditioned 
media were applied in our experiments, the cells already displayed 
contractile activity, indicating that the cells had progressed into a more 
differentiated/later state of development. It is very well possible that if 
the Wnt3a conditioned media would have been applied in the early 
stage of (re)-differentiation a different effect could have been observed. 
An inducing effect of both Wnt3 and Wnt5a on cardiomyocyte 
contraction has already been described by Toyofuku et al..[24] However, 
in their experiments, the response to the Wnts depended on the 
presence of additional fibroblasts. The results were thus affected by cell 
density, which as we previously demonstrated, even affects 
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cardiomyocyte differentiation in pure cardiomyocyte cultures.[3] In our 
experiments, supplementation of the culture media with either Wnt3a 
or Wnt5a had an immediate effect on the contractile activity of the 
cardiomyocytes. The frequency of contractions was strongly increased 
both in electrical pulsed and non-pulsed cells. This response was 
practically instantaneous and thus had to be initiated by fast acting 
mechanisms independent from transcription. A plausible explanation of 
this direct contraction activation could be the Akt mediated activation of 
L-type calcium channels.[25] 
The pattern of gene activation displayed by Wnt5a follows that of the 
series treated with verapamil. Interestingly, verapamil is a highly potent 
cardiomyogenesis-inducing agent while at the same time it reduces 
contractile activity. The down-regulation of Nppa in the presence of 
verapamil is in concordance with the stretch dependent-activation of 
Nppa as proposed by us and others in previous studies.[3, 19] 
As expected, based on the presence of the TCF7L2 site within their 
promoter, we found an up-regulation of Csrp3 and Myh6 in the 
cardiomyocyte-cultures in which ß-catenin was over-expressed.[10] 
Activation of ß-catenin suggests an involvement of elements of the β-
catenin dependent Wnt/Fzd pathway. Wnt5a induced expression of 
Csrp3 and Myh6 in a way similar to ß-catenin, suggesting that this ligand 
acts on these genes via the β-catenin dependent signaling pathway. 
Furthermore, our analyses showed that Fzd-2 mRNA-levels were 
significantly increased by electric stimulation as well as by Wnt5a, 
indicating a shared feedback mechanism. 
Besides the activation of Akt and the β-catenin dependent pathway, 
Wnt-signaling can act via the β-catenin independent pathway, whereby 
intracellular calcium levels are increased.[26] Higher calcium levels can 
also lead to a lower activity of GSK3-β, and thus again to increased β-
catenin levels.[27] Earlier, we showed that electric signals in 
cardiomyocytes activate calcium signaling independent from 
contraction and the enrichment of TCF7L2 binding sites in the 
promoters of pulsing responsive genes.[3] We thus believe that this 
calcium dependent increase in activity of β-catenin is a key switch in the 
transcriptional response to electric stimuli. Besides allowing for an 
activation of the β-catenin dependent pathway, the inactivation of GSK3-
β also enables GATA4 to become more active. Active GSK3-β results in 
decreased amounts of nuclear GATA4 by increasing its nuclear 
export.[28] This would suggest that as a result of electric signaling, the 
aforementioned increased expression of GATA4 could indeed also result 
in more GATA4 in the nucleus and thus activation of its target genes.  
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In short, taken into consideration all the aforementioned 
observations, the response of cardiomyocytes to electric signaling 
appears to be transmitted by transcriptional programs which to some 
extent are shared with the Wnt/Fzd signaling transduction cascade. The 
β-catenin independent Wnt signaling pathways enable the immediate 
response. The β-catenin dependent Wnt signaling pathway leads to the 
activation of for example GATA4, providing a link with the 
transcriptional machinery to enable long-term adjustments of the cell.  
Wnt/Fzd signaling is also known as one of the main transduction 
pathways in different diseases.[29] Based on the similarities between 
the physiological responses to Wnt5a and electrical pulsing, we 
hypothesize that for patients with a disease involving perturbed 
electric-signaling, the Wnt/Fzd signaling system could well provide an 
interesting target for therapeutic treatment. 
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Supplementary table 
Forward and reverse sequences of all primers. 
 
Gene Forward primer Reverse primer
Csrp3 CAGTTCCAACAATCCCCAAAG CAGAGAACTTGGAAGGGTTGCT 
Fzd1 AGCAGCACATTCTGAGGGAGGAG TCTCTCACCCATCAGTCAGTCCAC 
Fzd2 CTGCACTCGTGGAGGAAGTTC TTCACACGGTGGTCTCTCCAT 
Gja1 AAAAAGTTGCTGCTGGACATGA GAAGGTCGTTGGTCCACGAT 
Gata4 CCCTGCCCTTGTCCAACAC TCAGGTATGGGACACATGAGATG 
Myh6 ACAGAGTGCTTCGTGCCTGAT CAGTCACCGTCTTGCCGTTT 
Nppa CATCATGGGCTCCTTCTCCAT TGTACACAGGATTTGGTCCAATAGT 
Nppb AGGACCAAGGCCTCACAAAA TTGAGATATGTGTCACCTTGGAATTT 
Ppia TTCCTCCTTTCACAGAATTATTCCA CCACCAGTGCCATTATGG
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Abstract 
Despite the mitochondria ubiquitous nature, many of their 
components display divergences in their expression profile across 
different tissues. Using the bioinformatics-approach of guilt by 
association (GBA) we exploited these variations to predict the function 
of two so far poorly annotated genes: Coiled-coil-helix-coiled-coil-helix 
domain containing 10 (CHCHD10) and glioblastoma amplified sequence 
(GBAS). We predicted both genes to be involved in oxidative 
phosphorylation. Through in vitro experiments using gene-knockdown 
we could indeed confirm this and furthermore we asserted CHCHD10 to 
play a role in complex IV activity.  
Introduction 
Mitochondria are omnipresent organelles involved in various cellular 
processes such as energy metabolism and regulation of apoptosis.1 In 
spite of the ubiquitous nature of mitochondria, their protein 
composition varies between tissues, largely as a result of differentially 
expressed nuclear genes.[1] The expression of some components is even 
restricted to only a single type of tissue. A clear example of this is the 
cytochrome-c-oxidase (COX) complex/complex IV, the last enzymatic 
complex in the electron transport chain.[2, 3] COX6A2 and COX7A1 both 
encode isoforms of subunits of complex IV which are only expressed in 
cardiac muscle and not in any other cell-type.[1, 4, 5]  
Large scale proteomics analyses have been performed to dissect the 
mitochondrial protein composition of several tissues.[6, 7] Apart from 
registering the presence of known proteins these studies also aimed at 
identifying ‘new’ mitochondrial proteins and predicting their function. 
For these functional predictions proteomics databases have been the 
principal source, whereas genomics information hardly played any role 
despite the availability of huge amounts of easily accessible data 
through depositories such as NCBI’s Gene Expression Omnibus.[8] In 
other studies genomics based data has been widely used to identify 
functionally related genes and to predict the function of unknown 
genes.[9, 10] Walker et al., used genomics data from cDNA libraries to 
predict the involvement of novel genes in prostate cancer. In their 
approach, called Guilt-by-association (GBA), they scored whether a gene 
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was transcribed or not in samples from healthy and diseased tissues.[9] 
Based on the correlation between expression profiles predictions were 
made on whether genes were functionally linked. The method was thus 
solely based on co-expression profiles and not on sequence similarities. 
Since the study of Walker et al. extensive publicly accessible datasets 
have become available, providing researchers with a rich source of 
information on the expression of genes across various tissues.[11, 12] 
We report here on our strategy to use these genomics datasets to 
predict the function of CHCHD10/C22ORF16 and GBAS, which both have 
been described as mitochondrial proteins.[13] 
Materials and methods 
Tissue culture and transfection 
HELA cells were grown in 24 well plates in high glucose DMEM 
(Invitrogen) supplemented with 10% fetal bovine serum. Transfection 
of siRNA (Dharmacon, Chicago IL. USA) was done using the GeneSilencer 
system (Genlantis, San Diego USA) according to manufacturer’s 
instructions. Test transfections were performed at 100, 200 and 1000 
ng of siRNA per well of a 24-well plate. For all assays (ATP, apoptosis 
and enzymatic activity) siRNA concentration was set at 1000 ng/ well. 
RT-QPCR 
RNA was isolated using Trizol reagent (Invitrogen, Madison WI. USA). 
First strand cDNA was made using M-MLV reverse transcriptase 
(Finnzymes, Espoo Finland) starting from 1.0 µg of total RNA. QPCR was 
performed with qPCR master mix for SYBR Green (Eurogentec, Liège 
Belgium) in 10 µl reactions in 384 well format on an ABI7900 (Applied 
Biosystems, Melbourne Australia). 
Immunohistochemistry 
HELA cells were grown on Permanox chamberslides (Lab-Tek, 
Rochester NY, USA). Cultures were incubated with medium containing 
Mitotracker® Red CMXRos (Invitrogen, Paisley UK) according to 
manufacturer’s instructions for 20 minutes. Cells were fixated using 4% 
paraformaldehyde. For staining of CHCHD10 cells were washed 5 times 
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with PBS-Tween 0.05% and then blocked for 30 minutes with 1% BSA in 
PBS. Primary antibody, rabbit-anti-human CHCHD10 (Sigma, St. Louis 
MO, USA) in PBS-Tween 0.05%, was incubated for 45 minutes. After 
three washes of each 5 minutes with PBS-Tween 0.05%, the secondary 
antibody, goat-anti-rabbit FITC (Southern Biotech, Birmingham AL 
USA), was incubated in PBS-Tween 0.05% for 30 minutes. After three 
washes of each 5 minutes with PBS-Tween 0.05% and two washes with 
PBS, cells were mounted in 90% glycerol, containing 20 mM Tris-HCl pH 
8.0, 0.2% NaN3, and 2% 1,4-di-azobicyclo-(2,2,2)-octane (DABCO, 
Merck, Darmstadt, Germany). Nuclei were counterstained using 0.5 
μg/ml diamidino-2-phenylindole (DAPI; Sigma, St. Louis MO, USA). 
ATP assay 
Culture medium was replaced with serum free-medium 24 hours 
after siRNA transfection. After 16 hours of incubation in fresh serum-
free medium with applicable supplements oligomycin and/or FCCP 
were added to a final concentration of respectively 12 µM and 5 µM and 
the cells incubated for another 10 minutes. Medium was removed and 
ATP was measured using CellTiter-Glo (Promega, Madison WI. USA) on a 
Glomax96 luminometer (Promega, Madison WI. USA) according to the 
manufacturer’s instructions.  
Apoptosis assay 
Apoptosis was screened for using the Caspase-Glo 3/7 assay 
(Promega, Madison WI. USA). Luciferase measurements were performed 
with a Glomax96 luminometer (Promega, Madison WI. USA). 
Mitochondrial complex measurements  
HELA cells were resuspended at a concentration of 10 x 106 per mL 
in mito buffer consisting of 250 mM sucrose, 10 mM Tris-HCl, 0.2 mM 
EDTA, pH 7.8, supplemented with one Complete tablet (complete 
protease inhibitors cocktail; Roche Diagnostics) per 25 mL, snap-frozen 
in liquid nitrogen and thawed twice to permeabilize the cells. Citrate 
synthase activity and complex IV assays were performed as previously 
described.[14] Protein content was determined by the Bio-Rad DC 
protein assay (Bio-Rad Laboratories) with BSA as a standard. 
143 
Results 
Identification of heart-enriched mitochondrial genes 
A list of 1023 mitochondrial genes was obtained from the dataset of 
Pagliarini et al..[13] Within this set of genes we searched for genes more 
restricted to the heart by determining their Shanon entropy values as 
described by Schug et al..[15] These entropy values are indicative for the 
enrichment of the mRNA in one given tissue when compared a set of 
other tissues.15 The dataset containing the genome-wide expression 
data across 65 human tissues was obtained from a public accessible 
dataset via NCBI GEO.[12, 15] A table with all the entropy values of the 
mitochondrial genes in heart ventricle and atria is provided as an on-
line data supplement (supplementary file S1). Amongst the top ranking 
heart-enriched genes is CHCHD10/C22ORF16. In ventricle and atria it 
ranks at place 6 and 7, respectively.  
Besides computer predicted data no information is available on the 
possible function of this gene. Another poorly annotated gene of which 
its expression is enriched in heart is glioblastoma amplified sequence 
(GBAS) which ranks 10th in atria and 34th in ventricle. Of both genes we 
depicted the expression profiles across 65 human tissues in figure 1. As 
can be seen, the two genes display roughly the same profile with 
expression enriched in all striated muscles: heart, skeletal muscle and 
tongue. Overall, the expression levels of CHCHD10 are much higher than 
those of GBAS.  
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Figure 1: Tissue specificity of mitochondrial genes GBAS and CHCHD10.  
Expression profile of GBAS (A) and CHCHD10 (B) across 65 human tissues. 
Black bars indicate tissues with high expression levels of the genes. V: heart 
ventricle, A: heart atrium, S: skeletal muscle, T: tongue 
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Figure 2: CHCHD10 localizes to mitochondria in HELA-cells.  
After culturing and fixation, HELA-cells were stained using with Mitotracker 
(mitochondrion-selective probe) and an antibody staining specific for human 
CHCHD10. 
 
 
 
 
Table 1. Top 10 genes with gene expression profile similar to CHCHD10 
and GBAS. 
 
Rank Gene Pearson corr. Gene Pearson corr. 
CHCHD10 1.00 GBAS 1.00 
1 UQCR 0.94 CMYA5 0.96 
2 NNT 0.94 TTN 0.96 
3 DLAT 0.92 ZFP106 0.96 
4 ATP5J 0.92 SMPX 0.96 
5 NDUFB1 0.92 ACTN2 0.96 
6 NDUFB10 0.91 PDLIM5 0.96 
7 COX7B 0.90 LMOD2 0.96 
8 TMEM143 0.91 PPP1R3A 0.95 
9 NDUFS1 0.90 PDE4DIP 0.95 
10 MRPL41 0.90 COX6A2 0.95 
Genes are ranked by Pearson correlation score calculated from the correlation 
of all probe sets on the Affymetrix HG U133 plus 2.0 array on 65 human tissues. 
When represented by more than one probe set, genes were only included once 
and ranked by the probe set with highest correlation score. Genes in bold font 
are known mitochondrial genes. 
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Prediction of GBAS and CHCHD10 function through guilt-by-
association 
To obtain some indication of gene function of CHCHD10 and GBAS we 
employed the principle of GBA and compared their expression profiles 
over 65 human tissues with the profiles of all genes (>38,500) contained 
within the Affymetrix HGU133 plus 2.0 chip by a simple Pearson 
correlation test.[12] We calculated the correlation between genes on the 
basis of their expression data values instead of on the binary presence 
or absence scores as performed by Walker et al..[9] In table 1 we list the 
10 genes with the highest correlation rankings for the two genes 
separately. We found a high correlation of GBAS with several heart-
enriched genes with no direct mitochondrial function, whereas amongst 
the top 10 genes correlating with the expression of CHCHD10 were only 
genes with a known mitochondrial function. Amongst them are those 
encoding: the 6.4kDa-subunit of ubiquinol-cytochrome c reductase 
(UQCR), COX7B, subcomplexes of NADH dehydrogenase (ubiquinone) 1 
beta (NDUFB1 and NDUFB10) and NADH dehydrogenase (ubiquinone) 
Fe-S protein (NDUFS1).[16-19] Since these genes and COX6A2 too, 
encode subunits of oxidative phosphorylation complexes we anticipated 
both CHCHD10 and GBASs to be involved in this process. For similar 
reasons other groups also have been already investigating GBAS as 
possible candidate gene in relation to OXPHOS-disorders.[20] 
Protein domains in GBAS and CHCHD10 
A screening for protein domains using Interpro based on Refseq 
mRNA sequences NM_001483.2(GBAS) and NM_213720.1 (CHCHD10) 
revealed the presence of a NIPSNAP domain in GBAS and a coiled coil-
helix-coiled coil-helix (CHCH)-domain in CHCHD10.[21,22] The function 
of all the members of the NIPSNAP super family as well as the NIPSNAP 
domain itself have remained largely elusive.[22] The CHCH-domain 
observed in CHCHD10 has also been found in COX19 which is involved in 
the formation of complex IV.[23-25] This and the strong correlation of 
CHCHD10’s expression profile with that of the muscle-enriched complex 
IV subunit COX7B, pointed towards a possible involvement of CHCHD10 
in complex IV function.[26] 
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Gene knockdown reveals role of GBAS and CHCHD10 in ATP synthesis 
To assess a possible involvement of CHCHD10 and GBAS in oxidative 
phosphorylation we performed gene-knockdown experiments. A simple 
human model for studying gene expression activity in the heart is not 
available. However, gene-expression data shows that both CHCHD10 
and GBAS are expressed in HELA-cells, thus providing a model of human 
origin to study the function of the two genes. Using 
immunohistochemistry we verified the expression of CHDHD10 in 
HELA-cells and its’ localization to the mitochondria within these cells 
(figure 2). 
In our analyses we included Surfeit 1 (SURF1) as a positive control 
since this gene is known to be involved in complex IV assembly.[27] As 
negative control we employed siRNA specific against firefly luciferase 
(Luc). Via transfections with siRNA-pools we attained a >50 - 60% gene 
knockdown for GBAS, CHCHD10 and SURF1 (figure 3). By culturing in 
glucose-free medium supplemented with galactose cellular ATP-
synthesis is largely restricted to the OXPHOS system. In addition, we 
supplemented series of cultures with the ATP-synthase inhibitor 
oligomycin and/or the proton gradient uncoupling agent FCCP to reveal 
a possible role of the genes in specific steps of the OXPHOS system 
(figure 4).[28] HELA-cells transfected with siRNA against CHCHD10 or 
SURF1 displayed a significant reduced total ATP-level under all 
experimental conditions. Also for GBAS a significant decrease was found 
under most conditions, however, in the cultures supplemented with 
both oligomycin and FCCP the changes in ATP levels in the GBAS series 
just failed to reach significancy (p = 0.054). We excluded an increase in 
apoptosis as a cause for the decline in total cellular ATP-levels by 
analyzing capspase 3 and 7 activity. When compared to Luc siRNA 
transfected cells we did not observe an increased apoptotic activity due 
to the siRNA transfections for any of the series (figure 4B). 
 
CHCHD10 is involved in complex IV activity 
Based on the observed decrease in ATP formation, the presence of a 
conserved CHCHD-domain and the strong correlation of its expression 
profile with that of genes encoding complex IV subunits, we anticipated 
CHCHD10 to be involved in complex IV activity. Predictions of the 
function of GBAS were less strong. However, recently NIPSNAP1 which 
like GBAS also contains the NIPSNAP-domain, was reported to co-
148 
migrate with intermediates of complex I.[29] We therefore analyzed 
complex I and IV activity in siRNA transfected cells and in addition also 
citrate synthase activity was measured to correct for a possible change 
in mitochondrial copy number (table 2). We observed an increase in 
citrate synthase activity in the GBAS and CHCHD10 knockdown cells, 
indicating an increased mitochondrial biogenesis in both series. The 
change in CS-activity of the SURF1-knockdown series was just short of 
being significant (p = 0.055). After correction for CS-activity it becomes 
clear that CHCHD10-knockdown indeed leads to a reduced complex IV 
activity. In cells treated with siRNA for CHCHD10 the remaining complex 
IV-activity was about half that of the level observed in the Luc control 
series. 
 
 
 
 
 
Figure 3: Efficacy of siRNA mediated gene knockdown.  
Cultured HELA cells in a 24-well plate were transfected with siRNA at three 
different concentrations in (100, 200 or 1000 ng per well; respectively: black, 
grey and white bars). Gene-knockdown was determined through RT-QPCR on 
samples obtained two days post-transfection; cells transfected with luciferase 
specific siRNA at identical concentrations served as a reference. 
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Figure 4. Effect of gene knockdown on cellular ATP content. 
HELA-cells were transfected with siRNA specifically for either: Luc, GBAS, 
CHCHD10, or SURF1. One day post transfection cells were incubated overnight 
in glucose-free medium supplemented with galactose. Additionally several 
series were treated during the last 10 minutes with oligomycin, FCCP or a 
combination of these two. (A) For ATP content, total ATP in cell cultures was 
determined and normalized to the level of citrate synthase activity as a 
correction for the number of mitochondria. (B) Apoptosis was screened for 
using a proluminescent caspase 3/7 substrate to verify whether changes in ATP 
levels were not resulting from increased apoptosis. 
 
Discussion 
Various studies have described the protein composition of 
mitochondria in different tissues.[6, 7] Also CHCHD10 and GBAS have 
been found through this way to be mitochondrial proteins, however 
their exact role remained unknown. By correlating gene expression 
profiles of these genes with those of which the function is known it is 
possible to predict their function.[9, 10] Where other studies employed 
a collection of micro-array datasets of various experimental conditions 
to elucidate gene functions we made use of a dataset containing 
expression data of genes in a variety of human tissues.[10, 12] Starting 
from these public accessible datasets we predicted the genes CHCHD10 
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and GBAS to play a role in the process of energy generation by oxidative 
phosphorylation.[9] Results from our in vitro experiments supported 
this prediction: knock-down of either CHCHD10 or GBAS led to a 
significant reduction in total cellular ATP levels (figure 4 A). A 
contributing role of apoptosis to the decreased ATP levels was excluded 
as none of the siRNAs led to an induction of caspase 3/7 activity (figure 
4 B). We found that knock-down of CHCHD10 led to reduced complex IV 
activity, indicating that this gene is likely involved in the function of 
complex IV. Additional experiments however are required to examine 
how CHCHD10 exerts its role. In our experiments we also found GBAS to 
be involved in oxidative phosphorylation. Based upon the association of 
its family-member NIPSNAP1 with intermediates of complex I we 
investigated a possible role in complex I function.[29] Both complex I 
and IV activity were not affected by GBAS knock-down. Although we 
describe GBAS here as a gene involved in OXPHOS, its specific role in 
this process remains unclear. 
The positive control SURF1 is involved in complex IV assembly and 
its knock-down indeed displayed a decreased ATP synthesis, but not the 
anticipated decrease in complex IV activity.[27] These contradictory 
data may to some extent result from the limited number of 
measurements and large variation amongst the data from the complex 
IV activity measurements. The siRNA knock down level might not have 
been enough to show the expected effect for SURF1, also the protein 
half-life of SURF1 could be higher than the other proteins and therfore 
require a longer time post transfection prior to performing the analysis. 
A more efficient downregulation could reveal much more clear results, 
this also holds true for GBAS and CHCHD10. The use of transgenic or 
knock-out mice such as has been done in studying SURF1 could reveal 
much stronger effects and provide the opportunity to study the role of 
the proteins in more detail.[30] 
Alternatively it is possible that a more stronger effect could be observed 
for GBAS and CHCHD10 when performing similar experiments in 
striated muscle cells since the expression CHCHD10 and GBAS is higher 
within these cells. Skeletal muscle cells are known to contain two 
distinct groups of mitochondria: intermyofibrillar (IF) and 
subsarcolemmal (SS).[31] Amongst else, the two mitochondria pools 
differ in cytochrome-c oxidase activity. While their total cytochrome-c 
oxidase content is the same, the enzymatic activity is higher in the IF 
mitochondria.[31] At least for CHCHD10 it would be interesting to find 
out whether the protein is perhaps involved in this differential 
cytochrome-c oxidase activity. 
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Conclusions 
In all we showed here that using the principle of Guilt by Association 
we successfully identified CHCHD10 and GBAS to play a role in the 
energy metabolism and in addition identified a functional role of 
CHCHD10 in complex IV activity. Like CHCHD10 and GBAS many genes 
are still awaiting their functional anotation. For those uncharacterized 
genes the bioinformatics approach described here might turn out to be 
an extremely useful and cost-effective method in providing the primary 
hint towards the biological process in which they are involved. 
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A well balanced expression of genes lays at the base of the correct 
functioning of any organ. A key process enabling this, is transcription. 
This pas de deux of DNA and proteins, controls the spatial and temporal 
synthesis of the RNA. In this dissertation, we addressed various aspects 
of transcription in relation to genes with a cardiac-specific expression 
profile. Where other research typically treated individual genes, we took 
on the group of cardiac-specific genes as a whole when investigating the 
mechanisms that give rise to their cardiac specificity. In addition, we 
investigated how electrical pulses affect the transcriptome of cardiac 
muscle cells. Finally, we employed transcriptomics data to predict the 
function of poorly annotated genes with a cardiac-enriched expression 
profile. 
In order to validate our findings from our in silico analyses, we 
generated a number of reporter constructs containing human promoter 
sequences and verified their activity in vitro (chapter 3). In other 
studies on cardiac-specific genes, information is often only provided on 
which promoter sequences were sufficient for obtaining expression in 
cardiomyocytes and not whether this expression was specific. To 
overcome this limitation, we examined the activity of the promoter 
fragments not only in cardiomyocytes but also in cultures of skeletal 
muscle and smooth muscle cells. The importance of verifying the activity 
in related tissues is exemplified by the results we obtained for the 
CSRP3 promoter. A small fragment was sufficient to obtain high levels of 
expression in cardiomyocytes, but also displayed activity in both 
skeletal and smooth muscle cells. In vivo, CSRP3 is not expressed in the 
latter. Extending the promoter fragment to about 5 kb upstream 
completely abolished activity in the smooth muscle cells. Besides CSRP3, 
we also provided for the first time information on the human promoters 
of several other genes, FABP3, MYL3, MYL7, TCAP, and MYBPC1. 
A distinctive feature of cardiomyocytes is their continuous 
contractile activity. Various publications have shown that stretch has a 
large impact on the transcriptional program in all types of muscle.[1-6] 
Contractions are the result of fluxes in the intracellular calcium levels, 
which in turn can be triggered by applying electrical pulses.[7,8] 
Furthermore, exposing cardiomyocytes in vitro to surrogate electrical 
pulses was shown to affect the expression of cardiac-specific genes like 
NPPA and MYL2, and moreover, to improve the overall cardiomyocyte 
function.[8, 9] This brought us to take on the question, ‘What is the 
effect of electrical stimuli at the level of the transcriptome? Which genes 
and associated processes are hereby affected?’ 
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To facilitate studies on the role of electric pulses on the 
cardiomyocyte transcriptome we developed a culture system in which 
cells were continuously electrically pulsed using human pacemakers 
(chapter 4). A first analysis revealed that, although the non-pulsed 
cultures displayed continuous contractions, the application of electric 
stimuli for several days resulted in a dramatic change in cell 
morphology and strongly enhanced transcriptional activity of a 
promoter fragment of human alpha myosin heavy chain (MYH6). 
Using expression micro-arrays, we further investigated the changes 
in the cardiomyocyte transcriptome, resulting from the exposure to 
electric pulsing on a genome-wide scale (chapter 5). Similar to others 
we found that electric pulsing leads to altered cardiomyocyte 
morphology such as more defined sarcomere structures.[8, 10] At the 
level of gene expression however, some of our findings did not concur 
with those described in literature. For example, the expression of NPPA 
(encoding ANF) is often described as a marker to verify that cells are 
adequately stimulated.[8] Nonetheless, we found that under the 
conditions employed in our studies, expression of Nppa was not 
increased by electric stimulation. Even more so, we found evidence that 
Nppa is activated by stretch rather than by electrical stimulation, which 
is in agreement with the finding that ANF levels are increased by passive 
stretch.[11] These discordant results originate from the fact that often 
no clear distinction was made between effects derived from the 
response to electrical stimulation and the response to the evoked 
stretch. During the course of our studies, Frank et al., reported on the 
occurrence of a stretch specific program within cardiomyocytes.[3] Our 
observations lead us to pose the question, ‘is there, analogous to the 
stretch specific program also an electrical-pulsing specific response?’  
By applying electrical stimulation in the presence of the contraction-
inhibitor blebbistatin, we were able to distinguish the transcriptional 
responses derived from the electrical signals from those of the stretch 
normally evoked by these signals. With this approach we have shown 
that electrical signals indeed activate a transcriptional program 
‘independent’ from stretch and that genes encoding various elements of 
the calcium signaling were still activated by electrical stimuli in the 
absence of stretch. This indicates that calcium fluxes play a role in the 
pulse-response. In addition, we found that the activation of some genes, 
including Myh6, was even stronger when contraction was inhibited. This 
can be explained by the fact that cyclic stretch has an inhibitory effect on 
calcium handling.[1]  
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Furthermore, Myh7 was found to be more stretch dependent. The 
balance of the myosin heavy chain composition in the heart is of vital 
importance.[12, 13] This example of the myosin heavy chains shows 
how at any given time, the complete cardiac transcriptome requires to 
balance the interplay between the transcriptional programs activated by 
stretch and electrical signaling. Further research on the interplay 
between the two programs is necessary to obtain more insight into how 
a healthy status quo in the heart is maintained. 
It is also interesting to see that various genes involved in the fatty 
acid metabolism are activated by pulsing. Under normal healthy 
conditions, fatty acids are the primary energy source for the heart while 
under diseased conditions the heart has to rely on alternative sources 
such as glucose.[14] This provides an explanation how perturbations in 
the cardiac electrical signaling can directly affect the metabolism of the 
heart. 
 
In chapter 6, we investigated the promoters of genes specifically 
expressed in either cardiac, skeletal or smooth muscle. Our initial 
analysis was aimed at identifying motifs and modules responsible for 
the tissue specificity. The questions to be answered here were, ‘to what 
level does the cardiac gene expression program overlap with the 
programs of the other muscle tissues, and to what extent is it unique to 
the heart? Is there a common transcription regulatory program that lays 
at the basis of restricting the expression of genes to the heart?’ 
Our search for motifs responsible for the tissue specificity of genes, 
did not result in the identification of many more ‘new’ motifs than those 
described in the literature that became available during the course of 
our studies.[15-17] However, it did provide valuable information about 
the basic architecture of the cardiac-specific genes. The elements most 
likely responsible for the tissue-specific expression appeared to be 
enriched in the regions immediate 5’ proximal to the genes. This is in 
agreement with previous findings that a relatively short promoter 
fragment, of a few hundred base pairs, was sufficient for driving cardiac-
specific transcription of for example NPPA and MYH6.[18, 19] 
Furthermore, it supports the idea that the promoter fragments 
described in chapter 3, which with the exception of TCAP, all 
encompassed over 0.5 kb of the 5’ flanking region, indeed contain most 
of the regulatory elements required to obtain the same tissue-specific 
expression profile as the endogenous gene. 
In chapter 1 it was already indicated that co-factors, such as 
myocardin, are of great importance for distinguishing the 
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cardiomyocyte transcriptome from that of other types of cells including 
that of other types of muscle. The bioinformatics-approach used in our 
search for tissue-specific motifs, did not identify such co-factors. 
Furthermore, the employed approach failed to yield motifs like Nkx2-5 
and GATA4, even though these are known key players in regulating the 
cardiac transcriptome.[20-22] SRF however, was found as being 
overrepresented in the different muscle tissues. Both Nkx2-5 and 
GATA4 are known to be recruited to cardiac promoters as co-factors, 
acting via SRF.[23-25] Although the identification of statistically 
overrepresented motifs can provide valuable information, it appears 
that it is not possible (yet) to completely elucidate the transcriptome 
regulatory mechanisms in any type of cell by bioinformatics analysis of 
genomics data alone. 
 
Where Frank et al., identified a stretch specific program, we 
anticipated that certain genes’ transcription is activated by electric 
pulsing itself.[3] Besides the ‘tissue-specific elements’, we therefore also 
screened for regulatory motifs possibly involved in the cardiomyocytes’ 
response to electric stimuli. For this we selected, based upon our 
microarray data, genes that are specifically activated by electric pulsing. 
E-box 47 ranked at the top of the list with candidate motifs to be 
involved in the pulsing-response. Ojamaa et al., reported that this 
element plays a role in mediating the transcriptional response of MYH6 
to stretch.[26] However, the compounds employed in the latter study 
strongly affect calcium handling. This, together with the data from our 
studies presented here and findings from others, show that MYH6 is not 
stretch-responsive and that the ‘stretch-response’ proposed by Ojamaa 
et al., is in fact a transcriptional response to altered calcium signaling, as 
observed in reaction to electrical pulsing.[3, 26, 27] This renders E-box 
47 to be a pulsing responsive element as opposed to one involved in 
modulating the stretch signaling. 
Amongst the other motifs we found to be overrepresented in the 
proximal promoters of pulsing responsive genes was TCF/LEF. Through 
in vitro studies we showed that mutating the TCF7L2 binding site in the 
human CSRP3 promoter completely abolished transcriptional activity. 
Besides being a possible candidate for transmitting the pulse-response 
to the transcriptome, TCF7L2 thus appeared to play a crucial function in 
the transcriptional regulation of some genes expressed in the heart. 
 
TCF/LEF is well known as binding partner of β-catenin, a chief player 
in linking various signaling pathways to the transcriptional 
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machinery.[28] In relation to the heart, TCF/LEF has been described as 
being involved in activating NPPA in response to phenylephrine induced 
hypertrophy.[29] In our array-study, we did not find an increased 
activation of NPPA to electric stimuli. But we did observe an up-
regulation of several elements of the Wnt-signaling. Wnt signaling has 
been shown to enhance expression of cardiac genes like connexin-43 via 
β-catenin.[30] This combined with the foregoing, lead us to investigate 
whether some relation exists between the gene expression programs 
activated by electrical stimuli and that activated by Wnt signaling. In 
chapter 7 we described how we found Wnt5a and electrical stimulation 
to affect the transcription in a similar fashion. Evidence for a central role 
of calcium signaling in the pulse-response of several cardiac genes was 
obtained through experiments employing the calcium agonist BayK8644 
and the calcium antagonist verapamil. Addition of verapamil made the 
cardiomyocytes more susceptible to the electrical signals applied via the 
pacemakers. We found that promoter fragments of both CSRP3 and 
MYH6 were activated by pulsing. The promoter of each gene contains a 
TCF/LEF site, thus potentially enabling recruiting of β-catenin to the 
transcription initiating complex. As anticipated, both were also found to 
become activated by over expression of β-catenin. 
Our results further suggested a role for β-catenin dependent 
signaling in the response of these genes to Wnt5a. Interestingly, our 
analyses also revealed that Wnt5a supplementation as well as electrical 
pulsing leads to a significant increase in Fzd-2 expression, indicating a 
shared feedback mechanism.  
Addition of either Wnt5a or Wnt3a to the media leads to an instant 
two fold increase in the frequency of contraction of the cells. This speed 
at which this response arose indicates that transcription did not play an 
immediate role in this. The rapid contractions that occurred, again 
suggest that calcium handling activity was activated. Some of the effects, 
such as the increase in contractile activity had been reported 
earlier.[31] However, where the previous study suggested that 
fibroblasts were required, we show that the effects also occur in pure 
cardiomyocyte cultures. Based on our findings we concluded that at the 
transcriptional response to electric signaling is partially mediated 
through a calcium dependent activation and through activation of β-
catenin dependent pathways. Our data strongly suggest that the 
signaling mechanisms in response to electric pulses and Wnts are 
linked. Beta-catenin has been known to be of affect muscle development 
through interaction with MyoD.[32] For this activation TCF/LEF 
appeared to be not required.[32] We found however that disruption of a 
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TCF7L2 site resulted in the complete ablation of CSRP3 transcription. 
Therefore we concluded that, although β-catenin is likely to play an 
important role in the response, TCF7L2 is still required. However, a 
better understanding of their exact interplay in relation to the target 
promoters will require additional investigations. 
 
Besides utilizing gene expression data to understand cellular 
responses to various stimuli, gene expression data can also be employed 
to investigate, or even to some degree predict, the function of individual 
genes.[33] In chapter 8 we described how we employed already 
publicly available gene-expression data to predict the function of two 
genes, CHCHD10 and GBAS, which lacked any functional annotation 
short of being found to have a relation to the mitochondria.[34] Micro 
array data alone were sufficient to present us with the strong suggestion 
that the genes have a function related to oxidative phosphorylation. 
Additional ‘simple’ database searches and the presence of a specific 
protein domain brought us to suspect CHCHD10 to have a role in 
complex IV activity. In subsequent in vitro experiments we were indeed 
able to confirm that both GBAS and CHCHD10 have a function in 
oxidative phosphorylation. For CHCHD10 we were even able to show 
that the protein indeed has a role related to complex IV. These results 
demonstrated that bioinformatics analyses provide researchers with a 
fast and inexpensive way to perform an initial study, based on the 
results of which additional experiments can be designed. The number of 
targets to investigate can be greatly decreased in this way, saving costs 
as well as time. In this era of science, the most important piece of 
equipment in a lab might thus well be a computer with access to the 
internet. 
Future perspectives 
Our findings show once more the importance of in vitro model 
systems to be an as true as possible representations of the in vivo 
situation. In vivo, all muscle cells are regularly subjected to some form of 
stretch. For example smooth muscle cells in the wall of the larger 
arteries receive stretch signals as a result from the variations in blood 
pressure in the lumen. Skeletal muscles are contracting and stretching 
as a result of movement. The heart is continuously active, pumping the 
blood through the body with every beat. Stretch has a considerable 
impact on the transcriptome and eventual function of the cells.[3, 4, 35] 
It would therefore be highly desirable to incorporate some form of 
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stretch stimulation in any study involving an in vitro system based on 
muscle cell cultures.  
Also in transfection studies such as we performed, stretch could well 
affect the outcome.[36] Therefore, based on the aforementioned, a 
replication of the transfection studies, in both stretch stimulated 
skeletal and smooth muscle would be advisable. In addition it should be 
noted that, to be able to make reliable comparisons between various 
studies of gene-expression in cardiomyocytes or in any other type of 
muscle for that matter, it is necessary to include detailed statements on 
contractile status of the muscle cells or tissues employed in these 
studies. Parameters such as contractile force or shortening fraction and 
contraction frequency could be highly informative. 
Although electrical stimuli have the power to evoke contractions, a 
combined application of both electrical and mechanical stretch 
stimulation would provide the best model for studies involving 
cardiomyocytes. In our experiments we used pure cultures of 
cardiomyocytes, grown at a relatively low cell-density. This hampers the 
translation of our results to the in vivo situation. Also, interactions 
between the various types of cells that constitute the heart may affect 
the outcome. Further studies in to the role of electric signaling in the 
heart will therefore require the use of models that incorporate these 
factors. For example, 3D culture systems with multiple cell layers and 
co-cultures of cardiomyocytes and myofibroblasts or full mixed cell-
populations could prove helpful.[37] 
 
For a more comprehensive understanding of the (cardiac)muscle 
transcriptome, functional genomics data are required. A rich source of 
information on protein-DNA interactions is ChIP on chip, a technique 
through which chromatin regions can be identified that are targeted by 
a specific transcription factor.[38] Such array techniques can also be 
employed to determine binding specificity of individual transcription 
factors.[39] Binding specificity can also be investigated on a large scale 
by using massively parallel sequencing.[40] These approaches resolve 
binding specificity only on the level of individual factors, additional 
proteomics methods are still required to identify associating factors and 
co-factors. But for now no other (technological) solutions have become 
available to investigate this next level of interactions between the 
proteome and genome on a large scale. 
 
Further studies on the effects of electrical signaling on the 
cardiomyocyte transcriptome are clearly needed. Even when the 
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directly involved signaling mechanisms are not the focus of a study, 
researchers should be aware of the importance of the electrical 
component of the heart. After all we showed that it directly affects the 
expression of genes involved in many key cellular structures and 
processes: development, the contractile apparatus, intercellular 
signaling and metabolism.  
Pacemaker therapy is widely used to treat patients who suffer from 
heart-failure. Placement of a pacemaker requires surgical intervention, 
and considerable time often passes between the moment of diagnosis 
and the moment at which the device is placed. In the meantime, patients 
regularly receive treatment in the form of drugs such as diuretics, 
vasodilators, and inotropic agents, in order to reduce the workload of 
the heart.[41] However, no direct pharmacological activation of the 
pulsing-dependent pathways is undertaken at this point. We 
recommend to pursuit in to further studies on manipulating the pulsing-
dependent transcription program via pharmacological compounds. 
Drugs that activate the pathways excited by pulsing might well 
contribute to an improved outcome for the patients involved.  
 
Our study of the mitochondrial genes exemplifies the functional 
diversity of mitochondria within a single cell. As posed in chapter 8, we 
believe that highly enriched expression of both GBAS and CHCHD10 in 
striated muscle tissue, may well be related to the differences between 
the inter-filamentary and sub-sarcolemal mitochondria.[42] It will be 
interesting to find out what the underlying mechanisms are involved in 
this. The transcriptional activation of these muscle-enriched 
mitochondrial genes is likely to involve a transcription factor that more 
restricted to the striated muscle. Proteins like CSRP3 which are muscle-
specific and present functionalities in both the structure of sarcomeres 
as well as in transcriptional control could be interesting candidates to 
study within this context.[43,44] 
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A key mechanism in determining the spatial and temporal expression 
of genes is transcription, the process in which RNA intermediates are 
formed based on their DNA templates. In this dissertation we studied 
various aspects of transcription in cardiomyocytes, the highly 
specialized muscle cells that generate the contractile force of the heart. 
The heart muscle is one of the three types of muscle that are present in 
the human body. The other two are skeletal and smooth muscle. In 
chapter 2 we provided a review of how transcription regulating 
proteins (transcription factors) contribute to the cardiac-specific 
expression of genes. In addition we described how these activating and 
inhibitory factors interact with one another, and eventually form 
regulatory networks that govern the cardiomyocyte transcriptome. The 
core network regulating cardiomyocyte transcription seems to be one 
that is shared with the other muscles. Ubiquitously expressed factors 
such as SRF connect various elements in all muscle types. MEF2, which 
acts as a central player in skeletal and smooth muscle, is even so pivotal 
for transcription of various cardiac-specific genes. Besides the ‘shared 
muscle’ factors, however there are some, such as GATA4/6, NKX2-5, 
HAND2, of which the expression is strongly restricted to the 
cardiomyocytes. These factors assist in constituting tissue specificity, for 
example by lifting inhibitory mechanisms which block transcription in 
other types of cells. 
The DNA binding transcription factors target specific sequences. The 
bulk of these regulatory sequences are located in regions directly 5’-
proximal to the genes that they control. For many genes, little to nothing 
was known about these promoter regions. In chapter 3 we reported on 
how we identified promoter regions based on cross-species 
conservation and occurrence of elements known to be involved in 
regulating transcription in muscle cells. The genes included in this study 
were cysteine and glycine-rich protein 3 (CSRP3), fatty acid binding 
protein 3 (FABP3), lysyl oxidase-like 1 (LOXL1), myosin light chain 3 
(MYL3), myosin light chain 7 (MYL7), heat shock 27 kDa protein family 
member-7 (HSPB7) and titin-capping protein / telethonin (TCAP). The 
selected promoter fragments were cloned in luciferase reporter vectors. 
The resulting constructs were transfected in cardiomyocytes, skeletal 
muscle, smooth muscle cells and HELA cells to study their tissue 
specificity. Many of the selected fragments were shown to display an 
expression profile similar to that of the endogenous genes. For most of 
these genes, this study was the first to provide information about their 
human promoters. 
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In vivo, the heart is continuously contracting in response to electrical 
signals. It had been shown that electrical pulsing improve 
cardiomyocyte function in vitro, and that it directly affects the 
transcription of some heart-specific genes. To enable further studies on 
the effects of electrical pulses, we developed a culture system in which 
human pacemakers were employed to continuously provide electrical 
pulses to the cells in culture. This system is presented in chapter 4, 
together with a refined protocol for culturing neonatal rat ventricular 
cardiomyocytes (NRVCMs). 
Using micro-arrays and RT-QPCR we performed a genome wide 
study on the effect of electric pulsing on the transcriptome of NRVCMs 
in culture (chapter 5). By exposing NRVCMs to electric pulses in the 
presence and absence of the contraction inhibiting agent blebbistatin, 
we ascertained whether genes were responding to the electrical pulses 
themselves or to the contractions that were triggered by these pulses. 
Electrical pulsing appeared to activate various processes, including 
calcium handling, fatty acid metabolism and differentiation. In addition 
we observed an increased transcription of some genes in the pulsed 
cultures supplemented with blebbistatin, indicating that stretch 
negatively affected their expression. In all, we showed that electrical 
signals play a crucial role in cardiomyocyte development and function. 
Genes that are expressed in a similar spatial and temporal manner 
are prone to harbor a similar set of regulatory sequences in their 
promoters. In addition, there is often a strong conservation of these 
regulatory sequences across related species. Based on this, we described 
in chapter 6 on a bipartite bioinformatics analysis on the 5’ flanking 
promoter regions of cardiac-specific genes. In the first part, we screened 
the promoter regions for regulatory motifs and modules involved in 
obtaining cardiac-specific expression. In the second, we investigated 
which regulatory elements are involved in the transcriptional response 
to electric stimuli. Many of the motifs that arose from the search for 
cardiac-specific elements are shared with the other muscles. Only a very 
few, like muscle initiator sequence 19, appeared to be more unique to 
cardiac gene promoters. In the promoters of genes specifically activated 
by pulsing, we observed an enrichment of binding sites for various 
transcription factors including E-box 47, GATA, TBX5, MEF2, MYOG and 
TCF/LEF. By mutating selected promoter elements of MYOG/MyoD, SP1 
and LEF1 in a separate luciferase reporter constructs containing the 
CSRP3 promoter, we confirmed that all the sites were indeed of crucial 
importance for its transcriptional activity. In addition, data from our 
own studies, together with information from literature, led us to believe 
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that an E-box47 element in the MYH6 promoter is involved in the 
transcriptional response to altered calcium handling, activated by 
electrical pulsing, while it previously was described mistakenly as being 
a mediator of the stretch response. Further analysis showed that the 
LEF1 site in the CSRP3 promoter is targeted by TCF7L2.  
TCF7L2 is known to be acting in concert with β-catenin, a crucial 
player in Wnt signaling. In our array study we found that some elements 
of Wnt signaling were activated by pulsing. These two facts combined 
led us to further investigate the relation between electrical pulsing and 
Wnt signaling (chapter 7). NRVCMs were cultured with and without 
electrical pulsing in different media. The media of separate series were 
supplemented with either a calcium antagonist or agonist, Wnt3a or 
Wnt5a conditioned medium, or transiently transfected to obtain over-
expression of ß-catenin. We found that in the absence of pulsing, the 
addition of Wnt3a or Wnt5a led to an instantaneous increase in the 
frequency of contractions. Furthermore, we showed that several 
cardiac-specific genes respond to electrical pulsing in a similar fashion 
as in response to an activation of the β-catenin dependent Wnt 
signaling. Where we showed in chapter 6 that information available on 
spatial and temporal expression profiles can be used to identify the 
underlying regulatory motifs and modules, chapter 8 deals with the 
question how this information can assist in identifying the functional 
role of poorly annotated genes. Based on the hypothesis that 
functionally related genes share a similar expression profile, we set out 
to identify the functional role of two genes, Coiled-coil-helix-coiled-coil-
helix domain containing 10 (CHCHD10) and glioblastoma amplified 
sequence (GBAS). Although both had been identified previously as being 
involved in the mitochondria, their exact function remained unknown. 
Based on their expression profiles we predicted that both genes played 
a role in oxidative phosphorylation. This could be confirmed via 
experiments in which we silenced the genes. In addition we were able to 
determine that CHCHD10 plays a role in regulating complex IV activity. 
In summary, the major players required for cardiac-specific 
transcription appear to have been identified, although more study is still 
required to understand their exact interplay. We found that the cardiac 
transcriptome is greatly affected by pulsing and identified TCF and E-
box 47 as important mediators involved. Furthermore, we showed with 
the partial elucidation of GBAS and CHCHD10 function, that although 
many questions still remain in relation to the cardiac transcriptome, 
answers to other questions can already be found within available 
transcriptomics data.  
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Een belangrijk mechanisme bij het bepalen van waar en wanneer 
genen tot expressie komen is transcriptie, het proces waarbij de RNA 
tussenproducten worden gevormd op basis van hun DNA-sjablonen. In 
dit proefschrift hebben we verschillende aspecten van transcriptie 
onderzocht in cardiomyocyten, de zeer gespecialiseerde spiercellen die 
de contractiekracht van het hart genereren. De hartspier is een van de 
drie soorten spieren die aanwezig zijn in het menselijk lichaam. De 
andere twee zijn de skelet- en gladde spieren. In hoofdstuk 2 geven we 
een overzicht van hoe de eiwitten die transcriptie reguleren 
(transcriptiefactoren), bijdragen aan de hart-specifieke expressie van 
genen. Daarnaast beschrijven we hoe deze activerende en remmende 
factoren interageren met elkaar, en uiteindelijk regulerende netwerken 
vormen die het transcriptoom van de cardiomyocyt controleren. Het 
kern-netwerk dat cardiomyocyt transcriptie reguleert lijkt te worden 
gedeeld met de andere spieren. Alomtegenwoordige transcriptie 
factoren zoals SRF verbinden verschillende elementen met elkaar in alle 
spiertypes. MEF2, die fungeert als een centrale speler in skelet- en 
gladde spier, is cruciaal voor de transcriptie van verschillende hart-
specifieke genen. Naast de gedeelde spier factoren zijn er enkele, zoals 
GATA4 / 6, NKX2-5, HAND2, waarvan de expressie sterk beperkt is tot 
de hartspiercellen. Deze factoren helpen bij het vormen van de weefsel 
specificiteit, bijvoorbeeld door het opheffen van remmende 
mechanismen die de transcriptie blokkeren in andere celtypen. 
 
De DNA-bindende transcriptie factoren richten zich op specifieke 
sequenties. Het grootste deel van deze regulerende sequenties zijn 
gevestigd in een het deel van het DNA dat direct 5'-proximaal gelegen is 
van het gen die ze controleren. Voor vele genen is er weinig tot niets 
bekend over deze promoter regio's. In hoofdstuk 3 rapporteren we 
over hoe we promoter regio's geïdentificeerd hebben op basis van de 
conservering van deze elementen in verschillende diersoorten. De 
genen die in deze studie werden cysteïne en glycine-rijk eiwit 3 
(CSRP3), vetzuur-bindend eiwit 3 (FABP3), lysyl oxidase-achtige 1 
(LOXL1), myosine lichte keten 3 (MYL3), myosine lichte keten 7 (MYL7 
), heat shock 27 kDa eiwit familielid-7 (HSPB7) en titine-kap eiwit / 
telethonin (TCAP). De geselecteerde promotor fragmenten werden 
gekloond in luciferase reporter vectoren. De resulterende constructen 
werden getransfecteerd in cardiomyocyten, de skeletspieren, gladde 
spiercellen en HELA cellen om hun weefselspecificiteit te analyseren. 
Veel van de geselecteerde fragmenten vertoonden een expressie profiel 
vergelijkbaar met die van de endogene genen te geven. Voor de meeste 
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van deze genen, is deze studie de eerste die informatie verschaft over 
hun humane promotoren. 
In het lichaam trekt het hart voortdurend samen in reactie op 
elektrische signalen. Het is aangetoond dat elektrische pulsen de functie 
van cardiomyocyten verbetert in vitro, en dat zij rechtstreeks invloed op 
de transcriptie van een aantal hart-specifieke genen. Om verdere studies 
naar de effecten van elektrische pulsen, mogelijk te maken, 
ontwikkelden we een celkweek-systeem waarin pacemakers worden 
gebruikt om continu elektrische pulsen geven aan de cellen in cultuur. 
Dit systeem wordt gepresenteerd in hoofdstuk 4, samen met een 
protocol voor het kweken van ventriculaire cardiomyocyten verkregen 
uit neonatale ratten, (NRVCMs). 
Met behulp van micro-arrays en RT-QPCR hebben we een genoom-
wijde studie uitgevoerd naar de effecten van elektrische pulsen op het 
transcriptoom van NRVCMs in cultuur (hoofdstuk 5). Door NRVCMs 
bloot te stellen aan elektrische pulsen in de aanwezigheid en 
afwezigheid van de contractie-remmende stof blebbistatin, hebben we 
onderzocht of genen reageren op de elektrische pulsen zelf of aan de 
contracties die worden geactiveerd door deze pulsen. Elektrische pulsen 
blijken diverse processen te activeren, waaronder calciumhuishouding, 
vetzuurmetabolisme en differentiatie. Daarnaast zagen we een 
toegenomen transcriptie van bepaalde genen in de gepulste culturen 
waaraan blebbistatin was toegevoegd. Dit geeft aan dat de 
samentrekking van de cellen hun expressie negatief beïnvloedt. Alles 
samengenomen tonen we aan dat elektrische signalen een cruciale rol 
spelen in de ontwikkeling en het functioneren van cardiomyocyten. 
Voor genen die op dezelfde tijd en plaats tot expressie komen is het 
zeer waarschijnlijk dat zijn overeenkomstige regulerende sequenties 
hebben in hun promotoren. Daarnaast is er vaak een sterke 
conservering van deze regulerende sequenties in diersoorten met een 
vergelijkbare biologie. Op basis van hiervan presenteren wij in 
hoofdstuk 6 een tweeledige bioinformatica analyse van de 5'-
flankerende promoter regio van hart-specifieke genen. In het eerste deel 
hebben we de promotor regio's gescreend voor regulatoire motieven en 
modules die betrokken zijn bij het tot stand brengen van hart-specifieke 
expressie. In de tweede hebben we onderzocht welke elementen 
betrokken zijn bij de transcriptionele respons op elektrische prikkels. 
Veel van de motieven die naar voren kwamen in de zoektocht naar hart-
specifieke elementen worden gedeeld met de andere spieren. Slechts 
een zeer klein aantal, zoals spier-initiator sequentie 19, lijken meer 
uniek is voor de promotoren van de hart-specifieke genen. In de 
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promotoren van genen die specifiek geactiveerd worden door pulseren, 
zagen we een verrijking van bindingsplaatsen voor diverse transcriptie 
factoren, waaronder de E-box 47, GATA, TBX5, MEF2, MYOG en 
TCF/LEF. Door het muteren van geselecteerde promotor elementen van 
MYOG / MyoD, SP1 en LEF1 in aparte luciferase reporter constructen 
met de CSRP3 promotor, hebben we bevestigd dat deze elementen 
inderdaad van cruciaal belang zijn voor transcriptie. De resultaten van 
onze eigen studies, samen met de informatie uit de literatuur, 
impliceren dat een E-box47 element in de MYH6 promotor inderdaad 
betrokken is bij de transcriptionele respons op veranderde 
calciumhuishouding, geactiveerd door de elektrische pulsen, terwijl 
deze eerder ten onrechte werd omschreven als effector van de reactie 
op contractie. Verdere analyse toonde aan dat de LEF1 site in de CSRP3 
promotor een bindingsplaats is voor TCF7L2. 
 
Van TCF7L2 is bekend dat het, in samenwerking met beta-catenine, 
een cruciale speler is in Wnt-signalering. In onze array-studie vonden 
we dat sommige onderdelen van Wnt-signalering worden geactiveerd 
door pulseren. De combinatie van deze twee feiten leide ons ertoe om 
verder onderzoek te doen naar de relatie tussen elektrische pulsen en 
Wnt-signalering (hoofdstuk 7). NRVCMs werden gekweekt, met en 
zonder elektrische pulsen in verschillende kweekmedia. De media van 
aparte serie werden aangevuld met ofwel een calciumantagonist of 
agonist, Wnt3a of Wnt5a geconditioneerd medium, of transient 
getransfecteerd om over-expressie van beta-catenine te verkrijgen. We 
vonden dat in de afwezigheid van pulserende, de toevoeging van Wnt3a 
of Wnt5a leiden tot een onmiddellijke stijging van de frequentie van de 
contracties. Verder toonden we aan dat de reactie van verschillende 
hart-specifieke genen op elektrische pulsen sterke gelijkenis vertoond 
met de reactie die optreed wanneer de beta-catenine afhankelijke Wnt-
signalering wordt geactiveerd. 
 
In hoofdstuk 6 hebben we laten zien dat de beschikbare informatie 
over ruimtelijke en temporele expressie profielen gebruikt kunnen 
worden voor de identificatie van de onderliggende regulatoire motieven 
en modules. In hoofdstuk 8 demonstreren we hoe deze informatie 
gebruikt kan worden bij het identificeren van de functionele rol van 
slecht geannoteerde genen.  
Gebaseerd op de hypothese dat functioneel gerelateerde genen een 
soortgelijke expressie profiel te delen, hebben wij een studie 
ondernomen naar de functionele rol te identificeren van twee genen: 
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coiled-coil-helix-coiled-coil-helix domain containing 10 (CHCHD10) en 
glioblastoma geamplificeerde sequentie (GBAS). Hoewel beide al eerder 
waren geïdentificeerd als zijnde betrokken bij de mitochondriën, hun 
precieze functie is onbekend gebleven. Op basis van de expressie 
profielen voorspelden we dat beide genen een rol speelden in de 
oxidatieve fosforylering. We hebben dit kunnen bevestigen via 
experimenten waarin we de producten van genen, het mRNA, 
inactiveerden. Bovendien waren we in staat om dat te bepalen 
CHCHD10 een rol speelt in het reguleren van complex IV activiteit. 
 
Samengevat, de belangrijkste transcriptie factoren die nodig zijn voor 
hartspecifieke transcriptie lijken te zijn geïdentificeerd. Echter, meer 
studies zijn nog nodig om te begrijpen hoe het samenspel tussen deze 
factoren exact verloopt. We vonden dat het transcriptoom van het hart 
sterk wordt beïnvloed door elektrisch pulseren en we identificeerden 
TCF en E-box 47 als belangrijke mediatoren voor deze respons. Verder 
demonstreerden in onze studie naar de functie van GBAS en CHCHD10, 
dat bestaande publiek toegankelijke transcriptomics data gebruikt kan 
worden om nieuwe onderzoeksvragen te beantwoorden. 
  
176 
 
  
177 
 
 
 
 
DANKWOORD 
178 
Na al die pipeteer-sessies, de vele agarose-gelletjes, talrijke 
contracties van mijn eigen cardiomyocyten in vivo en die van ratten in 
vitro, en een afschrikwekkende hoeveelheid van typewerk en daaruit 
voortvloeiende computer-gerelateerde frustraties en 3 laptops later, is 
het dan eindelijk zover: het proefschrift is daar! Ja, niet mijn proefschrift 
maar hét proefschrift, immers dit epistel zou er niet zijn gekomen 
zonder enige vorm van medewerking van een aantal mensen. Deze wil 
ik hier nog ‘even’ mijn speciale dank toekennen. 
 
Als eerste Torik. Dit proefschrift is voortgekomen uit jouw geestekind: 
een onderzoeksproject voor het bestuderen van cardiovasculaire 
promotoren. Uiteindelijk is een en ander een beetje anders uitgevallen 
dan we bij de start hadden kunnen vermoeden, maar dat getuigd ook 
van de rijkdom aan ideeën die jij hebt. De verschillende 
brainstormingen leverden genoeg inspiratie op om desnoods nog een 
flink aantal proefschriften te vullen. Nu het boekje er ligt ervaar ik nog 
steeds een nasmaak van transcriptie, eentje die smaakt naar meer! 
Bedankt voor de fijne samenwerking en het delen van je kennis van de 
wetenschap, pepers (geen typefout!) en cocktails. 
 
Bert, een groot deel van mijn werkzaamheden had betrekking op andere 
zaken dan mito’s. Desondanks werd mijn verblijf in Popgen/Clinical 
Genomics toch gedoogd, en ben je ook nog eens promotor. Mede dankzij 
jouw commentaren op artikelen en aanvullingen op het onderzoeks-
budget heb ik het een en ander tot een goed einde kunnen brengen. 
Bedankt voor dit alles en zeker ook voor de hulp bij de laatste loodjes 
van het gehele promotie-traject.  
 
Joep, ik heb veel geleerd van jouw commentaren in de eerste fasen van 
mijn schrijfwerk van artikelen. En, ook al leverden de suggesties voor de 
verbeteringen van dit boekje flink wat extra type-werk op, ik heb deze 
toch zeker kunnen waarderen! Ervaring bleek maar weer eens van 
ongekende waarde te zijn.  
 
Erika en Bieke, mijn trouwe lab-maatjes. Op het lab hebben jullie het 
flink te verduren gehad. Sorry als ik jullie levensduur verkort blijk te 
hebben als ik weer eens onaangekondigd en (voor jullie) plotseling mijn 
entree maakte. Bedankt allebei voor jullie hulp bij het kweken van de 
vele celletjes, het slopen van ze, de arrays, het pipeteren van die 
afgrijselijke 384 well platen en al die andere zaken. En, Erika, oude 
pipeteer-beer, dankjewel dat je mij zo goed bekend hebt gemaakt met 
179 
het vocabulair dat regulier gebezigd wordt tussen de gebruikers van het 
lab. Er rust jouw denk ik nog een schone taak om de rest van de 
Universiteit Maastricht hierin te onderwijzen. Dit gezien de optrekkende 
wenkbrauwen van menig bezoeker. Ik ben blij dat ik het geheel kan 
afsluiten met jullie als paranimfen aan mijn zijde. 
 
Veel dank aan de mensen van Leuven. Wouter van Delm, Yves Moreau 
en Peter van Loo. Jullie hebben een groot deel van dit werk mede 
mogelijk gemaakt, super veel dank hiervoor. En ook voor jullie geduld 
en kunde om de geavanceerde bioinformatica te vertalen in een vorm 
die mensen zoals ik kunnen begrijpen. 
 
A special thanks to Gordana Vunjak Novakovic and Nina Tandon at 
Columbia University, New York City. Thank you for allowing me to 
spend some time in your lab and learn from your expertise on culturing 
cardiomyocytes. The experiences I was able to pick up in NYC were 
invaluable to completing the research presented here. 
 
Volkert Zeilemaker, ik zou niet weten hoe dit boekje er had uitgezien 
zonder de pacemakers en niet te vergeten ook jouw interesse voor ons 
onderzoek. Ik ben blij dat wij hebben kunnen delen in jouw rijkdom aan 
ervaring met deze schokkende apparaten. 
 
Wim Sluiter, jij hebt maar weer eens bewezen dat kant en klaar kitjes 
geen vervanging zijn voor echte expertise. Dankzij jouw analyses en 
onze gedachtenwisselingen via e-mail en ‘snail-mail’ is het mito verhaal 
toch wat completer geworden. 
 
Hoewel plaatjes schieten een van mijn hobbies is... zodra er nog een 
confocaal tussen zit wordt het toch wel andere koek. En filmpjes maken 
van die hyperactieve cellen is ook een kunst. Veel dank aan Jos Broers 
voor de hulp bij dit alles. 
 
Hoewel later nog wel een keer aan de beurt, hier alvast mijn 
wetenschappelijke dank aan Hilde. Dank je voor de fijne samenwerking. 
Het Wnt-verhaal wat toch een van de sluitstukken is geworden, was er 
zonder jouw bijdrage niet geweest. 
 
Dan..., mijn ‘lab-slaven’: Tom, Ronald, Cris en Lars. Slaaf in deze context 
staat (nog) niet in de Van Dale. Maar ja, een beetje V.O.C. mentaliteit op 
het lab ook niet verkeerd. Beste ‘lab-slaven’/gewaardeerde 
180 
medewerkers, jullie hebben het zwaar te verduren gehad, maar weet dat 
jullie harde werk echt gewaardeerd is en zeker ook heeft bijgedragen 
aan dit proefschrift. Ook jullie niet-wetenschappelijke bijdrages heb ik 
zeker kunnen waarderen. Iedere keer als ik een Kinder-surprise ei in 
handen krijg zal ik weer met weemoed aan jullie terugdenken. 
 
Tijd voor mijn kamer genoten. Eerst, de ‘oude’: Bianca (vrouwtje mito), 
Dr. Dr. Lars, Rudy en Nicole. Bedankt voor jullie gezelschap op de kamer. 
Jullie al dan wel of niet wijze AIO-levenslessen worden nog immer 
doorgegeven aan de nieuwe generaties van wetenschappers. 
 
Merci aan de dames die menige krachtterm en ook de vele mislukte 
lanceerpogingen van mijn laptop hebben moeten aanhoren. Florence, tja 
toch eerder!, An, toonbeeld van integratie in Holland! Rita, thanks for 
presenting me with a target for aiming my shuttle at, and introducing 
me to the tasty side of Portugal. I already started to miss it, especially 
the flamed chorizo and liquor shots in chocolate (served separately of 
course!). 
 
Mike, een gelijkgestemde in de buurt was soms wel eens fijn, voor ons 
dan. Zeker wanneer je onder hypoxische en oestrogeen-geïnfesteerde 
condities moet werken. Ik vertrouw erop dat je mijn gedachtegoed in 
leven houdt. En als je nog eens wilt oefenen in Nederlands spreken, je 
weet me te vinden! 
 
Mijn overige (voormalige) popgen/clinical genomics collega’s: Fons en 
Miroslav (daanke voor de hulp met jullie java tooltjes). Patrick, Jo, Ton 
bedankt voor de af en toe broodnodige IT support. Wanwisa, (B)Iris, 
Frank, Ellen, Marion, Sabine, Jos, Rosy, Roselie, Marij, Caroline. Merci 
voor alle bijdrages in o.a. de gezelligheid in het lab en er buiten. 
 
Ook al was het soms niet te merken, gelukkig bleek er nog een leven te 
zijn buiten het lab. Daarvoor wil ik ook hier nog even een paar mensen 
bedanken. 
 
Hilde, Bea en Erik, Ik heb veel genoten van de samenkomsten van ons 
kwartet. Biertjes, wijntjes en diners op het Vrijthof, bij iemand thuis tot 
zelfs in New York City, Daytona Beach en in het Mount Everest 
Basecamp in Tibet. Samen delen in de ervaringen in de wetenschap, 
zonsopgang bij de Atlantische oceaan, (smokey) whisky’s proeven bij 
Sue en de spaceshuttle Atlantis omhoog zien gaan. Allemaal speciale 
181 
momenten. Ik ben blij dat ik die met even zo speciale mensen heb 
mogen delen. En Erik, bedankt voor het badminton gezelschap, ik denk 
met veel plezier terug aan de vele duels die wij tegen en ook met elkaar 
hebben uitgevochten op het slagveld. Ook als we allemaal Dr. zijn 
moeten we met zijn vieren periodiek maar blijven evalueren of dat 
toevluchtsoord in de Stille Zuidzee er toch moet komen. 
Nu we toch in de feesten en partijen zijn beland. Natuurlijk is er nog ‘ de 
club’ Marion, Nuria, Esther en Mirjam, merci voor de gezelligheid, de 
geestelijke bijstand, de hulp bij het ledigen van mijn cocktail collectie in 
Meendaal 124B, de sportieve en zeker ook gezellige momenten in de 
sporthal, de films in Lumiere, de drankjes op het Vrijthof, de 
wandelingen door de bossen, de chocolademelk/koffie sesssies in de 
koffie corner, de bezoekjes aan de mergelgroeves, vuursteenmijn, etc 
etc... 
 
Hoewel Maastricht een leuke stad is en veel te bieden heeft, blijft een 
andere veilige thuishaven altijd van belang, zeker voor een ‘Hollander’ 
die niet veel van carnaval moet hebben. Bedankt dus aan mijn ouders bij 
wie ik altijd kan aankloppen op welk moment dan ook. Ook al zijn mijn 
activiteiten vaak voor jullie letterlijk een “ver het bed show”. Zonder 
jullie was ik nooit zover gekomen dus de eer van het bereiken van deze 
mijlpaal valt ook zeker jullie ten deel. Bedankt voor alles uit het 
verleden en alvast ook voor alles in de toekomst. 
Tevens een woord van dank naar de rest van het thuisfront zusjes en 
(schoon)-broer, bedankt voor jullie support van de afgelopen jaren.  
 
Klein van stuk maar van groots betekenis, zo ook mijn woorden:  
Mercikes voor alles.  
 
 
 
182 
CURRICULUM VITAE 
 
 
Sarkies Ruben Mattheus Martherus werd geboren in Eemnes op 30 
oktober 1977. Na het behalen van het diploma van het Hoger Algemeen 
Voortgezet Onderwijs in 1996 aan de Scholengemeenschap Werenfridus 
te Hoorn doorliep hij het Hogere Laboratorium Onderwijs aan de 
Hogeschool van Amsterdam, en ontving daar in 2000 zijn diploma van 
de opleiding biotechnologie. Vervolgens volgde hij aan de Universiteit 
van Wageningen het internationale Master of Science programma 
wederom met de specialisatie biotechnologie. Direct na het behalen van 
zijn Masters diploma in 2002 vertrok hij voor 15 maanden naar Wuhan 
in de Volksrepubliek China alwaar hij als onderzoeker in dienst was van 
het Laboratorim voor Moleculaire Virologie van de Chinese Academie 
van Wetenschappen. Na een jaar terug in Nederland waarin hij als 
uitzendkracht werkte begon hij in januari 2005 met zijn onderzoek aan 
de Universiteit van Maastricht. Verbonden aan de vakgroep Clinical 
Genomics verrichte hij daar onder leiding van Dr. Torik Ayoubi 
onderzoek uit naar verschillende aspecten van transcriptomics in relatie 
tot het hart. Dit onderzoek wordt gepresenteerd in dit proefschrift en 
delen hiervan zijn gepubliceerd in internationale wetenschappelijke 
literatuur. 
Sinds maart 2010 is de auteur werkzaam als Post-Doc onder leiding van 
Prof. Dr. Jeffrey Towbin bij het Heart Institute van Cincinnati Children’s 
Hospital in Cincinnati, Ohio in de Verenigde Staten van Amerika. 
 
183 
LIST OF PUBLICATIONS 
 
 
Martherus RS, Sluiter W, Timmer ED, VanHerle SJ, Smeets HJ, Ayoubi 
TA. 
Functional annotation of heart enriched mitochondrial genes GBAS and 
CHCHD10 through guilt by association.  
Biochem Biophys Res Commun. 2010 Nov 12;402(2):203-8.  
 
Martherus RS, Vanherle SJ, Timmer ED, Zeijlemaker VA, Broers JL, 
Smeets HJ, Geraedts JP, Ayoubi TA. 
Electrical signals affect the cardiomyocyte transcriptome independently 
of contraction.  
Physiol Genomics. 2010 Nov 29;42A(4):283-9. 
 
Martherus RS, Zeijlemaker VA, Ayoubi TA. 
Electrical stimulation of primary neonatal rat ventricular 
cardiomyocytes using pacemakers.  
Biotechniques. 2010 Jan;48(1):65-7. 
 
 
 
